informaŢii liliana simona gheorghe personale Ş · curs “actualităţi în patologia...

Curriculum Vitae

© Uniunea Europeană, 2002-2017 | europass.cedefop.europa.eu Pagina 1 / 65

INFORMAŢII PERSONALE

LILIANA SIMONA GHEORGHE

Centrul pentru Boli Digestive si Transplant Hepatic Institutul Clinic Fundeni Şoseaua Fundeni nr. 258 72437 Bucureşti, România

+4021 3180409(centrala); +4021 3180447(secretariat) Fax: +40213180447(secretariat); +40213180455(secretariat sectie)

[email protected]

Sexul Feminin | Data naşterii 28/07/1960 | Naţionalitatea Romana

DIPLOME, SUPRASPECIALIZARI SI COMPETENTE

ETAPE MEDICALE ŞI UNIVERSITARE

POZIŢIA CURENTA

- Profesor universitar, Departamentul Invatamant Clinic 5, Disciplina Gastroenterologie

si Hepatologie, Universitatea de Medicină şi Farmacie “Carol Davila” Bucureşti, România

- Şef de secţie, Secţia a-3a Gastroenterologie - Hepatologie Centrul pentru Boli Digestive si Transplant Hepatic Institutul Clinic Fundeni, Bucureşti, România

1985 Diploma medic no. 89/ 27 iunie 1987, Romania Registrul C, no. 89

1990 Certificat de Competenta in Endoscopie Digestiva No. 830/ 4 Decembrie 1990, Seria G, No. 2780, Romania

1992 Promovarea examenului de specialitate in gastroenterologie si confirmarea ca medic specialist gastroenterologie; ordinul MS 111/ 11 Februarie 1992;

1992 Certificat de Competenta in Ecografie Generala no. 42428/10 Decembrie 1992 1997 Promovarea examenului de primariat in gastroenterologie si confirmarea ca medic

primar gastroenterologie; ordinul MS no. 115 / 24 ianuarie 1997

2005 Certificat de competenta pentru desfasurarea de studii clinice, Basics on Good Clinical Practice for Investigators, SC Verum EDU SRL (Dr. Codruta Trandafir); Bucuresti

16 martie 2011 Certificate of attendance of GCP Training for Principal Investigators (Kathrin Laubacher, GCP Trainer and ISO certified QMS Auditor); Bucuresti


1979-1985 Studentă a Facultăţii de Medicină Generală din Craiova Scrieţi nivelul

EQF, dacă îl

cunoaşteţi 1985

Absolventă a Facultăţii de Medicină Generală din Craiova, şef de promoţie, media generală 10

nov.1985-nov.1987 4 stagii clinice de medicină internă, chirurgie generală, pediatrie şi obstetrică-ginecologie în cadrul Spitalului Clinic Universitar Bucureşti

1987-1991

Pregătire în specialitatea de gastroenterologie şi activitate de cercetare clinică în gastroenterologie, Centrul de Gastroenterologie şi Hepatologie, Institutul Clinic Fundeni

octombrie 1991 Promovarea examenului de cercetător ştiinţific în gastroenterologie noiembrie 1991

Promovarea examenului de medic specialist în gastroenterologie; încadrarea ca medic specialist la Centrul de Gastroenterologie şi Hepatologie Fundeni

ianuarie 1993 Promovarea examenului de asistent universitar la Catedra Gastroenterologie, Universitatea de Medicină şi Farmacie “Carol Davila”, Bucureşti

martie 1996 Promovarea examenului de medic primar gastroenterologie 1992-1996

Doctorand în specialitatea genetică medicală cu teza “Implicaţii genetice în cancerul colorectal”

4 iulie 1996 Obţinerea titlului de doctor în medicină, specialitatea genetică medicală 2001 Numirea ca şef de secţie Gastroenterologie-Hepatologie, Centrul de Gastroenterologie şi

Hepatologie, Institutul Clinic Fundeni – cu delegaţie

iunie 2002 Promovarea examenului de şef de lucrări la Catedra Gastroenterologie, Universitatea de Medicină şi Farmacie “Carol Davila”, Bucureşti

septembrie 2002 Promovarea examenului de şef de secţie – secţia a III-a Gastroenterologie-Hepatologie, Centrul de Gastroenterologie şi Hepatologie, Institutul Clinic Fundeni

aprilie 2003 Promovarea Examenului de Competenta in Managementul Serviciilor de Sanatate martie 2007 Promovarea examenului de conferentiar la Catedra Gastroenterologie, Universitatea de

Medicină şi Farmacie “Carol Davila”, Bucureşti

7 septembrie 2013 Transplant Medicine - Honorary Diploma (European Certification in Liver Transplantation, Transplant Medicine, Modules 1 & 4)

4 iulie 2014 Sustinerea Tezei de abilitare (Habilitation Thesis) pentru dreptul de a conduce doctorate Cercetarea clinica in hepatologie : o investitie in beneficiul pacientilor si comunitatii

26 ianuarie 2015 Promovarea examenului de profesor universitar pozitia 3 Departamentul Învățământ Clinic 5, Disciplina Gastroenterologie si Hepatologie, Universitatea de Medicină şi Farmacie “Carol Davila”, Bucureşti

Pregătire postuniversitară (CURSURI ŞI SPECIALIZĂRI)

1987-1989 Curs de Gastroenterologie - U.M.F. “Carol Davila”, Bucureşti 1988; 1991 Curs “Actualităţi în patologia tubului digestiv” - Centrul de

Gastroenterologie Fundeni

1989 Curs de Endoscopie digestivă - Centrul de Gastroenterologie Fundeni 1989

Curs “Actualităţi în patologia hepato-biliară şi pancreatică” - Centrul de Gastroenterologie Fundeni

1990 Curs teoretic şi practic de Ultrasonografie - Compartimentul de medicină nucleară şi imagistică medicală, Spitalul Clinic Fundeni

Curriculum Vitae


1991 Curs de Informatică Medicală - Centrul de Informatică Medicală din cadrul Ministerului Sănătăţii, Bucureşti

martie-aprilie 1993 “Second Advanced Postgraduate Course in Gastroenterology” - organizat de către Societatea Olandeză de Gastroenterologie, Olanda (Amsterdam, Rotterdam, Utrecht, Zwolle)

iulie 1993 Postgaduate Course - organizat de către European Association for Gastroenterology and Endoscopy (EAGE), Barcelona, Spania

decembrie 1993 “Second Postgraduate Course in Surgery and Gastroenterology” - organizat de către International Gastro-Surgical Club (IGSC), Atena, Grecia

septembrie 1994 “Progress in Hepatology” Postgraduate Course - organizat de către European Association for the Study of the Liver (EASL), Atena, Grecia

martie-aprilie 1995 “Journees Francophones d’Hepatologie et de Gastroenterologie” - curs şi stagiu clinic, Nantes- Paris, Franţa

septembrie 1995 Postgraduate Course - organizat de către European Association for Gastroenterology and Endoscopy (EAGE), Berlin, Germania

august 1996 Postgraduate Course organized by the European Association for the Study of the Liver, Geneva, Elveţia

noiembrie 1996 Postgraduate Course - organizat de către European Association for Gastroenterology and Endoscopy (EAGE), Paris, France

decembrie 1996 “4-th International Postgraduate Course” organizat de “International Gastro-Surgical Club”, Atena, Grecia

Aprilie 1997 Postgraduate Course - organizat de către European Association for the Study of the Liver (EASL), Londra, Marea Britanie

iunie 1997 “Endoscopia terapeutica: ce putem face practic in Romania?” Afectiuni inflamatorii cronice nesppecifice ale colonului, Simpozionul National de Gastroenterologie, Targu Mures

Noiembrie 1997 Postgraduate Course in Hepato-Gastroenterology organizat de Societatea Olandeză de Gastroenterologie, Arnhem-Rotterdam

Noiembrie 1997 Cursul organizat de European Postgraduate Gastro-Surgical School (EPGS): “Gastric malignancies”, Academic Medical Center, University of Amsterdam, Amsterdam, Netherland

5-6 februarie 1998 Curs organizat de European Postgraduate Gastro-Surgical School (EPSG): “Imaging and treatment of hepatic tumors”, Academic Medical Center, University of Amsterdam, Amsterdam, Netherland

aprilie 1999 Post-Graduate Course - organizat de către European Association for the Study of the Liver (EASL), Napoli, Italia

7-8 mai 1999 Primul Simpozion organizat de Secţiunea Română a International Gastro-Surgical Club (IGSC): “Cancerul de pancreas. Pancreatita cronică”

13 iunie 1999 Curs de specializare postuniversitar “Endoscopie Digestivă” şi “Urgenţe in Gastroenterologie”,Timişoara

14 noiembrie 1999 Postgraduate Course - organizat de către European Association for Gastroenterology and Endoscopy (EAGE), Rome, Italy: “New Horizons in Gastrointestinal and Liver disease” (7-th UEGW), Roma, Italia

16 noiembrie 1999 Postgraduate Course - organizat de către European Society for Gastrointestinal Endoscopy (ESGE): “Strictures of the Gastrointestinal Tract and of the Biliopancreatic Ducts”, Roma, Italia

21-22 aprilie 2000 Al doilea Simpozion si Curs Postuniversitar organizat de Secţiunea Română a International Association of Surgeons and Gastroenterologists (IASG): “Cancerul tubului digestiv superior” si “Actualitati in chirurgia hepatica”, Bucuresti, Romania

1 noiembrie 2000 Curs pre-simpozion “Endoscopia digestivă la început de mileniu” Simpozionul Naţional de Gastroenterologie şi Endoscopie Digestivă, Bucureşti


1 noiembrie 2000 Curs pre-simpozion “Gastroenterologia la început de mileniu” Simpozionul Naţional de Gastroenterologie şi Endoscopie Digestivă, Bucureşti

30 noiembrie 2000 Postgraduate Course: Therapeutic Endoscopy 8th United European Gastroenterology Week (8th UEGW) Brussels, Belgia

19 aprilie 2001 EASL Postgraduate Course: “Clinical Management of Portal Hypertension and Its Complications”, 36-th EASL Meeting, Praga, Cehia

27-28 aprilie 2001 Al III-lea Simpozion si Curs Postuniversitar al Secţiunii Române a IASG (International Association of Surgeons and Gastroenterologists) “Actualitati in chirurgia endoscopica”, Bucureşti, Romania

9-13 septembrie 2001 Mayo Clinic Gastroenterology and Hepatology Board Review, Mayo Clinic, Rochester, Minnesota

27 septembrie 2001 Curs de perfecţionare: “Icterele”; Congresul Naţional de Radiologie şi Imagistică Medicală, Timişoara

7 octombrie 2001 EASL Postgraduate Course: “Tumors in the Liver”, 9-th UEGW, Amsterdam, Olanda

7 octombrie 2001 EAGE Postgraduate Course: “Management of gastrointestinal lesions with malignant potential”, 9-th UEGW, Amsterdam, Olanda

1-4 noiembrie 2001 Al 11-lea Congres Mondial al International Association of Surgeons & Gastroenterologists (IASG), Heraklion, Creta, Grecia

15-17 noiembrie 2001 Al doilea Simpozion Naţional si Curs de Nutriţie Clinică, Poiana Braşov

24 februarie 2002 Postgraduate Course of Gastrintestinal Endoscopy, 12nd World Congress of Gastroenterology & 10th World Congress of Endoscopy, Bangkok, Thailanda

4-6 aprilie 2002 Al 4-lea Simpozion si Curs Postuniversitar al Sectiunii Romane a IASG (International Association of Surgeons and Gastroenterologists) “Actualitati in oncologia digestiva”, Bucureşti, Romania

17 aprilie 2002 Postgraduate Course, 37th Annual Meeting of the European Association for the Study of the Liver (EASL), Madrid, Spania

15-17 mai 2002 Cel XXI-lea Congres National de Chirurgie, Sinaia, Romania

13 iunie 2002 Curs Postuniversitar: “Afecţiuni colestatice hepatice” Simpozionul Naţional de Gastroenterologie, Hepatologie si Endoscopie Digestiva, Cluj-Napoca

28-29 septembrie 2002 Al XII-lea Congres National de Hepatologie, Teatrul National, Bucuresti

17-18 octombrie 2002 Primul Congres National al Asociatiei Romane pentru Chirurgie Endoscopica si alte Tehnici Interventionale (ARCE)

19 octombrie 2002 ESGE Postgraduate Course, 10th UEGW, Geneva, Elvetia

20 octombrie 2002 EASL Postgraduate Course: “Portal hypertension and its complications”, 10th UEGW, Geneva, Elvetia

30 octombrie 2002 Postgraduate Course of 12th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Istanbul, Turcia

11-13 noiembrie 2002 “Helicobacter pylori: From basic mechanisms to clinical cure”, Maui, Hawaii, USA

3-7 februarie 2003 Mayo Clinic Gastroenterology and Hepatology Biennial Course, Mayo Clinic & Mayo School of Continuing Medical Education, Grand Bahamas Island

21-22 februarie 2003 PegIntrone Investigators’ Update Meeting Londra, Marea Britanie

17-18 martie Tehnica de montare endoscopica a gastrostomei percutane Institutul Clinic Fundeni, Bucuresti

Curriculum Vitae


9-11 aprilie 2003 Al 5-lea Simpozion si Curs Postuniversitar al Sectiunii Romane a IASG “Actualitati in afectiunile ficatului”

26-30 aprilie 2003 10-th Fresenius Kabi Advanced Nutrition Course - FRANC’ 2003, Graz, Austria

17 mai 2003 AASLD Clinical Research Workshop, DDW, Orlando, Florida, USA

17-18 mai 2003 AGA Postgraduate Course, DDW, Orlando, Florida, USA

18 mai 2003 SSAT Postgraduate Course, DDW, Orlando, Florida, USA

21-22 mai 2003 ASGE Postgraduate Course, DDW, Orlando, Florida, USA

3-6 iulie 2003 EASL Postgraduate Course: “Chronic viral hepatitis – Understanding and managing resistence to treatment”, Geneva, Elvetia

24-27 septembrie Curs Postuniversitar, Al IX-lea Congres Roman de Gastroenterologie, Hepatologie si Endoscopie Digestiva, Craiova

24-26 octombrie 2003 Al IV-lea Simpozion si Curs de Nutritie Clinica cu participare internationala, Poiana Brasov

2 noiembrie 2003 EASL Postgraduate Course: “ASH, NASH and hepatoprotection”, 11st UEGW, Madrid, Spania

15-16 mai 2004 AGA Postgraduate Course: A New Era in Gastroenterology, Digestive Disease Week, New Orleans, LA, USA

19-20 mai 2004 ASGE Postgraduate Course: “Endoscopic Surgery: Endoscopy for the Next Millennium – A Problem-Based Approach”, Digestive Disease Week, New Orleans, LA, USA

1-3 septembrie 2004 „Actualitati in Gastroenterologie, Hepatologie si Endoscopie Digestiva”, Simpozionul National de Gastroenterologie, Hepatologie si Endoscopie Digestiva, Constanta

26 septembrie 2004 EASL Postgraduate Course : Liver Transplantation – State the Art and Novel Developments, Praga, Republica Ceha

11-14 noiembrie 2004 Al V-lea Simpozion si Curs de Nutritie Clinica si Metabolism ROSPEN, Poiana Brasov

11 decembrie 2004 Decision Making in Hepatology; Postgraduate Course of Asian Pacific Association for the Study of the Liver (APASL), New Delhi, India

27 aprilie 2005 2nd Postgraduate Course: Methodology of diagnosis and treatment in portal hypertension, 4th Baveno International Consensus Workshop and 2nd Postgraduate Course, Baveno, Italy

14-15 mai 2005 AGA Postgraduate Course: “Difficult Clinical Issues in Gastroenterology: Practical Advice and Its Scientific Basis”, Digestive Disease Week, Chicago, Statele Unite

18-19 mai 2005 ASGE Postgraduate Course: “Gastrointestinal Endoscopy: Evidence and Innovations”, Digestive Disease Week, Chicago, Statele Unite

9 iunie 2005 Curs Postuniversitar de Gastroenterologie, Simpozionul National de Gastroenterologie, Hepatologie si Endoscopie Digestiva, Timisoara

11 noiembrie 2005 AASLD/ILTS Course “Controverses in Liver Transplantation” AASLD Annual Meeting, San Francisco, Statele Unite

11-12 noiembrie 2005 AASLD Postgraduate course: “Acute and Chronic Liver Disease: Immunologic Mechanisms and Therapy” AASLD Annual Meeting, San Francisco, Statele Unite

5-6 decembrie 2005 Chronic Hepatitis C Exchange Program, Philadelphia, Pennsylvania, SUA

8-10 decembrie 2005 13th International IASG Postgraduate Course, Atena, Grecia


3-4 martie 2006 Impactul clinic al ecoendoscopiei diagnostice si terapeutice – Curs national cu participare internationala organizat de SRED Institutul Clinic Fundeni Bucuresti

24-25 martie 2006 Falk Symposium 151: Emerging Issues in Inflammatory Bowel Disease, Sydney, Australia

5-8 aprilie 2006 The 8th Symposium and Postgraduate Course of the Romanian Chapter of IASG: Advances in hepato-bilio-pancreatic surgery & liver transplantation, Bucharest, Romania

26-30 aprilie 2006 EASL Postgraduate Course: “Immunological phenomena in hepatitis C in and outside of the liver”, Viena, Austria

20-21 mai 2006 AGA Postgraduate Course: “Recognizing and reducing risk in GI practice”, Digestive Disease Week, Los Angeles, Statele Unite

5 octombrie 2006 “Basics on Good Clinical Practice for Investigators”, VERUM. EDU Interactive Seminar, Bucuresti, Romania

22 octombrie 2006 EASL Postgraduate Course: “Current and Future Therapeutic Options for Viral Hepatitis”, 14th UEGW, Berlin, Germania

26 octombrie 2006 “Introduction to ICD 10-AM & DRG Financing, using AR-DRG” Health Information Managers Association of Australia & Total Care Integrative Health Systems, Bucuresti, Romania

27 octombrie 2006 AASLD/ILTS Course “Liver Transplantation in the 21st Century: Clinical, Pathological and Radiologic Correlation in Liver Transplantation”, AASLD Annual Meeting, Boston, Statele Unite

27-28 octombrie 2006 AASLD Postgraduate Course: “Liver Disease: Mechanisms of Liver Injury and Emerging Therapies”, AASLD Annual Meeting, Boston, Statele Unite

7-9 decembrie 2006 14th International IASGO Postgraduate Course: “Advances in Diagnosis & Management of Abdominal Diseases”, Atena, Grecia

27-30 martie 2007 Interventional Technics in Hepatology; Postgraduate Course of Asian Pacific Association for the Study of the Liver (APASL), Kyoto, Japonia

11 aprilie 2007 EASL Postgraduate Course: “The Microscope at the Bedside”, Barcelona Spain

19-20 mai 2007 AGA Institute 2007 Spring Postgraduate Course “21st Century Tools for Managing Gastrointestinal and Liver Disease” DDW, Washington, Statele Unite

12-14 septembrie 2007 7th International Meeting on Therapy in Liver Diseases, Barcelona, Spania

27-28 octombrie 2007 15th UEGW Postgraduate Teaching Programme, Paris, Franta

2 noiembrie 2007 AASLD/ILTS Transplant Course: Therapeutic Challenges in Liver Transplantation: #1 Hepatocellular Carcinoma; #2 Alcoholic Liver Disease and Other Addictive States,, AASLD Annual Meeting, Boston, Statele Unite ale Americii

2-3 noiembrie 2007 Postgraduate Course: Pathophysiologic Basis for the Therapy of Liver Disease, AASLD Annual Meeting, Boston, Statele Unite ale Americii

13-15 decembrie 2007 15th International Postgraduate Course of IASGO: New Frontiers in Diagnosis and Management of GI Disease, Atena, Grecia

23-24 aprilie 2008 EASL Postgraduate Course: “Complications of Portal Hypertension”, Milano, Italia

17-18 mai 2008 AGA Institute 2008 Spring Postgraduate Course “Gastroenterology and Hepatology 2008: Challenges and Controversies” DDW, San Diego, Statele Unite

Curriculum Vitae


18-22 octombrie 2008 16th UEGW Postgraduate Teaching Programme, Viena, Austria

31 octombrie - 1

noiembrie 2008

Postgraduate Course: “The Changing Face of Hepatology - Integrating Scientific Concepts Into Patients Care” AASLD Annual Meeting, San Francisco, SUA

31 octombrie 2008 AASLD/ILTS Transplant Course “Liver Transplant for Viral Hepatitis and Fulminant Hepatic Failure”, AASLD Annual Meeting, San Francisco, SUA

18-19 decembrie 2008 32nd Annual New York Course NYSGE 2008 Gastrointestinal Endoscopy, New York SUA

22-23 aprilie 2009 EASL Postgraduate Course, Copenhaga, Danemarca

30 mai-1 iunie 2009 AGA Institute 2009 Spring Postgraduate Course “Applying New Evidence to Clinical Practice” DDW, Chicago, Statele Unite

8-9 iulie 2009 Postgraduate Course of the 15th Annual International Congress of International Liver Transplantation Society (ILTS)

30 octombrie 2009 AASLD/ILTS Transplant Course “Long-Term Outcome of Adult and Pediatric Liver Transplantation”, AASLD Annual Meeting, Boston, Statele Unite ale Americii

30-31 octombrie 2009 Postgraduate Course “Keeping the Patient with End-stage Cirrhosis Alive”, AASLD Annual Meeting, Boston, Statele Unite ale Americii

21-22 noiembrie 2009 17th UEGW Postgraduate Teaching Programme, Londra, Marea Britanie

26-27 martie 2010 Falk Symposium 172: The Keys to IBD 2010: treatment, Diagnosis and Pathophysiology, Miami Statele Unite

13-14 aprilie 2010 EASL Postgraduate Course, Viena, Austria

1 mai-2 mai 2010 AGA Institute 2010 Spring Postgraduate Course ”Managing Digestive Diseases in the Next Decade” DDW, New Orleans, Statele Unite

21-22 mai 2010 20th International Consensus Workshop and Postgraduate Course: “Curent consensus and future directions in the diagnosis and treatment of portal hypertension” (BAVENO V), Stresa, Italia

27-28 mai 2010 Radiofrequency Ablation of Malignant Tumors of the Liver (Curs Practic), Pisa, Italia

22 septembrie 2010 Anorectal and pelvic floor ultrasound course & Ultrasound “Hands on Lab” Workshop, Sorrento, Italia

16-17 octombrie 2010 ACG Postgraduate Course 2010, San Antonio, Statele Unite

29 octombrie 2010

AASLD/ILTS Transplant Course “Liver Transplantation - State of the Science”, AASLD Annual Meeting, Boston, Statele Unite ale Americii


29-30 octombrie 2010

Postgraduate Course “Viral hepatitis – Five Decades of Progress and Promises for the Future”, AASLD Annual Meeting, Boston, Statele Unite ale Americii

31 octombrie 2010 Hepatology Associated Course, AASLD Annual Meeting, Boston, Statele Unite ale Americii

15-18 dec 2010 Al 34-lea Curs Anual de Endoscopie Gastrointestinala: “The Basic refined, the future defined” New York Society for Gastrointestinal Endoscopy, New York

15-16 ianuarie 2011 4th Paris Hepatitis Conference, Paris, France

28-30 ianuarie 2011 ACG Western Regional Course “Smart Solutions for Difficult Problems”, Las Vegas, USA

14-16 februarie 2011 PATH Bologna Meeting, Bologna Italy

24-26 februarie 2011 6th Congress of ECCO, Dublin, Ireland

30-31 martie 2011 EASL Postgraduate Course “Cholestatic Diseases of the Liver and Bile Ducts”, Berlin, Germany

7-8 mai 2011 2011 AGA Spring Postgraduate Course ”Emerging Concepts and their Practical Applications” DDW, Chicago, Statele Unite

26-27 mai 2011 EUROEUS Workshop “EUS Meets Oncology”, Marseille, France

14-16 septembrie 2011 9th International Meeting on Therapy in Liver Diseases, Barcelona, Spania

30 septembrie-1

octombrie 2011

Falk Symposium 179: Revisiting IBD Management: Dogmas to be changed, Brussels, Belgium

7-8 octombrie 2011

Progress in Hepatitis C: Advancing Patient Care with Current and Novel Treatments, Berlin, Germany


Postgraduate Teaching Programme, 19th UEGW Stockholm, Sweden

4 noiembrie 2011 AASLD/ILTS Transplant Course: Liver Transplant Immunosuppression: “Does One Size Fit All?”; 62nd AASLD Meeting, San Francisco, USA

4-5 noiembrie 2011 Postgraduate Course of the AASLD: “Cirrhosis: Current Challanges and Future Directions”; 62nd AASLD Meeting, San Francisco, USA

1-3 decembrie 2011 2011 Advances in Inflammatory Bowel Diseases, Crohn’s and Colitis Fundation’s Clinical and Research Conference, Hollywood Florida, USA

15-17 decembrie 2011 EASL Special Conference on Liver Transplantation, Lisbon, Portugal

Curriculum Vitae


30-31 ianuarie 2012 6th Paris Hepatitis Conference: International Conference on the Management of Patients with Viral Hepatitis, Paris, France

15 februarie 2012 10th IBD Intensive Advanced Course for Gastroenterologists, 7th Congress of ECCO, Barcelona, Spania

18-19 aprilie 2012 EASL Postgraduate Course: Parasitic, “Imported” and Alcoholic Liver Disease, Barcelona, Spania

19-20 mai 2012 2012 AGA Spring Postgraduate Course “Practical Solutions for Your Everyday Clinical Management Problems”, DDW, San Diego, Statele Unite

31 august 2012 Bayer Oncology Academy, Sofia, Bulgaria

20 septembrie 2012 27th ECCO Educational Workshop: ECCO Guidelines, Sibiu 20 Septembrie 2012

27-29 septembrie 2012 ROMTRANSPLANT, Bucuresti

3-6 octombrie 2012 Falk Symposium 185, Interfaces and Controversies in Gastroenterology & Falk Symposium 186 Challenges of Liver Cirrhosis and Tumors: Prevent it, Treat it, Manage Consequences, Mainz, Germany

9 noiembrie 2012 AASLD/ILTS Transplant Course: Reaching the Summit: Challenges and Obstacles in Liver Transplantation, Boston, Statele Unite

9-10 noiembrie 2012 AASLD Postgraduate Course: Personalized Medicine and the Practice of Hepatology, Boston, Statele Unite

20-21 decembrie 2012 36th Annual New York Course – Gastrointestinal endoscopy: New Advances and Everyday Problems, New York, Statele Unite New Horizons in Hepatitis Therapy, New York, Statele Unite

16 februarie 2013 11th IBD Intensive Advanced Course for Gastroenterologists, 8th Congress of ECCO, Vienna, Austria

24-25 aprilie 2013 EASL Postgraduate Course: Transplantation and the Liver, Amsterdam, Olanda

18-19 mai 2013 2013 AGA Spring Postgraduate Course “Putting Patients First: Actionable Evidence for Clinical Practice”, DDW2013, Orlando, FL, Statele Unite

iulie 2013 Master Class Program on Pancreatic Diseases and Pancreatic Exocrine Insufficiency, Director: Prof. J. Enrique Dominguez-Munoz, University Hospital of Santiago de Compostela, Spain

2-5 octombrie 2013 Falk Symposium 190, Challenges in the Care of IBD in Patients of All Ages & Falk Symposium 191; Liver Diseases in 2013: Advances in Pathogenesis and Treatment, Londra, UK

26-28 septembrie 2013 1st Annual International Course for Pancreatic Disease, Bucuresti, Spitalul Militar de Urgenta “Carol Davila

1 noiembrie 2013 AASLD/ILTS Transplant Course: Liver Transplantation – First Quarter, Second Decade, Washington, Statele Unite

1-2 noiembrie 2013 AASLD Postgraduate Course: New Treatments in Liver Disease, Washington, Statele Unite

21-23 noiembrie 2013 1st Transylvanian Meeting for Liver Interventions & Digestive Endoscopy Workshop Cluj 2013

12-14 decembrie 2013 2013 Advances in Inflammatory Bowel Diseases, Crohn’s and Colitis Fundation’s Clinical and Research Conference, Hollywood Florida, USA


13-14 ianuarie 2014 7th Paris Hepatitis Conference: International Conference on the Management of Patients with Viral Hepatitis, Paris, France

17-18 ianuarie 2014 Leading Change in IBD 2014, Barcelona, Spain

24-25 ianuarie 2014 Central European Alliance to fight Hepatitis C – Inaugural Workshop: When to treat? How to treat? Whom to treat?, Austria Trend Hotel Park Royal Palace, Vienna

9-10 aprilie 2014 ILC/EASL Postgraduate Course “Viral Hepatitis”, Londra, Marea Britanie

3-4 mai 2014 2014 AGA Spring Postgraduate Course “Best Practices at the Bedside Critical Thinking for Common Conditions”, DDW2014, Chicago, IL, Statele Unite

23-25 octombrie 2014 Cursul National de Ghiduri si protocoale in Anestezie si terapie Intensiva si Medicina de Urgenta, Timisoara

24-25 octombrie 2014 Postgraduate Teaching Programme, 22nd UEGW, 24-27th October, Vienna Austria

7 noiembrie 2014 AASLD/ILTS Transplant Course: Catalysts for Innovation in Liver Transplantation, Boston, Statele Unite

7-8 noiembrie 2014 AASLD 2014 Postgraduate Course: Clinical Implications of Inflammation and Immunity in Acute and Chronic Liver Diseases: Advances in Diagnosis, Treatment and Clinical Practice Boston, Statele Unite

4-6 decembrie 2014 2014 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s National & Research Conference, Orlando, Florida

18-19 decembrie 2014 38th Annual New York Course of the New York Society for Gastrointestinal Endoscopy

19 februarie 2015 4th S-ECCO Master Class Course: “Novel strategies around IBD surgery”, Barcelona 10th Congress of ECCO, 18-21 February 2015

9-11 aprilie 2015 Baveno VI Consensus Workshop on Portal Hypertension, Baveno, Italy

22-26 aprilie 2015 50th International Liver Congress 2015, Viena, Austria

16-17 mai 2015 AGA Postgraduate Course: “Evidence that will change your practice: new advances for common clinical problems”, DDW 2015, Washington 16-19 May 2015,

16 mai 2015 Hepatology UpDate: The Year in Review, DDW 2015, Washington 16-19 May 2015

28-29 mai 2015 2nd UpDate on Hepatology Course Bucharest 2015: “Portal Hypertension and Its Complications after Baveno VI & Viral hepatitis Anno 2015: curing the disease”, Bucharest, Romania

29-30 mai 2015 EASL Monothematic Conference: “Liver Diseases in resource-limited Settings” Bucharest, Romania

11 iunie 2015 Curs Pre-congres Gastroenterologie, Hepatologie si Endoscopie; Al XXXV-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva, Iasi 11-13 iunie 2015

24-26 iunie 47th Annual Meeting of the European Pancreatic Club, Toledo, Spain

Curriculum Vitae


1-4 iulie 2015 Scoala Nationala de vara Paltinis, editia a XI-a: Actualitati in medicina interna si gastroenterologie, Paltinis, Romania

11-12 septembrie 2015 Bucharest PancreaticFest 2015, Bucuresti

24-26 septembrie 2015 7th Annual Meeting of Romanian Club for Crohn and Colitis, Cheile Gradistei, Romania

8-10 octombrie 2015 7th Digestive Endoscopy Course & 3rd Transylvanian Meeting of Interventional Hepatology

16-21 octombrie 2015 American College of Gastroenterology – Annual Scientific Meeting and Postgraduate Course, Honolulu, Hawaii

24-25 octombrie 2015 Postgraduate Course, 23rd UEGW, Barcelona, Spania

14 noiembrie 2015 AASLD Postgraduate Course “Managing Liver Disease – From the Clinic to the Community”, San Francisco, California

13 noiembrie 2015 AASLD/ILTS Transplant Course “Liver Transplantation – Bench and Bedside”, San Francisco, California

10-12 decembrie 2015 2015 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s National & Research Conference, Orlando, Florida

20-24 februarie 2016 APASL 25th Conference and Course: Modern Hepatology, Tokyo, Japan

16-17 martie 2016 14th IBD Intensive Advanced Course, 11th Congress of ECCO, Amsterdam,

13 aprilie 2016 EASL-ELITA-ILTS-LICAGE Postgraduate Course of Liver Transplant, The International Liver Congress (ILC), Barcelona, Spania

13-14 aprilie 2016 Postgraduate Course: Management of liver tumors

27-28 aprilie 2016 3rd UpDate on Hepatology Course Bucharest: Clinical Challenges, Unmet Needs and Emerging Therapies in Hepatology, Bucharest, Romania

21 mai 2016 AASLD Hepatology Update: The Year in Review, DDW 2016, San Diego, California

21-22 mai 2016 AGA Postgraduate Course: Cognitive and Technical skills for the Gastroenterologist, DDW 2016, San Diego, California

4-7 august 2016 Joint Conference of the International Association of pancreatology (IAP), the Japan Pancreas Society (JPS) and the Asian Oceanic Pancreatic Association (AOPA) – Consensus Conference 2016, Sendai, Japan

9-10 septembrie 2016 4th Pancreatic Disease Course and 5th EUS Workshop in Pancreatic Diseases, Bucharest Pancreatic Fest 2016

15-16 octombrie ACG Postgraduate Course: Achieving Diagnostic and Therapeutic Success in Gastroenterology, Annual Scientific Meeting of American College of Gastroenterology (ACG), Las Vegas, Nevada

24-26 noiembrie 2016 8th Digestive Endoscopy Course & 4th Transylvanian Meeting of Interventional Hepatology, Cluj-Napoca, Romania

11-12 noiembrie 2016 AASLD Postgraduate Course “Challenges in the Management of Common Liver Diseases”, Boston, Massachussets


11 noiembrie AASLD/ILTS Transplant Course “The Next 10 Years: Innovations Transforming Outcomes in Liver Transplantation” Boston, Massachussets

2001-in prezent şef secţia a III-a (Gastroenterologie-Hepatologie) Centrul de Gastroenterologie & Hepatologie Fundeni, Institutul Clinic de Boli Digestive si Transplant Hepatic Fundeni

martie 2005-in prezent Membra a Consiliului Stiintific al Agentiei Nationale de Transplant, Ministerul Sanatatii

iunie 2005-in prezent Membra a Conducerii Societatii Romane de Gastroenterologie si Hepatologie martie 2009 – 2012 Membra a Comisiei de Experti in Gastroenterologie si Hepatologie a

Ministerului Sanatatii din Romania martie 2009 – august 2010

Membra a Comisiei de Experti pentru Tratamentul Hepatitelor Virale si Tratamentul cu Agenti Biologici in Bolile Inflamatorii Intestinale a Casei Nationale de Asigurari de Sanatate (CNAS) din Romania

2009-in prezent Membra a Conducerii Clubului Roman de Crohn si Colita (RCCC) 2013-2015 President-elect a Clubului Roman de Crohn si Colita (RCCC) decembrie 2013 – in prezent

Membra a EASL Eastern European Concerted Action Group (EE – CAG)

FUNCŢII ADMINISTRATIVE ŞI DE CONDUCERE

Curriculum Vitae Gheorghe Liliana Simona


PREMII, BURSE, RECUNOSTEREA MERITULUI STIINTIFIC

5-8 iunie 1991 Premiul “Octavian Fodor” Prize al Congresului National de Gastroenterologie si Endoscopie

Digestiva, Bucuresti 29 octombrie – 1 noiembrie 1992 Premiul Poster

Simpozionul National de Gastroenterologie si Endoscopie Digestiva, Iasi martie-aprilie 1995

Bursă de participare) la “Journees Francophones d’Hepatologie et de Gastroenterologie”, Nantes-Paris, Franţa

17-21 septembrie 1995 Young Scientist Award al celei de a 4-a “Săptămâni Europene Unite de Gastroenterologie” (4th United European Gastroenterology Week), Berlin, Germania

25-29 august 1996 Travel Bursary Award, 31st Annual Meeting of European Association for the Study of the Liver (EASL), Geneva, Elvetia

9-12 aprilie 1996 Travel Bursary Award, 32nd Annual Meeting of European Association for the Study of the Liver (EASL), London, UK


Travel bursary Award, 6th UEGW, Birmingham, UK Citata in Programul Final UEGW, Birmingham 1997, pg. 238

8-12 aprilie 1999 Travel bursary, 34th Annual Meeting of European Association for the Study of the Liver (EASL), Napoli, Italia

9-10 iunie 2000, Cluj-Napoca, Romania

3rd Poster Prize "Cinnarizine - a new drug inducing cholestasis" Falk Symposium

25-27 septembrie 2003, Craiova, Romania

Premiul I, acordat de Societatea Romana de Endoscopie Digestiva (SRED) “Epidemiologia bolilor inflamatorii intestinale idiopatice in randul populatiei adulte ce se adreseaza serviciilor de gastroenterologie din Romania” Al 9-lea Congres de Gastroenterologie, Hepatologie & Endoscopie Digestiva, Craiova, Romania

1-3 septembrie 2004, Constanta, Romania

Premiul al II-lea pentru lucrarea “Eficienta ligaturii profilactice a varicelor esofagiene cu risc de sangerare la pacientii cu ciroza hepatica aflati pe lista de asteptare pentru transplantul hepatic” Simpozionul National de Gastroenterologie, Hepatologie si Endoscopie Digestiva

2006 Premiul “Victor Babes” al Academiei Romane pentru tratatul Chirurgia Ficatului editura universitara Carol Davila Bucuresti 2004 sub redactia Irinel Popescu (coautor)

17 septembrie 2008 Falk Workshop “Strategies of Cancer Prevention in Gastroenterology” Mainz Germany 1st Poster Prize pentru lucrarea “Early diagnosis of small hepatocellular carcinoma in cirrhotic patients using real-time elastography” Liana Gheorghe, Speranta Iacob, Razvan Iacob, Gabriel Becheanu, Mona Dumbrava, Cristian Gheorghe, Ioana Lupescu, Irinel Popescu

2011 Premiul „Eugen Proca”/ 2011 pentru Stiinte Medicale Pentru cartea „Transplantul Hepatic” Editura Medicala Bucuresti 2011

2012 EUROSON Madrid Liana Gheorghe, Iulia Simionov pentru lucrarea „Percuaneous radiofrequency ablation with ultrasound guidance of focal malignant liver lesions – experience of a single Romanian centre”

iunie 2012 Nominalizata pentru sustinerea Conferintei Tiberiu Sparchez: Liana Gheorghe: Hepatologia de transplant in Romania in anul 2012

Curriculum Vitae Scrieţi numele şi prenumele


2014 Premiul UEFISCDI pentru rezultatele cercetarii pentru studiul multicentric: Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Sporea I, Badea R, Popescu A, Sparchez Z, Sirli R, Danila M, Sandulescu L, Bota S, Calescu DP, Nedelcu D, Brisc C, Ciobaca L, Gheorghe L, Socaciu M, Martie A, Ioanitescu S, Tamas A, Streba CT, Iordache M, Simionov I, Jinga M, Anghel A, Cijevschi Prelipcean C, Mihai C, Stanciu SM, Stoicescu D, Dumitru E, Pietrareanu C, Bartos D, Manzat Saplacan R, Pirvulescu I, Vadan R, Smira G, Tuta L, Saftoiu A. Ultraschall Med 2014; 35 (3): 259-266

(99 in lista de lucrari) (cod PN-II-RU-PRECISI 2014-8-7366). uefiscdi.gov.ro

aprilie2015 Diploma de Excelenta si medalia comemorativa „15 Ani de Transplant Hepatic in Romania”

iunie 2015 Premiul de Excelenta al Societatii Romane de Gastroenterologie si Hepatologie, Al XXXV-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva, Iasi 11-13 iunie 2015

AFILIERE LA SOCIETATI SI PUBLICATII PROFESIONALE

1990 - in prezent 1998 - in prezent

Membra a Societatii de Gastroenterologie & Hepatologie (SRGH) Membra a Editorial Board al Romanian Journal of Gastroenterology Editor al “Education in Gastroenterology” din Romanian Journal of Gastroenterology

1990 – in prezent

Membra a Societatii Romane de Endoscopie Digestiva (SRED)

1992 – in prezent

Membra a International Association of Surgeons and Gastroenterologists (IASG)

1996 – in prezent Membra a European Association for Gastroenterology and Endoscopy (EAGE) 1996 – in prezent Membra a European Association for the Study of the Liver (EASL) 1996 – in prezent Membra a International Ascites Club 1997 – in prezent Membra a Balkan Medical Union (BMU)

Managing-Editor al Archives of the Balkan Medical Union 1999 – in prezent Membra a Fundatiei Romane pentru Chirurgia Ficatului (FRCF) 1999 – in prezent Membra a Societatii Romane de Nutritie Enterala si Parenterala (ROSPEN) 1999- in prezent Membra a American Institute of Ultrasound in Medicine (AIUM) 2000 – in prezent Membra a Editorial Board of the Annals of Fundeni Hospital

2000 – in prezent Membra a Societatii Romane de Chirurgie Endoscopica si alte Tehnici Interventionale (ARCE)

2000 – in prezent Membra a ROMTRANSPLANT 2002 – in prezent Membra a Comitetului editorial al Revistei de Educatie Medicala Continua 2003 – in prezent Membra a Societatii Romane pentru Studiul Ficatului 2004 – in prezent Membra a Societatii Americane de Gastroenterologie - American Gastroenterological

Association (AGA) 2004 – in prezent Membra a Societatii Americane pentru Studiul Ficatului - American Association for the

Study of Liver Disease (AASLD) 2005 - in prezent Membra a Consiliului Stiintific al Agentiei Nationale de Transplant 2007 – in prezent Membra al Clubului Roman de Crohn si Colita (RCCC)



ACTIVITATEA DE CERCETARE STIINTIFICA

2009 – in prezent Membra al Societatii Europene de Crohn si Colita (European Crohn’s and Colitis Organization) (ECCO)

2012 – in prezent Membra a Asociatiei pentru Patologie Pancreatica din Romania (APPR) 2014 – in prezent Co-director al Cursului Anual de Hepatologie al SRGH 2014 – in prezent Membra in Editorial Board al revistei Liver Cancer 2015 - 2017 Reviewer ILC-EASL Annual Meeting in domeniul „Hepatitis C: Therapy”

Arii de interes in cercetare

- Tratamentul afectiunilor hepatice virale si non-virale - Ciroza hepatica si complicatiile acesteia - Transplantul hepatic: selectia si listarea pacientilor pentru transplantul hepatic, alocarea grefelor, evaluarea cuplurilor

pentru living donor liver transplantation (LDLT), cresterea supravietuirii pacientilor aflati pe listele de asteptare prin prevenirea si tratamentul complicatiilor, terapia antivirala post-transplant hepatic, monitorizarea si tratamentul bolii recidivnte si complicatiilor pe termen mediu si lung post-transplant

- Cancerul hepatic primitiv: epidemiologie si preventie; progrese in diagnostic; supraveghere; progrese terapeutice; ablatia percutanata

- Bolile autoimune hepatice: diagnostic si tratament - Ultrasonografia in practica de gastroenterologie: Tehnici noi de diagnostic si terapie - Crearea unor Centre de Excelenta in Hepatologie - Managementul bolilor inflamatorii intestinale - Crearea Centrelor de Excelenta in Bolile Inflamatorii Intestinale



PROIECTE DE

CERCETARE-

DEZVOLTARE-INOVARE

OBTINUTE PRIN

COMPETITIE PE BAZA DE

CONTRACT/GRANT

TITLU (ACRONIM) Perioada Functie

1.

Proiect CNCSIS 184/2001 Aplicatii ale reologiei fluidelor in biologie si medicina

2001-2003

Cercetator

2.

Proiect VIASAN 324/2004 Rolul evidentei computerizate a pacientilor in identificarea potentialilor candidati pentru transplantul hepatic si in urmarirea dinamicii listei de asteptare (HEPASIST)

2004-2006

Director de de proiect

3.

Proiect VIASAN 322/2004 Rolul manometriei esofagiene in diagnosticul achalasiei la pacientii cu disfagie si in evaluarea eficientei tratamentului endoscopic sau chirurgical al afectiunii (ROMAC)

2004-2006

Executant

4.

Proiect VIASAN 428/2004 Evidenta computerizata prospectiva a pacientilor cu risc pentru dezvoltarea cancerului colorectal la care se impune screeningul si supravegherea (COLOCANS)

2004-2006

Executant

5.

Proiect CEEX 142/2006 Diagnosticul non-invaziv si markeri de prognostic ai hepatocarcinomului detectat in leziunile focale nodulare din ciroza hepatica (PROSONOHEP)

2006-2008

Director de de proiect

6.

Proiect CEEX 89/2006 Implicaţii diagnostice şi prognostice ale aspectului endomicroscopic al microvascularizaţiei leziunilor premaligne şi maligne ale tubului digestiv superior (DIAPROGENDO)

2006-2008

Cercetator in echipa coordonatorului (IC Fundeni)

7.

Proiect CEEX 65/2006 Potentialul terapeutic al celulelor stem hematopoetice in afectiunile hepatice (LIVER STEM) cu partener extern: Faculty of Medicine, Imperial College London Hammersmith Campus, London

2006-2008

Cercetator in

8.

Proiect CEEX 60/2006 Evaluarea fenotipica si genotipica a pacientilor cu boli inflamatorii intestinale cronice din Romania si generarea unui registru biregional computerizat de urmarire prospectiva (IBDPROSPECT)

2006-2008

Cercetator in echipa coordonatorului (UMF Carol Davila)

9.

Proiect 42170 ENDONERD (Valoare totala 1521600 RON) Valoarea endomicroscopiei confocale laser si a endoscopiei cu magnificatie, in banda ingusta (NBI), in diagnosticul bolii de reflux gastroesofagian nonerozive.

2008-2011

Cercetator

10. .

Proiect 42169 GENOWIL (Valoare totala 1963000 RONI) Valoarea diagnostica si prognostica a analizei genetice si corelatii genotip-fenotip la pacientii cu boala Wilson

2008-2011

Director

11.

Proiect 42162 BAROFAT (Valoare totala 1850000 RONI) Factori predictivi ai raspunsului serologic, imagistic, imunohistochimic si histologic hepatic la pacientii cu obezitate morbida si ficat gras nonalcoolic supusi chirurgiei bariatrice

2008-2011

Responsabil stiintificP1 (IC Fundeni)

12.

Molecular predictors of prognosis following curative treatment of hepatocellular carcinoma – the signifficance of liver stem/progenitor cells genes

2011-2016

Director



PUBLICATII SI COMUNICARI REZULTATE

PUBLICATII

I. 10 LUCRARI RELEVANTE

1. (58. din lista completa) L. Gheorghe, Iacob S, Csiki IE. Prevalence of hepatitis C in

Romania: Different from European rates. J Hepatology 2008; 49: 661-662 2. (67. din lista completa) L. Gheorghe, S. Iacob, M. Grigorescu, I. Sporea, R. Sirli, D.

Damian, C. Gheorghe, R. Iacob. Therapy in genotype-1 patients with histologically mild hepatitis C. J Gastrointest Liver Dis 2009; 18: 51-56

3. (68. din lista completa) L. Gheorghe, S. Iacob, R. Iacob, M. Dumbrava, G. Becheanu, V. Herlea, C. Gheorghe, I. Lupescu, I. Popescu. Real-time elastography – a non-invasive diagnostic method of small hepatocellular carcinoma in cirrhosis. J Gastrointest Liver Dis 2009; 18 (4): 439-447

4. (72. din lista completa) L. Gheorghe, O. Pascu, E. Ceausu, I.E. Csiki, S. Iacob, F. Caruntu, I. Simionov, R. Vadan. Access to peginterferon and ribavirin therapy for hepatitis C in Romania between 2002-2009. J Gastrointest Liver Dis 2010; 19 (2): 161-168

5. (76. din lista completa) Liana Gheorghe, Simona Baculea. Cost-Effectiveness of Peginterferon α-2a and Peginterferon α-2b Combination Regimen in Genotype-1 Naive Patients with Chronic Hepatitis C. Hepato-Gastroenterology 2010; 57: 939-944

6. (77. din lista completa) Liana Gheorghe, Irma Eva Csiki, Speranta Iacob, Cristian Gheorghe, Gabriela Smira, Loredana Regep. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: A nationwide survey 2006-2008. J Gastrointestin Liver Dis 2010; 19: 373-380

7. (81. din lista completa) Gheorghe L, Iacob S, Simionov I, Vadan R, Constantinescu I, Caruntu F, Sporea I, Grigorescu M. Weight-based dosing regimen of peginterferon α-2b for chronic hepatitis delta: a multicenter Romanian trial. J Gastrointestin Liver Dis 2011; 20 (4) : 377-382

8. (93. din lista completa) Gheorghe L, Csiki IE, Iacob S, Gheorghe C. Epidemiology of hepatitis B virus infection in general population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol 2013; 25(1): 56-64. Doi: 10.1097

9. (95. din lista completa) Gheorghe L, Iacob S, Iacob R, Smira G, Pietrareanu C, Hrehoret D, Brasoveanu V, Gheorghe C, Popescu I. Dynamics of the Romanian waiting list for liver transplantation after changing organ allocation policy. J Gastrointest Liver Dis 2013; 22: 299-303

10. (100. din lista completa) Gheorghe L, Iacob S, Simionov I, et al. A real-life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis. J Gastrointestin Liver Dis 2014; 23 (1): 45-50



II. LUCRARI ORIGINALE PUBLICATE IN EXTENSO IN REVISTE INDEXATE ISI

SAU MEDLINE 1. L. Gheorghe, I. Popescu, C. Gheorghe, G. Aposteanu, C. Popescu, Al. Oproiu. Fatal intestinal hemorrhage complicating ileal lymphoma after Cyclosporine for unresponsive celiac disease. Hepato-Gastroenterology 1997; 44: 1342-1345 2. C. Gheorghe, G. Aposteanu, C. Popescu, L. Gheorghe, A. Oproiu, I. Popescu. Long esophageal stricture in Crohn’s disease. Case report. Hepato-Gastroenterology 1998; 45: 738-741 3. C. Gheorghe, I. Sporea, G. Becheanu, L. Gheorghe. Endoscopic mucosal resection for early gastric cancer. Romanian J Gastroenterology 2002; 11: 33-38 4. M. Diculescu, C. Atanasiu, T. Arbanas, A. Croitoru, A. Mihalcea, G. Becheanu, S. Costinean, L. Gheorghe, R. Capsa. Chemoembolization in the treatment of metastatic ileocolic carcinoid. Romanian J Gastroenterology 2002; 11: 141-148

5. L. Gheorghe, I. Bancilă, C. Gheorghe, V. Herlea, C. Vasilescu, G. Aposteanu. Antro-duodenal tuberculosis causing gastric outlet obstruction – a rare presentation of a protean disease. Romanian J Gastroenterology 2002; 11: 149-152

6. C. Gheorghe, L. Gheorghe, A. Mihalcea, S. Georgescu. TIPS pentru HDS variceale severe la un pacient cu ciroză hepatică (Quiz). Romanian J Gastroenterology 2002; 11: 65-67

7. C. Preda, L. Gheorghe, C. Gheorghe, M. Diculescu, A. Mihalcea, S. Georgescu, I. Popescu. Pancreatită cronică complicată cu tromboză de venă portă, hipertensiune portală segmentară şi HDS prin ruptură de varice de fornix gastric (Quiz). Romanian J Gastroenterology 2002; 11: 159-161 8. L. Gheorghe, C. Gheorghe, A. Mihalcea, M. Grasu, S. Georgescu. Chemoembolization for hepatocellular carcinoma (Quiz). Romanian J Gastroenterology 2002; 11: 255-257 9. L. Gheorghe, A. Croitoru, A. Stoicescu, C. Gheorghe, G. Becheanu. Kruckenberg tumor secondary to colorectal carcinoma (Quiz). Romanian J Gastroenterology 2002; 11: 255-257 10. L. Gheorghe, C. Gheorghe, M. Badea, R. Vadan, I. Parvulescu, C. Toader, L. Tugui, O. Papuc, R. Ionescu, C. Preda, I. Calin, M. Diculescu. Infliximab for Crohn’s disease in clinical practice: the experience of a single center in Romania. Romanian J Gastroenterology 2003; 12: 7-13 11. C. Gheorghe, L. Gheorghe, R. Iacob, S. Iacob, I. Simionov, I. Bancilă. Argon plama coagulation for radiation proctitis. Romanian J Gastroenterology 2003; 12: 107-112 12. R. Vadan, L. Gheorghe, G. Becheanu, R. Iacob, S. Iacob, C. Gheorghe. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption. Romanian J Gastroenterology 2003; 12: 183-188

13. I. Popescu, M. Simionescu, D. Tulbure, A. Sima, C. Catana, L. Niculescu, N. Hancu, L. Gheorghe, M. Mihaila, S. Ciurea, V. Vidu. Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation. Transplantation 2003; 76: 1345-1350

14. Gheorghe L, Gheorghe C, Becheanu G. Non-alcoholic steato-hepatitis (NASH) (Quiz). Romanian J Gastroenterol 2003; 12: 65-67

15. Gheorghe L, Vadan R, Herlea V, Gheorghe C, Popescu I. Chronic recurrent hepatitis C after liver transplantations (Quiz). Romanian J Gastroenterol 2003; 12: 156-158

16. Ionescu A, Gheorghe L, Gheorghe C, Iacob S. Budd-Chiari syndrome (Quiz). Romanian J Gastroenterol 2003; 12: 247-249

17. M. Jinga, C. Gheorghe, M. Dumitrescu, L. Gheorghe, T. Nicolaie. Endoscopic ultrasound-guided fine needle aspiration biopsy in the diagnosis of pancreatic masses (Quiz). Romanian J Gastroenterology 2004; 13: 49-54 16. L. Gheorghe, S. Iacob, N. Bolog, A. Stoicescu, I. Parvulescu, I. Popescu. Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma. Case report. Romanian J Gastroenterology 2004; 13: 33-38 18. L. Gheorghe, S. Iacob, C. Gheorghe, R. Iacob, I. Simionov, R. Vadan, G. Becheanu, I. Parvulescu, C. Toader. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and cholestatic liver disease. European J Gastroenterology Hepatology 2004; 16: 585-592 19. C. Gheorghe, I. Bancila, R. Stoia, L. Gheorghe, G. Becheanu, C. Dobre, R. Brescan. Regression of gastric MALT-



lymphoma under specific therapy may be predicted by endoscopic ultrasound. Romanian J Gastroenterology 2004; 13: 129-134

20. L. GHEORGHE, I. POPESCU, S. IACOB, C. GHEORGHE, R. VADAN, A. CONSTANTINESCU, R. IACOB, G. BECHEANU, C. ANGELESCU, M. DICULESCU. WILSON’S DISEASE: A CHALLENGE OF DIAGNOSIS. THE 5-YEARS EXPERIENCE OF A TERTIARY CENTRE. ROMANIAN J GASTROENTEROLOGY 2004; 13: 179-185

21. C. Gheorghe, O. Pascu, L. Gheorghe, R. Iacob, E. Dumitru, M. Tantau, R, Vadan, A. Goldis, G. Balan, S. Iacob, D. Dobru, A. Saftoiu. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentric study. European J Gastroenterology Hepatology 2004; 16: 1153-1161

22. L. Gheorghe, S. Iacob, I. Popescu. Living donor liver transplantation and hepatitis C. Romanian J Gastroenterology 2004; 13: 317-327 23. Balan C, Balut C, Gheorghe L, Gheorghe C, Gheorghiu E, Ursu G. Experimental determination of blood permittivity and conductivity in simple shear flow. Clinical Hemorheology Microcirculation 2004; 30 (3-4): 359-364

24. Vadan R, Gheorghe L, Gheorghe C, Ghinea M, Georgescu S. Chronic pancreatitis requiring nutritional support (Quiz). Romanian J Gastroenterol 2004; 13: 64-65

25. Badea M, Gheorghe L, Becheanu G, Gheorghe C, Lupescu I, Georgescu S, Stanescu C, Popescu L. Carcinoid syndrome. Bronchic carcinoid with extensive metastasis involving the liver, lymph nodes, and bones successfully treated with lanreotid (Quiz). Romanian J Gastroenterol 2004; 13: 147-149

26. Iacob S, Gheorghe L, Becheanu G, Iacob R. Wilson disease associated with chronic hepatitis B (Quiz). Romanian J Gastroenterol 2004; 13: 254-256

27. Gheorghe C, Gheorghe L, Becheanu G, Iacob R, Iacob S. Peptic esophagitis (Quiz). Romanian J Gastroenterol 2004; 13: 349-350

28. Popescu I, Ionescu M, Tulbure D, Ciurea S, Baila S, Brasoveanu V, Hrehoret D, Sarbu-Boeti P, Pietrareanu D, Alexandrescu S, Dorobantu B, Gheorghe L, Gheorghe C, Mihaila M, Boros M, Croitoru M, Herlea V. Transplantul hepatic ortotopic de la donator cadavru la adult. Experienta Centrului de Chirurgie Generala si Transplant Hepatic Fundeni. Chirurgia 2005; 100: 13-26

29. L. Gheorghe, I. Popescu, R. Iacob, S. Iacob, C. Gheorghe. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Transplant International 2005; 18: 572-576

30. L. Gheorghe, S. Iacob, C. Gheorghe. Liver biopsy under ultrasound control for diffuse liver disease – toward a faster, safer, cost-effective and easy acceptable procedure (Letter). Romanian J Gastroenterology 2005; 14: 97-98

31. R. Vadan, L. Gheorghe. Progression of liver fibrosis in young blood donors infected with hepatitis C virus: different predictive factors? (Letter). Romanian J Gastroenterology 2005; 14: 99-100

32. L. Gheorghe, M. Grigorescu, S. Iacob, D. Damian, C. Gheorghe, R. Iacob, I. Simionov, R. Vadan, I. Parvulescu, I. Bancila. Effectiveness and tolerability of pegylated interferon α-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice. Romanian J Gastroenterology 2005; 14: 109-115

33. Liana Gheorghe, Razvan Iacob, Roxana Vadan, Speranta Iacob, Cristian Gheorghe. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Romanian J Gastroenterology 2005; 14: 231-238

34. Liana Gheorghe, Speranta Iacob, Iulia Simionov, Roxana Vadan, Cristian Gheorghe, Razvan Iacob, Iulia Parvulescu, Ileana Constantinescu. Natural history of compensated hepatitis B and D viruses cirrhosis. Romanian J Gastroenterology 2005; 14: 329-336 35. Razvan Iacob, Speranta Iacob, Liana Gheorghe, Cristian Gheorghe, Mircea Diculescu. The use of IT in the medical system has economic and research advantages – the experience of Fundeni Gastroenterology and Hepatology Center. Romanian J Gastroenterology 2005; 14: 426-429 36. Popescu I, Ionescu M, Ciurea S, Brasoveanu V, Sarbu-Boeti P, Hrehoret D, Tomulescu V, Alexandrescu S, Dorobantu B, Grigorie R, Jemna C, Gheorghe L, Anghel R, Croitoru A, Herlea V, Boros M. Tratamentul multimodal al carcinomului

Formatted: Font:(Default) Times New Roman, 11 pt,Romanian



hepatocelular. Analiza unei experiente clinice de 123 cazuri in 5 ani. Chirurgia 2005; 100; 321-331

37. Gheorghe L, Iacob S, Gheorghe C, Becheanu G. Antiviral therapy for AgHBe (-) HBV chronic hepatitis (Quiz). Romanian J Gastroenterol 2005; 13: 90-91

38. Gheorghe L, Iacob S, Gheorghe C. Profilaxia infectiei cu virus hepatitic B (Quiz). Rom J Gastroenterol 2005; 14: 308-309

39. Gheorghe L, Gheorghe C, Fleancu M, Popescu I. Rezectia hepatica pentru carcinomul hepatocelular (Quiz). Rom J Gastroenterol 2005; 14: 412-414

40. Gheorghe C, Gheorghe L, Iacob S, Iacob R, Popescu I. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation. Hepato-Gastroenterology 2006; 53: 552-557

41. Gheorghe C, Stanescu C, Gheorghe L, Bancila I, Herlea V, Becheanu G, Voinea D, Lupescu I, Anghel R, Croitoru A, Popescu I. The preoperative noninvasive EUS evaluation in patients with esophageal cancer considered for esophagectomy. J Gastrointestinal and Liver Diseases 2006; 15: 131-137

42. Gheorghe C, Gheorghe L, Becheanu G, Popescu I. Tumora stromala gastrica: diagnostic si tratament (Quiz). J Gastrointestin Liver Dis 2006; 15: 83-85

43. Gheorghe C, Bancila I, Gheorghe L, Pitrop A. Optiuni terapeutice in achalasie (Quiz). J Gastrointestin Liver Dis 2006; 15: 195-197

44. Gheorghe L, Iacob S, Gheorghe C, Lupescu I. Upper gastrointestinal bleeding caused by extrahepatic portal vein obstruction (Quiz). J Gastrointestin Liver Dis 2006; 15: 280-282

45. Angelescu C, Gheorghe C, Gheorghe L, Lupescu I, Herlea V, Ionescu M. Pancreatic neuroendocrine tumor (Quiz). J Gastrointestin Liver Dis 2006; 15: 403-405

46. Liana Gheorghe, Speranta Iacob, I. Sporea, M. Grigorescu, Roxana Sirli, Dana Damian, C. Gheorghe, R. Iacob. Efficacy, tolerability and predictive factors for early and sustained virological response in patients treated with weight-based dosing regimen of PegIFN α-2b and ribavirin in real-life healthcare setting. J Gastrointestinal and Liver Diseases 2007; 16: 23-30

47. Liana Gheorghe, Speranta Iacob, Razvan Iacob, Cristian Gheorghe, Irinel Popescu. Variation of MELD score as predictor of death on the waiting list for liver transplantation. J Gastrointestinal and Liver Diseases 2007; 16: 267-272

48. Liana Gheorghe, Cristian Gheorghe, Bogdan Cotruta, Andrei Carabela. Computer Tomographic Aspects of Gastrointestinal Stromal Tumors: Adding EUS and EUS Elastography to the diagnostic tools. J Gastrointestinal and Liver Diseases 2007; 16: 346-347 49. Speranta Iacob, Vito R Cincinnati, Philip Hilgard, Razvan A Iacob, Liana S Gheorghe, Irinel Popescu, Andreea Frilling, Massimo Malago, Guido Gerken, Cristoph Broelsch, and Susanne Beckebaum. Predictors of graft and patient survival in hepatitis C virus recipients; Model to predict HCV cirrhosis after liver transplantation. Transplantation 2007; 84: 56-63 50. Liana Gheorghe, G. Becheanu, C. Gheorghe, A. Carabela, Madalina Vasilica. An unusual cause of hepatosplenomegaly and malabsorbtion (Quiz). J Gastrointestin Liver Dis 2007; 16: 75-76

51. C. Gheorghe, B. Cotruta, V. Trifu, M. Grasu, Liana Gheorghe. Perineal abscesses and fistulas – always a mark of Crohn’s disease? (Quiz). J Gastrointestin Liver Dis 2007; 16: 307-308

52. Iulia Simionov, Liana Gheorghe, Gabriel Becheanu, Ioana Lupescu. Is any intrahepatic mass a tumor? J Gastrointestin Liver Dis 2007; 16: 453-454

53. A. Petria, I. Simionov, G. Becheanu, L. Gheorghe. A rare case of conjugated hyperbilirubinemia (Quiz). J Gastrointestinal and Liver Diseaseas 2008; 17: 199-200

54. S. Iacob, L. Gheorghe, D. Hrehoret, G. Becheanu, V. Herlea, I. Popescu. Pegylated interferon α-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases. J Gastrointestinal and Liver Diseases 2008; 17: 165-172 55. I.G. Lupescu, C. Dobromir, G. A. Popa, L. Gheorghe, S. A. Georgescu. Spiral computed tomography and magnetic resonance angiography evaluation in Budd Chiari syndrome. J Gastrointestinal and Liver Diseases 2008; 17: 223-226 56. C. Gheorghe, R. Iacob, L. Gheorghe. Projected Dynamics of Colonoscopic Screening and Surveillance for Colorectal



Cancer. Hepato-Gastroenterology 2008; 55: 1568-1572

57. Liana Gheorghe, Bogdan Cotruta, Viorel Trifu, Cristina Cotruta, Gabriel Becheanu, Cristian Gheorghe. Drug-induced Sweet’s syndrome secondary to hepatitis C antiviral therapy. International Journal of Dermatology 2008; 47: 957-959

58. Gheorghe L, Iacob S, Csiki IE. Prevalence of hepatitis C in Romania: Different from European rates. J Hepatology 2008; 49: 661-662 59. Ioana Lupescu, Razvan Capsa, Liana Gheorghe, Vlad Herlea, Serban Georgescu. Tissue specific MR contrast media role in the differential diagnosis of cirrhotic nodules. J Gastrointestinal and Liver Diseases 2008; 17: 341-346 60. I. Popescu, N. Habib, S. Dima, N. Hancu, L. Gheorghe, S. Iacob, M. Mihaila, B. Dorobantu, E. Matei, F. Botea. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-year follow-up. Clinical Transplantation 2008; 61. Liana Gheorghe, Speranta Iacob, Cristian Gheorghe. Real-time Sonoelastography – a New Application in the Field of Liver Disease. J Gastrointestinal and Liver Diseases 2008; 17:469-474 62. Iacob S, Hrehoret D, Matei E, Dorobantu B, Gangone E, Gheorghe L, Popescu I. Costs and efficacy of “on demand” low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian Program of Liver Transplantation. J Gastrointestinal and Liver Diseases 2008; 17:383-388 63. I. Popescu, N. Habib, S. Dima, N. Hancu, L. Gheorghe, S. Iacob, M. Mihaila, B. Dorobantu, E. Matei, F. Botea. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-year follow-up. Clin Transplant 2009; 23 (4): 565-570

64. S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, D. Hrehoret, I. Popescu. Exceptiile scorului MELD si un nou scor predictiv al decesului pe listele cu perioade lungi de asteptare pentru transplantul hepatic. Chirurgia 2009; 104: 267-274 65. R. Iacob, P. Sarbu-Boeti, S. Iacob, S. Dima, C. Gheorghe, L. Gheorghe, I. Popescu. Terapii cu celule stem in bolile hepatice si in afectiunile tubului digestiv. Chirurgia 2009; 104: 131-140 66. R. Vadan, L. Gheorghe, C. Gheorghe. Low prevalence and mild course of inflammatory bowel diseases in South Eastern Europe. J Gastrointest Liver Dis 2009; 18: 385 67. L. Gheorghe, S. Iacob, M. Grigorescu, I. Sporea, R. Sirli, D. Damian, C. Gheorghe, R. Iacob. Therapy in genotype-1 patients with histologically mild hepatitis C. J Gastrointest Liver Dis 2009; 18: 51-56

68. L. Gheorghe, S. Iacob, R. Iacob, M. Dumbrava, G. Becheanu, V. Herlea, C. Gheorghe, I. Lupescu, I. Popescu. Real-time elastography – a non-invasive diagnostic method of small hepatocellular carcinoma in cirrhosis. J Gastrointest Liver Dis 2009; 18 (4): 439-447

69. L. Gheorghe, A. Carabelea, R. Vadan, G. Becheanu. Contrast-enhanced ultrasound (CEUS) for the detection and assessment of treatment efficacy in focal liver lesions. J Gastrointest Liver Dis 2009; 18 (4): 473-474

70. F.A. Caruntu, A. Streinu-Cercel, L.S. Gheorghe, M. Grigorescu, I. Sporea, C. Stanciu, et al. Efficacy and safety of peginterferon alfa-2a (40KD) in HBeAg-positive chronic hepatits B patients. J Gastrointest Liver Dis 2009; 18 (4): 425-432

71. G. Smira, L. Gheorghe, S. Iacob, D. Coriu, C. Gheorghe. Budd Chiari syndrome and V617/JAK 2 mutation linked with mieloproliferative disorders. J Gastrointest Liver Dis 2010; 19 (1): 108-109

72. L. Gheorghe, O. Pascu, E. Ceausu, I.E. Csiki, S. Iacob, F. Caruntu, I. Simionov, R. Vadan. Access to peginterferon and ribavirin therapy for hepatitis C in Romania between 2002-2009. J Gastrointest Liver Dis 2010; 19 (2): 161-168

73. G. Smira, L. Gheorghe, C. Gheorghe, G. Becheanu, A. Croitoru (QUIZ HQ 57). Multicentric carcinomas of the gastrointestinal tract. J Gastrointest Liver Dis 2010; 19 (2): 204

74. Ioan Sporea, Roxana Sirli, Manuela Curescu, Liana Gheorghe, Alina Popescu, Simona Bota, Speranta Iacob. Outcome of Antiviral Treatment in Patients with Chronic Genotype 1 HCV Hepatitis. A Retrospective Study in 507 Patients. J Gastrointest Liver Dis 2010; 19 (3)



75. I. Popescu, M. Ionescu, V. Brasoveanu, D. Hrehoret, E. Matei, B. Dorobantu, R. Zamfir, S. Alexandrescu, M. Grigorie, D. Tulbure, L. Popa, M. Ungureanu, D. Tomescu, G. Droc, H. Popescu, A. Cristea, L. Gheorghe, S. Iacob, C. Gheorghe, M. Boros, I. Lupescu, L. Vlad, V. Herlea, M. Croitoru, P. Platon, A. Alloub. Transplantul hepatic – indicatii, tehnica, rezultate – analiza unei serii clinice de 200 de cazuri. Chirurgia 2010; 105: 177-186

76. Liana Gheorghe, Simona Baculea. Cost-Effectiveness of Peginterferon α-2a and Peginterferon α-2b Combination Regimen in Genotype-1 Naive Patients with Chronic Hepatitis C. Hepato-Gastroenterology 2010; 57: 939-944

77. Liana Gheorghe, Irma Eva Csiki, Speranta Iacob, Cristian Gheorghe, Gabriela Smira, Loredana Regep. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: A nationwide survey 2006-2008. J Gastrointestin Liver Dis 2010; 19: 373-380

78. Roxana Vadan, Liliana Simona Gheorghe, Alexandra Constantinescu, Cristian Gheorghe. The prevalence of malnutrition and the evolution of nutritional status in patients with moderate to severe forms of Crohn’s disease treated with Infliximab. Clinical Nutrition 2011; 30: 86-91

79. Pascu O, Gheorghe L, Voiculescu M, Ceausu E, Mateescu B. How severe is chronic hepatitis with HCV genotype 1b? A study of 1220 cases on the waiting list for antiviral therapy in Romania. J Gastrointestin Liver Dis 2011; 20 (1): 51-55

80. Pascu O, Voiculescu M, Gheorghe L, Micu L, Seicean A, Iliescu L, Mocan T, Ceausu E, Mateescu B. Early virological response in 1220 patients with HCV (genotype Ib) chronic hepatitis and cirrhosis treated with Peginterferon plus Ribavirin. Rom J Intern Med 2011; 49 (2): 105-112

81. Gheorghe L, Iacob S, Simionov I, Vadan R, Constantinescu I, Caruntu F, Sporea I, Grigorescu M. Weight-based dosing regimen of peginterferon α-2b for chronic hepatitis delta: a multicenter Romanian trial. J Gastrointestin Liver Dis 2011; 20 (4) : 377-382

82. Gheorghe C, Cotruta B, Iacob R, Becheanu G, Dumbrava M, Gheorghe L. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis. J Gastrointestin Liver Dis 2011; 20 94): 432-436

83. Gologan S, Iacob R, Preda C, Vadan R, Cotruta B, Catuneanu AM, Iacob S, Constantinescu I, Gheorghe L, Iobagiu S, Gheorghe C, Diculescu M. Higher titer of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn’s disease. J Gastrointestin Liver Dis 2012; 21 (1): 39-44

84. Gheorghe L, Vadan R, Cerban R, Gheorghe C. Clostridium difficile infection in gastroenterology settings: more frequent or better diagnosed ? J Gastrointestin Liver Dis 2012; 21 (1): 110-111

85. Lepori MB, Zappu A, Incollu S, Dessi V, Mameli E, Demelia L, Nurchi AM, Gheorghe L, Maggiore G, Sciveres M, Leuzzi V, Indolfi G, Bonafe L, Casali C, Angeli P, Barone P, Cao A, Loudianos G. Mutation analysis of the ATP7B gene in a new group of Wilson’s disease patients: contribution to diagnosis. Mol Cell Probes 2012; 26 (4): 147-150

86. Iacob R, Iacob S, Nastase A, Vagu C, Ene AM, Constantinescu A, Anghel D, Banica C, Paslaru L, Coriu D, Dima S, Gheorghe C, Ionica E, Gheorghe L. The His1069Gln mutation in the ATP7B gene in Romanian patients with Wilson’s disease referred to a tertiary gastroenterology center. J Gastrointestin Liver Dis 2012; 21 (2): 181-185

87. Cerban R, Gheorghe L, Becheanu G, Serban V, Gheorghe C. Primary focal T-cell lymphoma of the liver: a case report and review of the literature. J Gastrointestin Liver Dis 2012; 21 (2): 213-216

88. Rugina M, Predescu L, Salagean M, Gheorghe L, Gheorghe C, Tulbure D, Popescu I. Bubenek-Turconi S. Pre-liver transplantation cardiac assessment. Chirurgia 2012; 107: 283-290

89. Croitoru A, Gramaticu I, Dinu I, Gheorghe L, Alexandrescu S, Buica F, Luca I, Becheanu G, Herlea V, Simionov I, Hrehoret D, Lupescu I, Popescu I, Diculescu M. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma – a retrospective study. J Gastrointestin Liver Dis 2012; 21(3): 277-284 90. Sporea I, Popescu A, Gheorghe L, Cijevschi-Prelipcean C, Sparchez Z, Voiosu R. „Quo vadis” liver biopsy? A multicentre Romanian study regarding the number of liver biopsies performed for chronic viral hepatitis. J Gastrointestin Liver Dis 2012; 21(3): 326 91. Gheorghe C, Borca A, Gheorghe L. The role of EUS for accurate preoperative differential diagnosis between GIST and pancreatic rest. J Gastrointestin Liver Dis 2012; 21(4): 442-443 92. Pirvulescu I, Gheorghe L, Csiki IE, Becheanu G, Dumbrava M, Fica S, Martin S, Sarbu A, Gheorghe C, Diculescu M,



Copaescu C. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Chirurgia 2012; 107(6): 772-779 93. Gheorghe L, Csiki IE, Iacob S, Gheorghe C. Epidemiology of hepatitis B virus infection in general population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol 2013; 25(1): 56-64. Doi: 10.1097 94. Gheorghe C, Pascu O, Iacob R, Vadan R, Iacob S, Goldis A, Tantau M, Dumitru E, Dobru D, Miutescu E, Saftoiu A, Fraticiu A & Gheorghe L. Nutritional risk screening and prevalence of malnutrition on admission to gastroenterology departments: a multicentric study. Chirurgia 2013; 108: 535-541 95. Gheorghe L, Iacob S, Iacob R, Smira G, Pietrareanu C, Hrehoret D, Brasoveanu V, Gheorghe C, Popescu I. Dynamics of the Romanian waiting list for liver transplantation after changing organ allocation policy. J Gastrointest Liver Dis 2013; 22: 299-303 96. Iacob R, Iacob S, Gheorghe L, Gheorghe C, Hrehoret D, Brasoveanu V, Croitoru A, Herlea V, Popescu I. Outcome of liver transplantation for hepatocellular carcinoma – a single center experience. Chirurgia 2013; 108: 446-450 97. Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rossario M, Sankoh S, Xu J, Stephens K, Parikh A; Gemini 2 Study Group (Gheorghe L). Vedolizumab as induction and maintenance therapy for Crohn’s disease. N Engl J Med 2013; 369: 711-721 98. Smira G, Matei E, Gheorghe L, Popescu I. The MELD score exception for polycystic liver disease. Chirurgia 2013; 108: 418-421

99. Sporea I, Badea R, Popescu A, Sparchez Z, Sirli R, Danila M, Sandulescu L, Bota S, Calescu DP, Nedelcu D, Brisc C, Ciobaca L, Gheorghe L, Socaciu M, Martie A, Ioanitescu S, Tamas A, Streba CT, Iordache M, Simionov I, Jinga M, Anghel A, Cijevschi Prelipcean C, Mihai C, Stanciu SM, Stoicescu D, Dumitru E, Pietrareanu C, Bartos D, Manzat Saplacan R, Pirvulescu I, Vadan R, Smira G, Tuta L, Saftoiu A. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall Med 2014; 35 (3): 259-266

100. Gheorghe L, Iacob S, Simionov I, et al. A real-life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis. J Gastrointestin Liver Dis 2014; 23 (1): 45-50

101. Tugui L, Dumitru M, Iacob S, Gheorghe L, Preda C, Dinu I, Becheanu G, Dumbrava M, Nicolae I, Andrei A, Lupu A, Diculescu M. The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensated liver cirrhosis. Rev Med Chir Soc Med Nat Iasi 2014; 118 (2): 368-375

102. Lucian Negreanu, Simona Bataga, Cristina Cijevschi-Prelipcean, Daniela Dobru, Mircea Diculescu, Eugen Dumitru, Dan Ionut Gheonea, Liana Gheorghe, Cristian Gheorghe, Adrian Goldis, Bogdan Mateescu, Marcel Tantau, Anca Trifan. Excellence Centers in Inflammatory Bowel Disease in Romania: a Measure of the Quality of Care. J Gastrointestin Liver Dis 2014; 23 (3): 333-337

103. Lupu A, Diculescu M, Diaconescu R, Tantau M, Tantau A, Visovan I, Gheorghe C, Lupei C, Gheorghe L, Cerban R, Vadan R, Goldis A. prevalence of anemia and iron defficiency in Romanian patients with inflammatory bowel disease: A prospective multicenter study. J Gastrointestin Liver Dis 2015; 24: 15-20

104. Gheorghe C, Seicean A, Saftoiu A, Tantau M, Dumitru E, Jinga M, Negreanu L, Mateescu B, Gheorghe L, Ciocirlan M, Cijevschi C, Constantinescu G, Dima S, Diculescu M. Romanian Guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency. J Gastrointestin Liver Dis 2015; 24: 117-123

105. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Trifan A, Grigorescu M, et al. Hepatitis delta virus infection in Romania: Prevalence and risk factors. J Gastrointestin Liver Dis 2015; 24: 413-422 106. Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, Gheorghe L, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries. J Viral Hepat 2015; 22 (Dec) (Suppl 4): 4-20. doi: 10.1111/jvh.12475 107. Sibley A, Han KH, Abourached A, … Gheorghe L, et al. The present and future disease burden of hepatitis C virus infections with today’s treatment paradigm. J Viral Hepat 2015; 22 (Dec) (Suppl 4):21-41. doi: 10.1111/jvh.12476 108. Alfaleh FZ, Nugrahini N, Matičič M, ….Gheorghe L, et al. Strategies to manage hepatitis C virus infection disease burden. J Viral Hepat 2015; 22 (Dec) (Suppl 4):42-65. doi: 10.1111/jvh.12474 109. Zaharie R, Tantau A, Zaharie F, Tantau M, Gheorghe L, Gheorghe C, et al, on behalf of the IBDPROSPECT Study Group. Diagnostic delay in Romanian patients with inflammatory bowel disease: Risk factors and impact on the disease course and need for surgery. JCC 2016; 10 (3): 306-314. doi: 10.1093/ecco-jcc/jjv215 110. Dimitriu A, Iacob R, Nicula S, Cojocaru M, Gheorghe C, Diculescu M, Gheorghe L. Causes of hospitalization and



characteristics of UC in a population-based cohort in Romania (2014-2015): Are there any differences in comparison with the Hungarian population? J Gastrointestin Liver Dis 2016; 25 (1): 121-122. Doi:10.15403/jgld.2014.1121.251.hun. 111. Preda CM, Fulger LE, Gheorghe C, Gheorghe L, Manuc M, Negreanu L, Meianu C, Slavulete BI, Diculescu MM. Tuberculin skin test and Quantiferon TB Gold Test in Romanian BCG vaccinated, immunosuppressed patients with moderate-to-severe Crohn’s disease: A comparison with a Hungarian cohort. J Gastrointestin Liver Dis 2016; 25(2): 260-261: doi:10.15403/jgld.2014.1121.252.tbg. 112. Iacob S, Ester C, Lita M, Gheorghe L. Real-life perception and practice patterns of NAFLD/NASH in Romania: Results of a survey completed by 100 board-certified gastroenterologists. J Gastrointestin Liver Dis 2016; 25(2): 183-189. Doi: 10.15403/jgld.2014.1121.252.naf. 113. Gheorghe C, Dimitriu A, Gheorghe L. Assessing mucosal healing in IBD in daily practice. J Gastrointestin Liver Dis. 2017 Mar;26(1):95-96. doi: 10.15403/jgld.2014.1121.261.ibd. 114. European Union HCV Collaborators (Gheorghe L). Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol. 2017 May;2(5):325-336. doi: 10.1016/S2468-1253(17)30045-6. Epub 2017 Mar 15. 115. Sporea I, Lupușoru R, Mare R, Popescu A, Gheorghe L, Iacob S, Șirli R. Dynamics of liver stiffness values by means of transient elastography in patients with HCV liver cirrhosis undergoing interferon free treatment. J Gastrointestin Liver Dis. 2017 Jun;26(2):145-150. doi: 10.15403/jgld.2014.1121.262.dyn. 116. Gheorghe L, Sporea I, Iacob S, Şirli R, Trifan A, Dobru D, Diculescu M, Stanciu C, Pascu O, Acalovschi M, Brisc C, Cijevschi C, Gheorghe C, Spârchez Z, Rogoveanu I, Dumitrascu D. Position paper on treatment of hepatitis C in Romania, 2017. Part one. J Gastrointestin Liver Dis. 2017 Jun;26(2):171-181. doi: 10.15403/jgld.2014.1121.262.rom.

117. Popescu I, Ionescu M, Braşoveanu V, Hrehoreţ D, Copca N, Lupaşcu C, Botea F, Dorobanţu B, Alexandrescu S, Grigorie M, Matei E, Zamfir R, Lungu V, Tomescu D, Droc G, Ungureanu D, Fota R, Manga G, Popescu M, Popa L, Gheorghe L, Iacob S, Pietrăreanu C, Mihailă M, Mic L, Constantinescu S, Gheorghe C, Cotruta B, Lupescu I, Grasu M, Boroş M, Dumitru R, Toma M, Paslaru L, Vlad L, Constantinescu I, Dima I, Herlea V, Becheanu G, Pecheanu C, Sasalovici D. The Romanian National Program for Liver Transplantation - 852 Procedures in 815 Patients over 17 Years (2000-2017): A Continuous Evolution to Success. Chirurgia (Bucur). 2017 May-Jun;112(3):229-243. doi: 10.21614/chirurgia.112.3.229.

118. Botea F, Ionescu M, Braşoveanu V, Hrehoreţ D, Alexandrescu S, Grigorie M, Stanciulea O, Nicolaescu D, Tomescu D, Droc G, Ungureanu D, Fota R, Croitoru A, Gheorghe L, Gheorghe C, Lupescu I, Grasu M, Boroş M, Dumitru R, Toma M, Herlea V, Popescu I. Liver Resections in a High-Volume Center: Form Standard Procedures to Extreme Surgery and Ultrasound-guided Resections. Chirurgia (Bucur). 2017 May-Jun;112(3):259-277. doi: 10.21614/chirurgia.112.3.259.

119. Grigorie R, Alexandrescu S, Smira G, Ionescu M, Hrehoreţ D, Braşoveanu V, Dima S, Ciurea S, Boeţi P, Dudus I, Picu N, Zamfir R, David L, Botea F, Gheorghe L, Tomescu D, Lupescu I, Boroş M, Grasu M, Dumitru R, Toma M, Croitoru A, Herlea V, Pechianu C, Năstase A, Popescu I. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center. Chirurgia (Bucur). 2017 May-Jun;112(3):289-300. doi: 10.21614/chirurgia.112.3.289

120. Preda CM, Popescu CP, Baicus C, Voiosu TA, Manuc M, Pop CS, Gheorghe L, Sporea I, Trifan A, Tantau M, Tantau A, Ceausu E, Proca D, Constantinescu I, Ruta SM, Diculescu MM, Oproiu A. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis. Liver Int. 2017 Aug 17. doi: 10.1111/liv.13550. [Epub ahead of print]

121. Gheorghe L, Iacob S, Curescu M, Brisc C, Cijevschi C, Caruntu F, Stanciu C, Simionov I, Sporea I, Gheorghe C, Iacob R, Arama V, Sirli R, Trifan A. Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis. J Gastrointestin Liver Dis. 2017 Sep; 26(3):275-281. doi: 10.15403/jgld.2014.1121.263.iac.



122. Gheorghe L, Sporea I, Iacob S, Sirli R, Trifan A, Diculescu M, Stanciu C, Pascu O, Acalovschi M, Brisc C, Cijevschi C, Gheorghe C, Spârchez Z, Rogoveanu I, Dobru D, Dumitrascu DL. Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two. J Gastrointestin Liver Dis. 2017 Sep; 26(3):309-317. doi: 10.15403/jgld.2014.1121.263.rom.

123. Marshall AD, Cunningham EB, Nielsen S, Aghemo A, Alho H, Backmund M, Bruggmann P, Dalgard O, Seguin-Devaux C, Flisiak R, Foster GR, Gheorghe L, Goldberg D, Goulis I, Hickman M, Hoffmann P, Jancorienė L, Jarcuska P, Kåberg M, Kostrikis LG, Makara M, Maimets M, Marinho RT, Matičič M, Norris S, Ólafsson S, Øvrehus A, Pawlotsky JM, Pocock J, Robaeys G, Roncero C, Simonova M, Sperl J, Tait M, Tolmane I, Tomaselli S, van der Valk M, Vince A, Dore GJ, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU). Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe. Lancet Gastroenterol Hepatol. 2017 Oct 3. pii: S2468-1253(17)30284-4. doi: 10.1016/S2468-1253(17)30284-4. [Epub ahead of print] 124. Manuc M, Preda C, Popescu CP, Baicuș C, Voiosu T, Pop CS, Gheorghe L, Sporea I, Trifan A, Tanțău M, Tanțău A, Ceaușu E, Proca D, Constantinescu I, Ruta SM, Fulger LE, Diculescu M, Oproiu A. New epidemiologic data regarding hepatitis C virus infection in Romania. J Gastrointestin Liver Dis. 2017 Dec; 26(4): 381-386

III. LUCRARI ORIGINALE PUBLICATE IN REZUMAT IN REVISTE INDEXATE ISI SAU MEDLINE

1. C. Gheorghe, T. Marinescu, G. Aposteanu, L. Combei, Al. Oproiu. Culture of peritoneal biopsy specimens –

Improvement of the method in the diagnosis of bacillary peritonitis. Endoscopy 1994; 26: 446 2. L. Gheorghe, C. Gheorghe, G. Aposteanu, C. Popescu, Al. Oproiu, M.Ionescu, I. Banacu. Establishment of a county

Polyposis Register in Romania. Endoscopy 1994; 26: 454 3. C. Gheorghe, G. Aposteanu, L. Gheorghe, Gh. Jovin. The value of ultrasound guided aspiration cytology and bioptic

histology in the diagnosis of primary malignant liver neoplasms. J Hepatology 1994; 21 (Suppl 1): S 158 4. L. Gheorghe, G. Aposteanu, Al. Oproiu, C. Gheorghe. Correlation between hepatic ultrasound and histology in diffuse

fatty liver. J Hepatology 1994; 21 (Suppl 1): S 158 5. C. Gheorghe, G. Aposteanu, L. Gheorghe, Al. Oproiu. Diagnosis of primary malignant liver tumours by ultrasound-

guided aspiration cytology and bioptic histology. HPB Surg 1995; 8 (Suppl): 98 6. C. Gheorghe, L. Gheorghe, G. Aposteanu, Al. Oproiu. Portal hypertensive gastropathy and overt bleeding: a prospective

study. J Hepatology 1996; 25 (Suppl 1): 171 7. L. Gheorghe, C. Gheorghe, G. Aposteanu, G. Jovin, Al. Oproiu. Natural history of hepatocellular carcinoma

associated with cirrhosis: ultrasound and survival analysis. J Hepatology 1996; 25 (Suppl 1): 196 8. C. Gheorghe, L. Gheorghe, G. Aposteanu, Al. Oproiu. Correlation between endoscopic findings and histology in portal

hypertensive gastropathy. Endoscopy 1996; 28: S24 9. L. Gheorghe, C. Gheorghe, G. Aposteanu, Al. Oproiu. Screening for hereditary non-polyposis colorectal cancer within a

County Register in Romania. Gut 1996; 39 (Suppl 3): A132 10. C. Gheorghe, G. Aposteanu, L. Gheorghe, C. Vlaiciu, Al. Oproiu. Percutaneous liver biopsy in outpatients. J Hepatology

1997; 26 (Suppl 1): 280 11. L. Gheorghe, C. Gheorghe, Al. Oproiu. Ultrasound criteria predicting the evolution from mild to severe portal-

hypertensive gastropathy in cirrhosis. Gut 1997; 41 (Suppl 3): A234 12. C. Gheorghe, G. Aposteanu, L. Gheorghe, C. Vlaiciu, Al. Oproiu. Percutaneous liver biopsy in outpatients. J Hepatology

1997; 26 (Suppl 1): 280 13. L. Gheorghe, C. Gheorghe, Al. Oproiu. Correlation between ultrasound criteria for portal hypertension and portal-

hypertensive gastropathy in hepatic cirrhosis. J Hepatology 1997; 26 (Suppl 1): 98 14. L. Gheorghe, C. Gheorghe, Al. Oproiu. Ultrasound criteria predicting the evolution from mild to severe portal-

hypertensive gastropathy in cirrhosis. Gut 1997; 41 (Suppl 3): A234 15. C. Gheorghe, G. Aposteanu, L. Gheorghe, Al. Oproiu. Gastric polyps: Frequency, histologic types, and their relationship

to gastritis. Endoscopy 1997; 29: E59

Formatted: Font:(Default) Times New Roman, 11 pt,Romanian, Check spelling and grammar, Not All capsFormatted: Font:(Default) Times New Roman, Bold,Romanian


Formatted: Font:(Default) Times New Roman, 11 ptFormatted: Font:(Default) Times New Roman, 11 pt



16. C. Gheorghe, L. Gheorghe, S. Grigoruţă, A. Oproiu. Endoscopic and ultrasound criteria predicting less development of portal-hypertensive gastropathy in hepatic cirrhosis. J Hepatology 1998; 28 (Suppl 1): 164

17. L. Gheorghe, C. Gheorghe, A. Ioniţă, A. Oproiu. The prevalence of ultrasound-ddetected abdominal lymphadenopathies in chronic viral hepatitis. Is there a relationship with the effectiveness of α-interferon therapy? J Hepatology 1998; 28 (Suppl 1): 206

18. C. Gheorghe, C. Bălan, L. Gheorghe, Al. Oproiu. Proposal of a new mechanism for esophageal perforation in the course of esophageal dilation. Digestion 1998; 59 (Suppl 3): 635 (FoLM 4332)

19. L. Gheorghe, C. Gheorghe, G. Aposteanu, C. Popescu, C. Popescu, Al. Oproiu. Ulcerative colitis in Southern Romania – incidence and epidemiological features 1990-1997. Digestion 1998; 59 (Suppl 3): 158 (FoLM 1383)

20. C. Gheorghe, L. Gheorghe, R. Vadan, I. Simionov, Al. Oproiu. Prevalence, endoscopic and ultrasound criteria predicting the development of portal-hypertensive colopathy in hepatic cirrhosis. J Hepatology 1999; 30 (Suppl 1): 86

21. L. Gheorghe, A. Ionita, C. Gheorghe, G. Aposteanu, C. Pietrareanu, L. Tugui, Al. Oproiu. Ultrasound-detected abdominal lymphadenopathy and response rate to IFN in chronic hepatitis C. J Hepatology 1999; 30: (Suppl 1): 230

22. L. Gheorghe, C. Gheorghe, G. Aposteanu, G. Becheanu, C. Toader-Dragulin, L. Tugui, Al. Oproiu. The risk of complications and mortality in classic versus atypical celiac disease. Gut 1999; 45 (Suppl V): A 290

23. C. Gheorghe, L. Gheorghe, G. Aposteanu, G. Becheanu, V. Herlea, I. Simionov, R. Vadan, Al. Oproiu. Reproducibility of Goseki grading of gastric cancer assessed at endoscopy and surgery. Endoscopy 1999; 31 (Suppl 1): E 101

24. C. Gheorghe, L. Gheorghe, R. Vădan, I. Simionov, I. Iova, G. Aposteanu. Portal- hypertensive colopathy: prevalence and predictive factors. J Hepatology 2001; 34 (Suppl 1): 56 (226)

25. C. Gheorghe, L. Gheorghe, R. Vadan, D. Hrehoret, I. Popescu. Prophylactic banding ligation of high risk esophageal varices in patients on the waiting list for liver transplantation: An interim report. J Hepatology 2002; 36 (Suppl 1): 38 (114)

26. I. Simionov, L. Gheorghe, C. Gheorghe, R. Vadan. Compliance of cirrhotic patients with spontaneous bacterial peritonitis to prophylactic antibiotic therapy: influence on the recurrence. J Hepatology 2002; 36 (Suppl 1): 55 (177)

27. R. Vadan, C. Croitoru, L. Gheorghe, A. Frujinoiu, C. Mihăilă, C. Constantin, I. Iova, I. Băncilă. Liver steatosis in chronic hepatitis C: a factor of severity ? J Hepatology 2002; 36 (Suppl 1): 249 (897)

28. L. Gheorghe, C. Gheorghe, R. Vadan, C. Croitoru, C. Mihaila, I. Bancila, I. Iova. Effect of high-calorie, high-protein diet in cirrhotic patients with hepatic encephalopathy. J Hepatology 2002; 36 (Suppl 1): 171 (605)

29. C. Gheorghe, L. Gheorghe, G. Becheanu, A. Frujinoiu, C. Mihaila. Diminutive colonic adenomas and the risk for colorectal cancer. Gut 2002; 51 (Suppl 3): A261

30. R. Vadan, C. Gheorghe, I. Iova, C. Mihaila, A. Frujinoiu, C. Croitoru, L. Gheorghe. Predictive factors of rebleeding in patients with endoscopic variceal ligation. Gut 2002; 51 (Suppl 3): A184

31. I. Parvulescu, L. Gheorghe, C. Gheorghe. Frequency of extraintestinal complications in Crohn’s disease and their relationship with the Vienna classification. Romanian J Gastroenterology 2002; 11 (Suppl 1): 53

32. I. Parvulescu, L. Gheorghe, I. Simionov, I. Stanel, C. Gheorghe. Efficacy of famotidin therapy for endoscopic-negative gastroesophageal reflux disease. Romanian J Gastroenterology 2002; 11 (Suppl 1): 54-55

33. L. Gheorghe, C. Toader-Dragulin, C. Gheorghe, C. Abramescu, C. Pietrareanu, M. Badea. Hepato-renal syndrome – new therapeutic strategy using terlipressine and human albumin. Romanian J Gastroenterology 2002; 11 (Suppl 1): 64

34. L. Tugui, L. Gheorghe, A. Croitoru, A. Frujinoiu, C. Mihaila, M. Diculescu. Hereditary colorectal cancer – an epidemiological study. Romanian J Gastroenterology 2002; 11 (Suppl 1): 69

35. R. Vadan, G. Becheanu, L. Gheorghe, C. Croitoru, A. Frujinoiu, C. Mihăilă, I. Iova, I. Băncilă, C. Gheorghe. Liver steatosis in chronic hepatitis C: a factor of severity ? Romanian J Gastroenterology 2002; 11 (Suppl 1): 64-65

36. R. Vadan, C. Gheorghe, G. Becheanu, M. Badea, I. Bancila, I. Parvulescu, L. Gheorghe. Indeterminate colitis treated with infliximab – a short series. Romanian J Gastroenterology 2002; 11 (Suppl 1): 91

37. C. Gheorghe, C. Toader-Dragulin, L. Gheorghe, I. Parvulescu, M. Badea, M. Ionescu, D. Pietrareanu, I. Popescu. Surgical treatment for Crohn’s disease: frequency, indications, relapse after surgery. Romanian J Gastroenterology 2002; 11 (Suppl 1): 94

38. C. Angelescu, I. Stanel, I. Pintoiu, N. Zamfirescu, L. Gheorghe, C. Gheorghe, M. Ionescu, I. Popescu. Pouchitis in patients with proctocolectomy, ileal pouch, and ileo-ano-anastomosis for inflammatory bowel disease versus non-inflammatory bowel disease. Romanian J Gastroenterology 2002; 11 (Suppl 1): 95

39. C. Gheorghe, A. Frujinoiu, C. Mihaila, C. Croitoru, L. Gheorghe. Relationship between endoscopical/histological features of left side colonic polyps and the presence of syncronous colonic neoplasms. Romanian J Gastroenterology 2002; 11 (Suppl 1): 96




40. L. Gheorghe, I. Simionov, R. Vadan, I. Iova, N. Sablici, I. Constantinescu, C. Gheorghe. Combined treatment with PegIntron and Rebetol in patients with chronic hepatitis C. Romanian J Gastroenterolagy 2002; 11 (Suppl 1): 115-116

41. C. Toader-Dragulin, R. Stoia, V. Mirea, R. Vadan, M. Badea, L. Gheorghe, I. Popescu. Wilson disease with acute fulminant failure, hemolysis and intravascular diseminated coagulopathy successfully treated by orthotopic liver transplantation. Romanian J Gastroenterology 2002; 11 (Suppl 1): 129

42. I. Stanel, A. Croitoru, L. Gheorghe, D. Stanescu, C. Angelescu, C. Chirion, I. Simionov, C. Tudor, H. Marinescu, D. Oprea, A. Delecase. Predictive value of alpha-foetoprotein in hepatocellular carcinoma complicated with vascular invasion. Romanian J Gastroenterology 2002; 11 (Suppl 1): 134

43. C. Toader-Dragulin, L. Gheorghe, C. Pietrareanu, S. Georgescu, V. Herlea, I. Popescu. Inflammatory pseudotumor of the liver - a rare lesion. Romanian J Gastroenterology 2002; 11 (Suppl 1): 136-137

44. I. Stanel, D. Stanescu, L. Gheorghe, C. Angelescu, M. Ionescu, C. Vasilescu, V.Popescu, M. Gogoasa, C. Stroescu, V. Brasoveanu, I. Popescu. Medical versus surgical treatment in uncomplicated hydatic cysts of the liver. Romanian J Gastroenterology 2002; 11 (Suppl 1): 141-142

45. C. Gheorghe, L. Gheorghe, G. Becheanu, A. Frujinoiu, C. Mihaila. Diminutive colonic adenomas and the risk for colorectal cancer. Gut 2002; 51 (Suppl 3): A261

46. R. Vadan, C. Gheorghe, I. Iova, C. Mihaila, A. Frujinoiu, C. Croitoru, L. Gheorghe. Predictive factors of rebleeding in patients with endoscopic variceal ligation. Gut 2002; 51 (Suppl 3): A184

47. L. Gheorghe, C. Gheorghe, R. Vadan, C. Toader, I. Simionov. Efficacy of simultaneously administration of terlipressine and human albumin versus terlipressine and plasma expanders for the reversion of type I hepato-renal syndrome in patients on the waiting list for liver transplantation. Gut 2002; 51 (Suppl 3): A68

48. L. Gheorghe, C. Gheorghe, R. Vadan, I. Parvulescu. Overlap of autoimmune hepatitis and primary cholestatic liver disease: frequency and predictive factors Gut 2002; 51 (Suppl III): A38

49. L. Gheorghe, C. Gheorghe, M. Badea, R. Vadan, I. Parvulescu, C. Toader, L. Tugui, I. Popescu. Infliximab for refractory and fistulizing Crohn’s disease: saving patients from surgical treatment. Hepato-Gastroenterology 2002; 49 (Suppl 2): CXII-CXIII (P033)

50. C. Gheorghe, G. Becheanu, I. Parvulescu, L. Gheorghe. Minimal histopathological changes in non-erosive gastroesophageal reflux disease. Hepato-Gastroenterology 2002; 49 (Suppl 2): CCXXVI (P306)

51. I. Parvulescu, C. Gheorghe, G. Becheanu, L. Gheorghe. Efficacy of the treatment with Famotidine in non-erosive gastroesophageal reflux disease. Hepato-Gastroenterology 2002; 49 (Suppl 2): CCXXVI-CCXXXVII (P307)

52. I. Simionov, L. Gheorghe, G. Becheanu, I. Constantinescu. The role of HBV coinfection on severity of liver disease and the response to treatment compared with HCV infection only. J Hepatology 2003; 38 (Suppl 2): 174

53. L. Gheorghe, S. Iacob, R. Iacob, M. Diculescu, C. Gheorghe, I. Constantinescu, A. Ionescu, M. Ciocarlan. Profilul reactiilor adverse si tolerabilitatea Peginterferonului alfa-2a in combinatie cu ribavirina comparativ cu interferonul alfa-2a standard si ribavirina la pacientii cu hepatita cronica C. Romanian J Gastroenterology 2003; 12 (Suppl 1): 15

54. R. Iacob, C. Gheorghe, M. Diculescu, M. Manuc, D. Pitigoi, L. Gheorghe, G. Becheanu, E. Craciun, C. Mihaila, R. Brescan, D. Bucur, S. Iacob. Frecventa infectiei HP detectata prin testul rapid la ureaza la pacientii cu ulcer gastric. Romanian J Gastroenterology 2003; 12 (Suppl 1): 44-45

55. A. Ionescu, L. Gheorghe, C. Gheorghe, M. Badea. Boala Crohn cu localizare pancolonica, enterala si duodenala, complicata cu colangita sclerozanta primitiva si asociata cu hepatita cronica VHC. Romanian J Gastroenterology 2003; 12 (Suppl 1): 54-55

56. C. Preda, M. Diculescu, L. Gheorghe, A. Andrei, S. Vermeire, P. Rutgeerts, M. Sedai, A. Oproiu. Semnificatia ASCA in diagnosticul bolilor inflamatorii intestinale. Romanian J Gastroenterology 2003; 12 (Suppl 1): 56-57

57. C. Gheorghe, O. Pascu, R. Iacob, L. Gheorghe, S. Iacob, et al. Studiu epidemiologic al bolilor inflamatorii intestinale idiopatice in cadrul populatiei adulte ce apeleaza la serviciile de asistenta medicala de gastroenterologie in Romania. Romanian J Gastroenterology 2003; 12 (Suppl 1): 57-59

58. F. Patrascu, A. Croitoru, R. Jarcau, L. Gheorghe, R. Iacob, V. Herlea, D. Hrehoret, I. Popescu. Cancerul colorectal la tineri – caracteristicile tratamentului si stadializarii. Romanian J Gastroenterology 2003; 12 (Suppl 1): 74-75

59. C. Gheorghe, I. Bancila, R. Iacob, N. Zamfirescu, L. Gheorghe, S. Iacob, R. Brescan, C. Popescu, C. Zaharia. Complicatiile dilatarii endoscopice cu balon in achalasie: studiu prospectiv pe 100 de pacienti. Romanian J Gastroenterology 2003; 12 (Suppl 1): 83

60. R. Iacob, C. Gheorghe, M. Diculescu, S. Iacob, L. Gheorghe. Beneficiile si dezavantajele ligaturii varicelor esofagiene in comparatie cu scleroterapie endoscopica – Metanaliza incluzand 11 studii randomizate. Romanian J Gastroenterology 2003; 12 (Suppl 1): 84-85




Formatted: Font:(Default) Times New Roman, 11 pt,RomanianFormatted: Font:(Default) Times New Roman, 11 pt,RomanianFormatted: Font:(Default) Times New Roman, 11 pt,Romanian



61. D. Bucur, A. Croitoru, I. Stanel, L. Gheorghe, A. Mihalcea, S. Georgescu, I. Popescu, M. Ionescu, C. Gheorghe. Particularitatile carcinomului hepatocelular la varstnici. Romanian J Gastroenterology 2003; 12 (Suppl 1): 89

62. L. Gheorghe, R. Vadan, V. Herlea, C. Gheorghe, D. Hrehoret, S. Iacob, I. Popescu. Hepatita cronica recurenta VHC post-transplant hepatic. Romanian J Gastroenterology 2003; 12 (Suppl 1): 93

63. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe, A. Stoicescu, I. Popescu. Factori predictivi ai decesului pe lista de asteptare pentru transplantul hepatic. Romanian J Gastroenterology 2003; 12 (Suppl 1): 94

64. C. Gheorghe, R. Vadan, R. Iacob, S. Iacob, L. Gheorghe, M. Diculescu. Eficienta tratamentului combinat cu propranolol si ligatura endoscopica la pacientii cu ciroza hepatica si hemoragie variceala. Romanian J Gastroenterology 2003; 12 (Suppl 1): 94-95

65. S. Iacob, R. Iacob, L. Gheorghe, C. Gheorghe, A. Stoicescu, I. Popescu. Este scorul MELD cea mai buna alegere pentru listele cu perioade lungi de asteptare pentru transplantul hepatic ? Romanian J Gastroenterology 2003; 12 (Suppl 1): 95-96

66. I. Parvulescu, S. Iacob, R. Iacob, L. Gheorghe. Valoarea predictiva a scorurilor MELD, Child-Pugh si Maddrey pentru mortalitatea pe termen scurt in hepatita acuta alcoolica supraimpusa cirozei etanolice. Romanian J Gastroenterology 2003; 12 (Suppl 1): 99-100

67. I. Simionov, L. Gheorghe, S. Iacob, R. Iacob, I. Bancila, C. Gheorghe. Istoria naturala a cirozei hepatice compensate – studiu retrospectiv pe o durata de 10 ani. Romanian J Gastroenterology 2003; 12 (Suppl 1): 106

68. A. Ionescu, L. Gheorghe, C. Gheorghe, C. Toader-Dragulin, M. Badea, I. Parvulescu. Budd-Chiari syndrome. Sindrom Budd-Chiari. Sindrom antifosfolipidic, Decompresie portala prin TIPS. Romanian J Gastroenterology 2003; 12 (Suppl 1): 114

69. A. Ionescu, L. Gheorghe, C. Gheorghe, M. Badea. Sindromul Budd-Chiari – prevalenta, spectru etiologic si modalitati terapeutice. Romanian J Gastroenterology 2003; 12 (Suppl 1): 120

70. I. Simionov, L. Gheorghe, A. Constantinescu, S. Iacob. Prevalenta si semnificatia steatozei hepatice la pacientii cu teste hepatice normale. Romanian J Gastroenterology 2003; 12 (Suppl 1): 135

71. S. Iacob, R. Iacob, L. Gheorghe, M. Diculescu, C. Gheorghe, G. Becheanu, M. Dumbrava, I. Constantinescu, A. Ionescu. Poate fi histologia un factor predictiv al efectelor secundare in cazul hepatitei cronice C tratate cu Peginterferon alfa-2a ? Romanian J Gastroenterology 2003; 12 (Suppl 1): 146

72. S. Iacob, R. Iacob, M. Diculescu, L. Gheorghe, I. Simionov, R. Vadan, I. Stanel. Frecventa infectiei VHB drept cauza a hepatopatiilor cronice – utilitatea unui test rapid de diagnostic. Romanian J Gastroenterology 2003; 12 (Suppl 1): 147

73. I. Simionov, L. Gheorghe, G. Becheanu, I. Constantinescu. Rolul coinfectiei HBV – HCV versus infectia cronica VHC asupra severitatii si raspunsului terapeutic. Romanian J Gastroenterology 2003; 12 (Suppl 1): 147

74. I. Stanel, L. Gheorghe, A. Mihalcea, D. Stanescu, S. Georgescu, M. Ionescu, C. Vasilescu, I. Popescu, C. Gheorghe, A. Oproiu. Influenta etiologiei asupra complicatiilor severe in pancreatita cronica remitenta. Romanian J Gastroenterology 2003; 12 (Suppl 1): 159

75. L. Tugui, L. Gheorghe, C. Gheorghe, G. Becheanu, R. Iacob, M. Diculescu. Modificarea tabloului clinic in enteropatia glutenica – studiu retrospectiv 1993-2001. Romanian J Gastroenterology 2003; 12 (Suppl 1): 179

76. R. Vadan, A. Constantinescu, L. Gheorghe, C. Angelescu, M. Badea, C. Gheorghe. Modalitati clinice de prezentare si rolul testelor diagnostice in boala Wilson. Romanian J Gastroenterology 2003; 12 (Suppl 1): 179-180

77. R. Vadan, M. Badea, L. Gheorghe, S. Iacob, A. Moise, C. Gheorghe. Prevalenta malnutritiei intr-o clinica de gastroenterologie – studiu transversal. Romanian J Gastroenterology 2003; 12 (Suppl 1): 180-181

78. A. Croitoru, F. Patrascu, R. Jarcau, L. Gheorghe, M. Diculescu, I. Simionov, et al. Caracteristicile clinico-patologice si tratamentul sarcoamelor abdominale. Rom J Gastroenterol 2003; 12 (Suppl 1): 185

79. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe, A. Stoicescu, I. Popescu. Predictors of death on the waiting list for liver transplantation in Romania. Gut 2003; 52 (Suppl 6): A160 (TUE-G-213)

80. C. Gheorghe, R. Iacob, L. Gheorghe, S. Iacob, I. Simionov, I. Bancila. Argon-plasma coagulation in the treatment of radiation proctitis – what power setting to choose? Gut 2003; 52 (Suppl 6): A188 (WED-G-050)

81. R. Vadan, L. Gheorghe, G. Becheanu, R. Iacob, M. Dumbrava, C. Gheorghe. The influence of moderate alcohol intake on the severity of chronic hepatitis C. Gut 2003; 52 (Suppl 6): A104 (MON-G-226)

82. R. Iacob, S. Iacob, L. Gheorghe, M. Diculescu, C. Gheorghe, I. Constantinescu, A. Ionescu, M. Ciocarlan. The side effect profile and tolerability of Peginterferon alpha 2a in combination with RBV compared with conventional interferon alpha 2a and RBV in patients with chronic hepatitis C. Gut 2003; 52 (Suppl 6): A104 (MON-G-227)

83. S. Iacob, R. Iacob, M. Diculescu, L. Gheorghe, I. Simionov, R. Vadan, I. Stanel. A rapid diagnostic test for HBV infection: efficacy and advantages. Hepato-Gastroenterology 2003; 50 (Suppl I): CLII (P75)







84. I. Parvulescu, S. Iacob, R. Iacob, L. Gheorghe. MELD, Child-Pugh and Maddrey scores in assessing the prognosis of patients with alcoholic hepatitis superimposed on alcoholic cirrhosis. Hepato-Gastroenterology 2003; 50 (Suppl I): CXXVI (P127)

85. S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, A. Stoicescu, I. Popescu. An alternative model to predict survival for patients on the waiting list for liver transplantation useful in the case of long waiting period. Hepato-Gastroenterology 2003; 50 (Suppl I): CXXIX (P7136)

86. C. Gheorghe, R. Iacob, I. Bancila, N. Zamfirescu, L. Gheorghe, S. Iacob, R. Brescan, C. Popescu, C. Zaharia. Efficacy and complications of endoscopic dilation in achalasia. Hepato-Gastroenterology 2003; 50 (Suppl I): CXXXIV (P41)

87. R. Iacob, C. Gheorghe, M. Diculescu, S. Iacob, L. Gheorghe. Pros and cons of band ligation versus sclerotherapy in the treatment of variceal bleeding. Hepato-Gastroenterology 2003; 50 (Suppl I): CXXXV (P43)

88. I. Simionov, L. Gheorghe, A. Constantinescu, R. Iacob. Prevalence and significance of steatosis in subjects with normal hepatic function tests. J Hepatol 2004; 40 (Suppl 1): 176 (601)

89. R. Vadan, L. Gheorghe, M. Badea, S. Iacob, C. Gheorghe. The prevalence and risk factors for malnutrition in patients with cirrhosis. Clinical Nutrition 2004; 23: 872 (04-A-622-ESPEN)

90. L. Gheorghe, S. Iacob, C. Gheorghe, R. Vadan, R. Iacob, A. Constantinescu, C. Angelescu, I. Popescu. Diagnosis of Wilson’s disease: still a challenge. Gut 2004; 53 (Suppl VI): A 91

91. R. Iacob, G. Becheanu, M. Dumbrava, S. Iacob, L. Gheorghe, C. Gheorghe. Concordance between three histologic scoring systems used for the evaluation of chronic hepatitis C. Gut 2004; 53 (Suppl VI): A 173

92. L. Tugui, L. Gheorghe, C. Gheorghe, G. Becheanu, R. Vadan, I. Simionov, A. Dumitru, R. Iacob, M. Diculescu. Hepatic involvement in celiac disease: prevalence, etiopathogenesis, and risk factors. Gut 2004; 53 (Suppl VI): A 199

93. C. Gheorghe, R. Iacob, I. Bancila, G. Becheanu, L. Gheorghe, S. Iacob. Small colorectal advanced adenomas: what incidence and associated risk factors ? Gut 2004; 53 (Suppl VI): A 268

94. M. Ciocarlan, M.E. Ciocarlan, L.S. Gheorghe, C. Angelescu, I. Simionov, C. Preda, A. Croitoru, M. Diculescu. How can we predict associated portal vein thrombosis when hepatocellular carcinoma is diagnosed in liver cirrhosis ? Gut 2004; 53 (Suppl VI): A 254

95. C. Gheorghe, R. Iacob, L. Gheorghe, S. Iacob, R. Vadan, M. Diculescu, A. Goldis, E. Dumitru, D. Dobru, E. Miutescu, A. Saftoiu, A. Fraticiu, O. Pascu. Prevalence of malnutrition and risk factors in patients with liver diseases referred to tertiary gastroenterology assistance: a multicentric study. J Gastroenterol Hepatol 2004; 19 (Suppl): A799

96. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe. Natural history of compensated hepatitis B and D virus - related cirrhosis. J Gastroenterol Hepatol 2004; 19 (Suppl): A806

97. S. Iacob, L. Gheorghe, A. Istrate, R. Crintea, R. Iacob, C. Gheorghe. Predictive factors of non-neoplastic portal vein thrombosis in cirrhotic patients. J Hepatology 2005; 42 (Suppl 2): 81

98. S. Iacob, L. Gheorghe, C. Gheorghe, R. Iacob. Istoria naturala a cirozei hepatice secundare coinfectiei VHB – VHD versus ciroza hepatica VHB. Romanian J Gastroenterology 2005; 14 (Suppl 1): 32-33

99. L. Gheorghe, S. Iacob, C. Gheorghe, R. Iacob, I. Simionov, I. Parvulescu, R. Vadan. Steatoza hepatica in infectiile virale B si C: metabolica sau virala? Romanian J Gastroenterology 2005; 14 (Suppl 1): 39-40

100. R. Vadan, C. Gheorghe, I. Parvulescu, M. Badea, L. Gheorghe. Rolul imunonutritiei enterale preoperatorii la pacientii cu gastrectomie pentru neoplasm gastric. Romanian J Gastroenterology 2005; 14 (Suppl 1): 52-53

101. C. Gheorghe, R. Iacob, S. Iacob, L. Gheorghe, A. Goldis, D. Dobru, E. Dumitru, D. Tulbure, I. Popescu. Studiu comparativ prospectiv multicentric de evaluare a eficientei administrarii Pantoprazolului in bolus intravenos versus perfuzie continua in ulcerul hemoragic. Romanian J Gastroenterology 2005; 14 (Suppl 1): 53-54

102. L. Tugui, C. Angelescu, L. Gheorghe, C. Gheorghe, G. Becheanu, V. Herlea, R. Iacob, M. Diculescu. Ampulomul vaterian – pondere in cadrul sindromului de icter obstructiv si modalitati de debut. Romanian J Gastroenterology 2005; 14 (Suppl 1): 84

103. C. Gheorghe, S. Iacob, L. Gheorghe, R. Iacob. Ciroza ca factor de risc pentru polipii colorectali. Studiu prospectiv la pacientii inclusi pe lista de asteptare pentru transplant hepatic. Romanian J Gastroenterology 2005; 14 (Suppl 1): 112

104. C. Gheorghe, S. Iacob, L. Gheorghe, R. Iacob. Ciroza ca factor de risc pentru polipii colorectali. Studiu prospectiv la pacientii inclusi pe lista de asteptare pentru transplant hepatic. Romanian J Gastroenterology 2005; 14 (Suppl 1): 112

105. R. Vadan, C. Angelescu, S. Iacob, G. Becheanu, L. Gheorghe, I. Calin, C. Gheorghe. Boala Wilson – o cauza rara de steatoza hepatica. Romanian J Gastroenterology 2005; 14 (Suppl 1): 151

106. I. Simionov, R. Iacob, S. Iacob, L. Gheorghe, C. Gheorghe. Factori predictivi ai raspunsului terapeutic la pacientii cu hepatita autoimuna. Romanian J Gastroenterology 2005; 14 (Suppl 1): 169

107. I. Simionov, L. Gheorghe. Caracteristici clinico-evolutive ale hepatitei autoimune la varstnici. Romanian J Gastroenterology 2005; 14 (Suppl 1): 170



108. I. Simionov, L. Gheorghe. Particularitati clinico-evolutive si asocieri morbide ale sindromului de overlap colangita sclerozanta primitiva – hepatita autoimuna. Romanian J Gastroenterology 2005; 14 (Suppl 1): 171

109. S. Iacob, R. Iacob, L. Gheorghe, C. Gheorghe, M. Diculescu. Steatoza la pacientii cu hepatita C – influenta asupra eficacitatii tratamentului antiviral. Romanian J Gastroenterology 2005; 14 (Suppl 1): 174

110. L. Gheorghe, S. Iacob, C. Gheorghe, R. Iacob. Ciroza hepatica compensata secundara coinfectiei cu VHB si VHD: complicatii si prognostic. Romanian J Gastroenterology 2005; 14 (Suppl 1): 175-176

111. S. Iacob, L. Gheorghe, A. Istrate, R. Crintea, C. Gheorghe, R. Iacob, V. Uscatescu. Tromboza non-maligna de vena porta la pacientii cu ciroza hepatica. Romanian J Gastroenterology 2005; 14 (Suppl 1): 176-177

112. I. Parvulescu, C. Gheorghe, L. Gheorghe, R. Iacob. Frecventa pancreatitei acute biliare la pacientii cu calculi coledocieni. Romanian J Gastroenterology 2005; 14 (Suppl 1): 223

113. C. Gheorghe, S. Iacob, I. Bancila, L. Gheorghe, R. Iacob, M. Fleancu, C. Marica. Changing epidemiologic pattern of gastric pattern in Romania. Hepato-Gastroenterology 2005; 52 (Suppl 1): A86

114. C. Gheorghe, S. Iacob, L. Gheorghe, R. Iacob, I. Popescu. Risk factors for colorectal polyps in cirrhostic patients included on the waiting list for liver transplantation. Hepato-Gastroenterology 2005; 52 (Suppl 1): A135

115. C. Gheorghe, L. Gheorghe, S. Iacob, R. Iacob. Malnutrition as a risk factor for bleeding after endoscopic band ligation in patients with liver cirrhosis. Clinical Nutrition 2005; 24: 619 (P168)

116. C. Gheorghe, S. Iacob, L. Gheorghe, R. Iacob. Is cirrhosis a risk factor for colorectal polyps? Prospective study in patients included on the waiting list for liver transplantation. Gut 2005; 54 (Suppl VII): A194

117. R. Iacob, J. Quinton, F. Guillemot, F. Pattou, I. Bancila, C. Gheorghe, S. Iacob, L. Gheorghe, M. Diculescu. Esophageal manometry abnormalities after gastric banding for morbid obesity. Gut 2005; 54 (Suppl VII): A14

118. S. Iacob, L. Gheorghe, C. Gheorghe, R. Iacob, D. Bucur, A. Croitoru. Predictors of hepatocellular carcinoma occurrence in patients with cirrhosis. Hepatology 2005; 42 (Suppl 1): 396A

119. S. Iacob, S. Beckebaum, R. Iacob, V. Cicinnati, C. Klein, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. A model to predictone year graft failure in patients transplanted for HCV cirrhosis. J Hepatology 2006; 44 (Suppl 2): S62 (Abstract#144)

120. S. Iacob, S. Beckebaum, V. Cicinnati, R. Iacob, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. Predictive factors of sustained virological and histological response after combined antiviral therapy in transplanted patients with recurrent hepatitis C. J Hepatology 2006; 44 (Suppl 2): S215 (Abstract#580)

121. S. Iacob, S. Beckebaum, V. Cicinnati, R. Iacob, C. Klein, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. Protective factors for severe recurrence of hepatitis C after liver transplantation. Gastroenterology 2006; 130 (Suppl 2): A-79 (Abstract 541)

122. S. Iacob, S. Beckebaum, R. Iacob, V. Cicinnati, C. Klein, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. Predictive factors for graft and patient survival following liver transplantation for hepatitis C. Gastroenterology 2006; 130 (Suppl 2): A-500: (Abstract T1221)

123. C. Gheorghe, I. Parvulescu, L. Gheorghe, R. Iacob, I. Bancila. Frequency and predictive factors for acute biliary pancreatitis in patients with choledocolithiasis. Hepato-Gastroenterology 2006; 53 (Suppl I): 192

124. M. Jinga, C. Gheorghe, T. Nicolae, L. S. Gheorghe, F. Vasilescu, P. Nuta, R. Costache, D. G. Popescu, L. F. Florea, R. Brescan, E. Michiu, T. Tabaran. M. Cojocaru, L. S. Verdes, F. Ionita Radu. Endoscopic ultrasonography in evaluation and diagnosis of gastrointestinal submucosal masses. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 14

125. I. Bancila, R. Iacob, C. Gheorghe, D. Bucur, D. Voinea, S. Iacob, L. Gheorghe, M. Manuc, D. Pitigoi, M. Diculescu. Evaluation of material resources needed for colonoscopic surveillance of patients who underwent endoscopic polipectomies of colorectal adenomatous polyps in a tertiary gastroenterology referal center – Data of COLOCANS Registry. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 21

126. R. Iacob, I. Bancila, C. Gheorghe, D. Voinea, S. Iacob, L. Gheorghe, A. Croitoru, I. Ciurea, M. Manuc, D. Pitigoi, M. Diculescu. The prospective evaluation of material resources needed for colonoscopic surveillance of patients with curative resection for colorectal cancer in a tertiary gastroenterology referal center – Data of COLOCANS Register. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 25

127. R. Vadan, L. Gheorghe, M. Badea, C. Toader, C. Marica, I. Calin, C. Gheorghe, M. Diculescu. Crohn’s disease confined to the small bowel: clinical presentation and prognostic factors. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 25-26

128. R. Vadan, L. Gheorghe, C. Gheorghe, R. Iacob, I. Calin, A. Constantinescu. The efficacy of infliximab treatment in the maintenance of remission in patients with colonic inflammatory Crohn’s disease. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 35



129. I. Parvulescu, C. Gheorghe, G. Becheanu, L. Gheorghe, I. Lupescu, I. Popescu. Carcinoma of the ampulla of Vater – a rare cause of acute necrotizing hemorrhagic pancreatitis – a case report. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 69-70

130. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe, I. Popescu. The evaluation of the liver transplantation waiting list dynamics: Results of the VIASAN Project HEPASIST. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 80

131. R. Vadan, L. Gheorghe, G. Constantinescu, M. Badea, L. Tugui, I. Calin, C. Gheorghe, M. Diculescu.The frequency of tyroid disfunction in patients with chronic hepatitis C treated with Peginterferon and Ribavirin. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 81

132. S. Iacob, L. Gheorghe, S. Dima, O. Bancescu, I. Constantinescu, V. Sarbu, C. Ionescu-Targoviste, I. Popescu. Combined liver-pancreatic islet transplantation in a patient with HCV cirrhosis and insulin-dependent diabetes. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 81

133. L. Gheorghe, R. Vadan, C. Gheorghe, R. Iacob, I. Calin, A. Constantinescu. Adverse reactions during infliximab treatment for maintenance of remission in a Crohn’s disease. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 85

134. L. Gheorghe, M. Rugina, C. Gheorghe, M. Bengus, S. Iacob, C. Ginghina, E. Apetrei, I. Popescu. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 92

135. S. Iacob, L. Gheorghe, L. Popa, D. Hrehoret, D. Tulbure, M. Malago, I. Popescu. ABO-incompatible living donor liver transplantation: a succesful case using emergency desensitization protocol. J Gastrointestinal Liver Diseases 2006; 15 (Suppl 1): 104

136. M. Jinga, C. Gheorghe, T. Nicolae, L. S. Gheorghe, F. Vasilescu, P. Nuta, R. Costache, D. G. Popescu, L. F. Florea, R. Brescan, E. Michiu, T. Tabaran. The role of endoscopic ultrasonography in diagnosis and management of the subepithelial lesions in the upper gastrointestinal tract. Endoscopy 2006; 38: P13

137. Iacob R, Bancila I, Gheorghe C, Bucur D, Voinea D, Iacob S, Gheorghe L, Croitoru A, Ciurea S, Pitigoi D, Manuc M, Diculescu M, Popescu I. The prospective evaluation of resources needed for colonoscopic surveillance of patients with curative resection for colorectal cancer in a Romanian gastroenterology referral center – Data of COLOCANS Registry. Gut 2006; 55 (Suppl 5): 188

138. Speranta Iacob, R. Iacob, Liana Gheorghe, C. Gheorghe, I. Popescu. Prediction of death on the waiting list for liver transplantation based on MELD score variation. Gastroenterology 2007 (Suppl 2); 132: A672 (Abstract #W1157)

139. L. Gheorghe, S. Iacob, B. Cotruta, R. Iacob, A. Carabela, C. Gheorghe. Screeningul pacientilor cirotici si incidenta nodulilor de hepatocarcinom. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 6

140. R. Vadan, C. Gheorghe, G. Becheanu, L. Gheorghe, M. Dumbrava, M. Badea, M. Diculescu. Frecventa si factorii de risc ai displaziei in boala Crohn. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 12

141. R. Vadan. L. Gheorghe, C. Gheorghe, N. Zamfirescu, M. Badea, M. Diculescu. Frecventa si evolutia sarcinii la pacientele cu boli inflamatorii intestinale nespecifice. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 20

142. Iulia Simionov, Liana Gheorghe, G. Becheanu, Mona Dumbrava, M. Diculescu, I. Iova. Manifestari extrahepatice in hepatita autoimuna. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 22

143. C. Gheorghe, B. Cotruta, V. Herlea, A. Carabelea, G. Becheanu, R. Iacob, I. Bancila, S. Iacob, L. Gheorghe. Tumorile gastrointestinale stromale: prevalenta, prezentare clinica si management. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 25

144. C. Gheorghe, B. Cotruta, R. Iacob, I. Parvulescu, S. Iacob, I. Bancila, L. Gheorghe. Tromboza extrahepatica a venei porte in absenta cirozei hepatice: etiologie si modalitati de prezentare. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 27

145. R. Iacob, I. Vartan, L. Gheorghe, B. Cotruta, S. Iacob, L. Tugui, I. Bancila, C. Gheorghe. Particularitati clinice si demografice la pacientii cu polipoza adenomatoasa familiala inregistrati in cadrul Centrului de Gastroenterologie si Hepatologie Fundeni. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 49

146. R. Iacob, C. Baceanu, I. Parvulescu, R. Vadan, B. Cotruta, S. Iacob, L. Gheorghe, C. Gheorghe, M. Diculescu. Modalitati de prezentare fenotipica a pacientilor cu boli inflamatorii intestinale cronice. Generarea registrului IBD-prospect.J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 56

147. R. Vadan, L. Gheorghe, C. Gheorghe, I. Calin, M. Badea, M. Diculescu. Tratamentul de intretinere cu Infliximab in boala Crohn: 18 luni de remisiune clinica. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 57

148. Narcisa Zamfirescu, Speranta Iacob, Liana Gheorghe, C. Gheorghe, Iulia Simionov, Iuliana Parvulescu, Roxana Vadan, Corina Angelescu, G. Becheanu, Mona Dumbrava. Factorii predictivi ai anemiei induse de terapia combinata cu interferon pegylat si ribavirina la pacientii cu hepatita cronica virala C. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 72



149. B. Cotruta, L. Gheorghe, V. Trifu, C. Cotruta, S. Iacob, G. Becheanu, R. Vadan, A. Carabelea, C. Gheorghe. Dermatoza neutrofilica acuta (sindrom Sweet) – o noua reactie adversa la terapia antivirala cu interferon – prezentare de caz. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 72

150. Iulia Simionov, Liana Gheorghe, C. Gheorghe, M. Diculescu, I. Iova. Manifestari extrahepatice in afectiunile hepatice autoimune colestatice. J Gastrointestinal Liver Diseases 2007; 16 (Suppl 1): 73

151. Liana Gheorghe. Should we treat mild chronic hepatitis C ? Hepato-Gastroenterology 2007; 54 (Suppl 1): A24 (FP-45)

152. Gheorghe L, Iacob S, Dumbrava M, Becheanu G, Iacob R, Cotruta B, Carabelea A, Gheorghe C. Sonoelastographic evaluation of small hepatocellular carcinoma in cirrhotic patients – A pilot study. Hepato-Gastroenterology 2007; 54 (Suppl 1): A98 (TO2-P-02)

153. Gheorghe C, Cotruta B, Herlea V, Mihai M, Ardeleanu C, Becheanu G, Iacob R, Iacob S, Gheorghe L, Popescu I. Gastrointestinal stromal tumors: the prevalence, clinical presentation and outcome. Hepato-Gastroenterology 2007; 54 (Suppl 1): A121 (TO4-P-04)

154. Gheorghe C, Vadan R, Becheanu G, Gheorghe L, Dumbrava M, Badea M, Diculescu M. Dysplasia in Crohn’s disease: a matter of time since diagnosis ? Hepato-Gastroenterology 2007; 54 (Suppl 1): A141 (TO6-P-05)

155. Iacob R, Vartan I, Gheorghe L, Cotruta B, Iacob S, Tugui L, Bancila I, Ionescu M, Popescu I, Gheorghe C. Familial Polyposis Syndrome Registry – Screening, diagnosis, treatment and follow-up. Hepato-Gastroenterology 2007; 54 (Suppl 1): A142 (TO6-P-07)

156. Vadan R, Gheorghe L, Gheorghe C, Calin I, Badea M, Diculescu M. Mucosal healing in Crohn’s disease – A consequence of long-term therapy with Infliximab. Hepato-Gastroenterology 2007; 54 (Suppl 1): A146 (TO6-P-17)

157. Vadan R, Gheorghe L, Gheorghe C, Zamfirescu N, Badea M, Diculescu M. The outcome of pregnancy-onset inflammatory bowel diseases. Hepato-Gastroenterology 2007; 54 (Suppl 1): A146 (TO6-P-18)

158. Iacob S, Iacob R, Gheorghe L. Successful pregnancies in symptomatic and asymptomatic Wilson’s disease patients. Hepato-Gastroenterology 2007; 54 (Suppl 1): A165 (TO8-P-10)

159. Iacob S, Gheorghe L, Grigorescu M, Sporea I, Simionov I, Vadan R, Pirvulescu I, Sirli R, Damian D. Antiviral therapy in mild chronic hepatitis C: beyond “watch and wait”strategy. Hepato-Gastroenterology 2007; 54 (Suppl 1): A165 (TO8-P-11)

160. Simionov I, Gheorghe L. Pregnancy in women with autoimmune liver disease. Hepato-Gastroenterology 2007; 54 (Suppl 1): A167 (TO8-P-15)

161. Simionov I, Gheorghe L, Gheorghe C, Diculescu M. Frequency of extrahepatic manifestations in autoimmune liver diseases. Hepato-Gastroenterology 2007; 54 (Suppl 1): A167 (TO8-P-16)

162. Popescu I, Ionescu M, Ciurea S, Brasoveanu V, Sirbu-Boeti P, Hrehoret D, Tomulescu V, Alexandrescu S, Grigorie R, Gheorghe L, Croitoru A, Boros M, Herlea V. Multimodal treatment of hepatocellular carcinoma : 12 years’ experience of Fundeni General Surgery and Liver Transplantation Center (Bucharest, Romania). Hepato-Gastroenterology 2007; 54 (Suppl 1): A182 (TO9-P-16)

163. Popescu I, Ionescu M, Gheorghe L, Ciurea S, Brasoveanu V, Hrehoret D, Matei E, Dorobantu B. Liver Transplantation – Experience of Fundeni Center of General Surgery and Liver Transplantation (Bucharest, Romania). Hepato-Gastroenterology 2007; 54 (Suppl 1): A197 (T11-P-02)

164. Simionov I, Gheorghe L, Becheanu G, Gheorghe C. Overlap syndrome primary biliary cirrhosis - autoimmune hepatitis: How often and when can we see it? Hepato-Gastroenterology 2007; 54 (Suppl 1): A211 (T13-P-08)

165. Cotruta B, Gheorghe C, Gheorghe L, Iacob R, Pirvulescu I, Iacob S, Bancila S. Non-cirrhotic, non-neoplastic extrahepatic portal vein thrombosis: etiology, presentation and management. Hepato-Gastroenterology 2007; 54 (Suppl 1): A248 (T17-P-07)

166. Gheorghe L, Iacob S. Referral for liver transplantation: MELD and beyond. Hepato-Gastroenterology 2007; 54 (Suppl 1): A24 (FP-46)

167. S. Iacob, R. Iacob, L. Gheorghe, C. Gheorghe, I. Popescu. MELD score variation: predictor of death on waiting list for liver transplantation. Transplant International 2007; 20 (Suppl 2): 260 (P677)

168. M. Diculescu, R. Iacob, I. Constantinescu, A. Toader, B. Cotruta, C. Baceanu, I. Parvulescu, R. Vadan, L. Gheorghe, C. Gheorghe, C. Preda. ASCA and ANCA serology in Romanian IBD patients. Journal of Crohn’s & Colitis 2008; 2: 90 (P291)

169. Liana Gheorghe, Speranta Iacob, Razvan Iacob, Gabriel Becheanu, Mona Dumbrava, Cristian Gheorghe, Iulia Simionov, Ioana Lupescu, Irinel Popescu. Real-Time Elastography – A Pilot Study for Non-Invasive Detection of Small Hepatocellular Carcinoma in Cirrhotic patients. Gastroenterology 2008; 134 (Suppl): A-827 (Abstract T1947)



170. L. Gheorghe, S. Iacob, I. Lupescu, G. Becheanu, M. Dumbrava, I. Simionov. Real-time elastography – A useful method for the detection of hepatocellular carcinoma in small cirrhotic nodules. J Hepatol 2008; 48 (Suppl): S115 (Abstract 287)

171. Gheorghe Cristian, Iacob Speranta, Cotruta Bogdan, Iacob Razvan, Gheorghe Liana, Becheanu Gabriel, Dumbrava Mona, Suciu Sebastian, Bancila Ion, Popescu Irinel. Prevalenceof clinically significant histology in small colonic neoplastic polyps. Hepato-Gastroenterology 2008; 55 (Suppl I): A162 (P125)

172. Razvan Iacob, Daniela Iancu, Speranta Iacob, Bogdab Cotruta, Carla Baceanu, Cristian Gheorghe, Liana Gheorghe, Silviu Iobagiu, Ligia Barbarii, Mircea Diculescu. Multiplex ligation-dependent probe amplification (MLPA) inflammatory gene expression profiling in patients with inflammatory bowel disease. Hepato-Gastroenterology 2008; 55 (Suppl I): A339 (P558)

173. Gheorghe Liana, Iacob Speranta, Iacob Razvan, Becheanu Gabriel, Dumbrava Mona. Real-time elastography – A novel approach to assess liver fibrosis in patients with chronic hepatitis C. Hepato-Gastroenterology 2008; 55 (Suppl I): A73 (OP178)

174. R. Iacob, M. Diculescu, I. Constantinescu, A. Toader, B. Cotruta, C. Baceanu, S. Gologan, I. Parvulescu, R. Vadan, S. Iacob, L. Gheorghe, C. Gheorghe, C. Preda.ASCA and ANCA serology in Romanian IBD patients. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 45

175. Roxana Vadan, Liana Gheorghe, C. Gheorghe, Gabriela Smira, Alina Petria. Adalimumab treatment: A good alternative in a patient with severe infusional reaction to Infliximab. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 52

176. Roxana Vadan, Liana Gheorghe, C. Gheorghe, I. Calin, Narcisa Maria Zamfirescu, Mihaela Badea, M. Diculescu. Maintenance treatment with Infliximab in Crohn’s disease: A prospective study. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 53

177. Liana Gheorghe, Irma Csiki, Speranta Iacob, Anca Trifan, C. Stanciu, Loredana Regep. Hepatitis B virus infection epidemiology in Romania. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 79

178. Gabriela Smira, G. Mavrogenis, Liana Gheorghe, Irma Csiki, Speranta Iacob, Iuliana Pirvulescu, Anca Trifan, C. Stanciu, Loredana Regep. The prevalence of anti-hepatitis B-core antibodies in Romania. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 81

179. Liana Gheorghe, Speranta Iacob, M. Grigorescu, I. Sporea, Roxana Sirli, Dana Damian, C. Gheorghe, R. Iacob. Should we treat patients with mild hepatitis C? Yes, of course! J Gastrointest Liver Dis 2008; 17 (Suppl 1): 128

180. Liana Gheorghe, Speranta Iacob, R. Iacob, G. Becheanu, M. Dumbrava, C. Gheorghe, I. Lupescu, I. Popescu. Real-time elastography – A non-invasive diagnostic tool of small hepatocellular carcinoma in cirrhotic patients. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 160

181. Liana Gheorghe, Speranta Iacob, R. Iacob, C. Gheorghe, I. Popescu. Prediction of death on large waiting lists for liver transplantation using MELD exceptions. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 176

182. Speranta Iacob, Liana Gheorghe, Doina Hrehoret, R. Iacob, G. Becheanu, V. Herlea, C. Gheorghe, I. Popescu. Patient and graft survival following liver transplantation for HCV liver cirrhosis – Predictive factors identified in the Romanian Transplant Program. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 177

183. Iuliana Pirvulescu, C. Gheorghe, Liana Gheorghe, Alina Petria, Ioana Lupescu. Autoimmune pancreatitis associated with systemic extrapancreatic lesions. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 200

184. Speranta Iacob, Liana Gheorghe, Alexandrina Constantinescu, R. Iacob, R. Cerban, C. Gheorghe, I. Popescu. Wilson’s disease – Type of presentation and outcomes of treatment: Experience of a tertiary centre. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 202

185. S. Suciu, C. Gheorghe, L. Tugui, Liana Gheorghe, V. Boboc, B. Cotruta. Desmoid tumors associated with familial adenomatous polyposis (FAP) in FAP Database Fundeni – Case Report. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 204

186. Roxana Vadan, C. Gheorghe, Liana Gheorghe, Gabriela Smira, Alina Petria. Diagnostic and treatment challenges in a rare case of upper gastrointestinal bleeding: Dieulafoy lesion. J Gastrointest Liver Dis 2008; 17 (Suppl 1): 243

187. Razvan Iacob, Daniela Iancu, Ligia Barbarii, Ileana Constantinescu, Adela Toader, Bogdan Cotruta, Speranta Iacob, Serban Gologan, Carla Baceanu, Roxana Vadan, Liana Gheorghe, Cristian Gheorghe, Silviu Iobagiu, Mircea Diculescu. Model to Predict Crohn’s Disease Behaviour Using Mucosal Inflammatory Genes Expression Profile and ASCA Titer. Gastroenterology 2009; 136 (Suppl 1): S1737

188. S. Iacob, S. Dima, E. Matei, R. Iacob, L. Gheorghe, C. Gheorghe, I. Popescu. Usefulness of staging systems for hepatocellular carcinoma in predicting recurrence after surgical therapy. Gut 2009; 58 (Suppl 1): A 486 (P1894)

189. R. Vadan, L. Gheorghe, C. Gheorghe. Evolutia starii de nutritie la pacientii cu forme severe de boala Crohn tratati cu infliximab. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 31-32



190. C. Gheorghe, S. Suciu, B. Cotruta, I. Lupescu, R. Iacob, C. Radu, S. Anton, L. Gheorghe. Eficienta si siguranta dilatarii endoscopice cu balon pentru stenozele colonice in boala Crohn. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 39

191. C. Gheorghe, R. Stoia, G. Becheanu, S. Anton, S. Suciu, L. Gheorghe. EUS in diagnosticul si urmarirea pacientilor cu limfoame gastrice primitive. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 49

192. L. Gheorghe, I. Csiki, S. Iacob, C. Gheorghe, G. Smira, L. Regep. Estimarea complicatiilor pe termen lung ale infectiei cu VHC in Romania. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 60

193. L. Gheorghe, I. Csiki, S. Iacob, C. Gheorghe, G. Smira, L. Regep. Prevalenta si factorii de risc ai infectiei cu virus hepatitic C in Romania. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 75

194. R. Vadan, I. Simionov, L. Gheorghe, G. Becheanu, M. Dumbrava, C. Angelescu, C. Gheorghe. Siguranta si eficienta punctiei hepatice ghidata ecografic in diagnosticul proceselor inlocuitoare de spatiu hepatice. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 78

195. L. Gheorghe, S. Iacob, M. Dumbrava, G. Becheanu, R. Iacob, C. Gheorghe, I. Simionov, R. Vadan. Elastografia in timp real – un prim pas catre biopsia hepatica virtuala in hepatita cronica virala C. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 82

196. L. Gheorghe, S. Iacob, R. Iacob, G. Becheanu, M. Dumbrava, V. Herlea, C. Gheorghe, I. Lupescu, I. Popescu. Elastografia in timp real poate prezice prezenta hepatocarcinomului precoce la pacientii cirotici. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 91

197. R. Vadan, G. Becheanu, I. Simionov, M. Dumbrava, C. Angelescu, L. Tugui, C. Preda, C. Tudor, L. Gheorghe. Exista o corelatie intre dimensiunea fragmentului de biopsie hepatica si numarul de spatii porte ? J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 92

198. L. Gheorghe, S. Iacob, M. Onu, R. Iacob, I. Lupescu, C. Gheorghe. Analiza semiautomata computerizata a imaginilor obtinute la ecografia cu contrast pentru diagnosticul leziunilor focale maligne la pacientii cirotici. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 96

199. M. Diculescu, R. Iacob, L. Barbarii, S. Iacob, B. Cotruta, S. Gologan, C. Baceanu, A. Catuneanu, C. Gheorghe, L. Gheorghe, S. Iobagiu. Investigarea profilului de expresie a genelor implicate in procesele inflamatorii la pacientii cu IBD, utilizand tehnica MLPA (multiplex ligation-dependent probe amplification). J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 110

200. I. Pirvulescu, S. Suciu, A. Lupu, L. Gheorghe, M. Diculescu. Prevalenta si impactul steatozei hepatice nonalcoolice in hepatita cronica VHB. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 13

201. A. Constantinescu, L. Gheorghe, D. Hrehoret, I. Popescu. Spectrul clinic al bolilor hepatice cronice la copiii inclusi pe lista de asteptare pentru transplant hepatic. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 69

202. I. Sporea, R. Sirli, M. Curescu, L. Gheorghe, S. Iacob, S. Bota, A. Popescu, M. Danila. Raspunsul viral sustinut intr-o serie de pacienti cu hepatita cronica VHC tratati cu PegInterferon si Ribavirina. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 73

203. R. Vadan, I. Simionov, C. Angelescu, C. Preda, L. Tugui, I. Pirvulescu, C. Tudor, L. Gheorghe. Factorii de risc si frecventa complicatiilor biopsiei hepatice ecoasistate in cazul afectiunilor hepatice difuze. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 83

204. I. Sporea, Alina Popescu, M. Focsa, G. Becheanu, Roxana Sirli, Maria Cornianu, Liana Gheorghe, Cristina Cijevschi Prelipcean, Catalina Mihai, I. Rogoveanu, Larisa Sandulescu. Calitatea fragmentului bioptic obtinut in functie de tipul de ac folosit la biopsia hepatica. J Gastrointestin Liver Dis 2009; 18 (Suppl 1): 89

205. L. Gheorghe, A. Carabelea, A. Ogica, R. Vadan, I. Simionov, G. Smira. Rolul ecografiei cu contrast si sonoelastografiei in caracterizarea si urmarirea leziunilor focale de hepatocarcinom. J Gastrointest Liver Dis 2009; 18 (Suppl 1): 96

206. Iulia Simionov, Roxana Vadan, L. Gheorghe. Este biopsia hepatica percutana o manevra care se poate efectua ambulator ? J Gastrointest Liver Dis 2009; 18 (Suppl 1): 97

207. L. Gheorghe, R. Vadan, G. Smira, C. Angelescu, S. Suciu, C. Gheorghe. The safety of biological anti-TNF treatment for inflammatory bowel diseases in a country with high prevalence of tuberculosis. Proceeding of the Falk Symposium 170; 2009: 28

208. R. Vadan, L. Gheorghe, G. Smira, C. Angelescu, M. Ciocirlan, C. Preda, C. Gheorghe. Azathioprine use, efficacy and tolerance in the treatment of Crohn’s disease in a region with low prevalence of severe cases of the disease. Proceeding of the Falk Symposium 170; 2009: 58

209. I. Bancila, R. Vadan, C. Gheorghe, G. Becheanu, L. Gheorghe. Frequency and treatment of IBS-like symptoms in Crohn’s disease patients with endoscopic remission. Proceeding of the Falk Symposium 170; 2009: 62



210. Reddy KR, Shiffman ML, Rodrigues-Torro M, Bakulin I, Cheinquer H, Horban A, El-Kashab M, Gheorghe L. Buggisch P, Rabbia M, McKenna M, Harrison SA, On behalf of the PROGRESS Study Investigators. Predictors of relapse among patients treated with standard or induction dose of peginterferon alfa-2a (40KD) combined with standard or higher dose ribavirin in difficult-to-cure patients. J Hepatol 2010; 52: S123: Poster 239

211. I. Pirvulescu, L. Gheorghe, S. Suciu, C. Gheorghe, M. Diculescu. The impact and the prevalence of nonalcoholic fatty liver disease on chronic hepatitis B. J Hepatol 2010; 52: S151: Poster 366

212. L. Gheorghe, R. Vadan, C. Gheorghe. Maintenance treatment with Infliximab versus Azathioprine in Crohn’s disease: a prospective study. Falk Proceedings. Falk Symposium 172, 2010

213. C. Gheorghe, R. Vadan, L. Gheorghe. The evolution of nutritional status in patients with severe forms of Crohn’s disease treated with Infliximab. Falk Proceedings. Falk Symposium 172, 2010

214. Liana Gheorghe, Iulia Simionov, Roxana Vadan, Iuliana Pirvulescu, Gabriela Smira, Speranta Iacob, Andrei Carabelea, Corina Angelescu, Cristian Gheorghe. Rolul ultrasonografiei cu contrast in caracterizarea leziunilor hepatice: o serie de 100 de cazuri. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 3 (MG4)

215. R. Iacob, S. Gologan, D. Iancu, R. Vadan, B. Cotruta, S. Iacob, C. Preda, C. Baceanu, C. Pojoga, S. Iobagiu, C. Gheorghe, L. Gheorghe, L. Barbarii, M. Diculescu. Date actuale privind genetica bolilor inflamatorii intestinale in Romania – proiectul IBDPROSPECT. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 10 (MG13)

216. Roxana Vadan, Liana Gheorghe, Cristian Gheorghe, Mircea Diculescu. Influenta tratamentului de mentinere a remisiunii asupra vindecarii mucosale in boala Crohn: o comparatie intre infliximab si azatioprina. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 94 (G43)

217. Roxana Vadan, Liana Gheorghe, Alexandrina Constantinescu, Cristian Gheorghe. Prevalenta malnutritiei si evolutia statusului nutritional la pacientii cu forme moderat-severe de boala Crohn tratati cu infliximab. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 96 (G45)

218. G. Smira, L. Gheorghe, S. Iacob, D. Coriu, C. Gheorghe. Sindromul Budd Chiari si identificarea mutatiei V617F/JAK2 la pacientii diagnosticati cu sindrom mieloproliferativ. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 176 (H58)

219. Gabriela Smira, Sebastian Suciu, Speranta Iacob, Razvan Iacob, Liana Gheorghe, Cristian Gheorghe. Rifaximina in administrare cronica timp de 6 luni pentru mentinerea remisiunii encefalopatiei hepatice – studiu prospectiv. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 178 (H61)

220. L. Gheorghe, C. Gheorghe, G. Smira, S. Suciu, C. Radu, M. Baloi. Tromboza de vena porta la pacientii cirotici in program de bandare endoscopica variceala. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 178 (H62)

221. I. Pirvulescu, L. Gheorghe, S. Suciu, C. Gheorghe. Elastografia tranzitorie: test noninvaziv de screening pentru diferentierea pacientilor cu Ag HBs pozitiv / Ag HBe negativ. J Gastrointestin Liver Dis 2010; 19 (Suppl 1): 208 (H107)

222. L. Gheorghe, O. Pascu, E. Ceausu, IE Csiki, S. Iacob, F. Caruntu. Access to combined antiviral therapy for hepatitis C in Romania (OP201). Gut 2010; 59 (Suppl III): A45

223. G. Smira, C. Gheorghe, L. Gheorghe, S. Iacob, R. Iacob. Chronic administration of Rifaximin for the maintenance of remission of hepatic encephalopathy. Gut 2010; 59 (Suppl III): A55

224. G. Smira, C. Gheorghe, L. Gheorghe, S. Suciu. Portal vein thrombosis in liver cirrhostic patients with endoscopic treatment. Gut 2010; 59 (Suppl III): A428

225. I. Pirvulescu, L. Gheorghe, S. Suciu, C. Gheorghe, S. Iacob, M. Diculescu. The impact and the prevalence of nonalcoholic fatty liver disease on chronic hepatitis B. Gut 2010; 59 (Suppl III): A432

226. L. Gheorghe, S. Iacob, I. Simionov, R. Vadan, I. Constantinescu, I. Sporea, M. Grigorescu. Efficacy of pegylated interferon alpha-2b in a Romanian cohort with chronic hepatitis delta. J Hepatol 2011; 54: S285 (A711)

227. Speranta Iacob, Liana Gheorghe, Gabriel Becheanu, Mona Dumbrava, Irinel Popescu. Influence of cholestasis and hepatocytolisis on liver stiffness in recurrent hepatitis C following liver transplantation. Transplant International 2011; 24 (Supplement 2): 310 (P-335)

228. Speranta Iacob, Razvan Iacob, Anca Nastase, Daniel Coriu, Liana Paslaru, irinel Popescu, Liana Gheorghe. IL28B gene polymorphism for prediction of early virological response in Romanian patients with recurrent hepatitis C after liver transplantation. Transplant International 2011; 24 (Supplement 2): 263 (P-135)

229. Suciu S, Gheorghe C, Vadan R, Radu C, Ghinea B, Gheorghe L. Infliximab – o terapie eficienta in tratamentul formelor fistulizante de boala Crohn. J Gastrointestin Liver Dis 2011; 20 (1): 22 (2.08)

230. Gheorghe L, Cerban R, Vadan R, Gheorghe C. Tratamentul cu succes al bolii inflamatorii intestinale si sarcina : prezentare a doua cazuri, unul tratat cu infliximab si cel de al doilea cu terapie standard. J Gastrointestin Liver Dis 2011; 20 (1): 24 (2.09)



231. Liana Gheorghe, Speranta Iacob, Iulia Simionov, Roxana Vadan, Ileana Constantinescu, Florin Caruntu, Ioana Sporea, Mircea Grigorescu. Eficienta tratamentului cu interferon pegylat alfa-2b la pacientii romani cu hepatita cronica delta. J Gastrointestin Liver Dis 2011; 20 (1): 44 (4.01)

232. I. Pirvulescu, L. Gheorghe, S. Suciu, S. Iacob, C. Radu, C. Gheorghe. The prevalence and the liver stiffness values in hepatitis D virus co-infection compared to hepatitis B virus monoinfection. J Gastrointestin Liver Dis 2011; 20 (1): 56 (4.19)

233. Gheorghe L, Cerban R, Pirvulescu I, Vadan R, Simionov I, Suciu S. Is the serum alanine transaminase (ALT) level a predictor for histologic severity in chronic hepatitis B and D infection ? J Gastrointestin Liver Dis 2011; 20 (1): 56 (4.20)

234. Speranta Iacob, Razvan Iacob, Anca Nastase, Daniel Coriu, Liliana Paslaru, Irinel Popescu, Liana Gheorghe. Poate fi utilizat polimorfismul genei IL28B pentru predictia raspunsului virusologic precoce la pacientii cu hepatita recurenta C post-transplant hepatic ? J Gastrointestin Liver Dis 2011; 20 (1): 71 (4.43)

235. Gheorghe L, Pirvulescu I, Cerban R, Vadan R, Simionov I. Comparison of histological features in patients with hepatitis B alone and patients with delta virus associated infection. J Gastrointestin Liver Dis 2011; 20 (1): 72 (4.45)

236. Liana Gheorghe, Razvan Iacob, Speranta Iacob, Anca Nastase, Cristian Gheorghe, Daniel Coriu, Liliana Paslaru. Investigarea polimorfismului genei IL-28B la pacientii cu hepatita cronica C tratati cu interferon pegylat si ribavirina. J Gastrointestin Liver Dis 2011; 20 (1): 72 (4.44)

237. Speranta Iacob, Razvan Iacob, Razvan Cerban, Gabriela Smira, Alexandrina Constantinescu, Liana Gheorghe. Predictia prognosticului nefast in ciroza Wilson. J Gastrointestin Liver Dis 2011; 20 (1): 103 (5.31)

238. Liana Gheorghe, Cristian Gheorghe, G. Smira, S. Iacob, S. Suciu. Optimal donor selection for adult-to-adult living donor liver transplantation in Romania. J Gastrointestin Liver Dis 2011; 20 (1): 104 (6.01)

239. Liana Gheorghe, Iulia Simionov. Ablatia percutanata prin radiofrecventa in carcinomul hepatocelular. J Gastrointestin Liver Dis 2011; 20 (1): 105 (7.01)

240. Liana Gheorghe, Speranta Iacob, Carmen Ghidu, Razvan Cerban, Iulia Simionov, Mirela Danila, Ioan Sporea, Adina Croitoru, Marian Croitoru, Doina Hrehoret si Irinel Popescu. Terapia curativa si paleativa a hepatocarcinomului in centrele tertiare de gastroenterologie in Romania. J Gastrointestin Liver Dis 2011; 20 (1): 110 (7.10)

241. Iulia Simionov, Liana Gheorghe. Evolutia si complicatiile sindromului de overlap ciroza biliara primitiva – hepatita autoimuna. J Gastrointestin Liver Dis 2011; 20 (1): 129 (10.01)

242. I. Pirvulescu, L. Gheorghe, G. Becheanu, S. Fica, M. Dumbrava, S. Suciu, C. Radu, C. Gheorghe, M. Diculescu. Serum high-sensitivity C-reactive protein (hPCR): a new noninvasive biomarker for distinguish between steatohepatitis and simple steatosis in morbidly obese patients. J Gastrointestin Liver Dis 2011; 20 (1): 130 (10.02)

243. Iulia Simionov, Liana Gheorghe. Prevalenta si factorii predictivi ai sindromului de overlap autoimun la pacientii cu ciroza biliara primitiva. J Gastrointestin Liver Dis 2011; 20 (1): 132 (10.05)

244. I. Pirvulescu, L. Gheorghe, G. Becheanu, S. Fica, M. Dumbrava, C. Copaescu, C. Gheorghe, M. Diculescu. Serum high sensitivity C-reactive protein (hs-CRP) – a noninvasive biomarker in differentiating non-alcoholic steatohepatitis and simple steatosis in morbidly obese patients. Gut 2011; 60 (Suppl 3): A134

245. I. Pirvulescu, L. Gheorghe, S. Iacob, C. Radu, C. Gheorghe. The prevalence and the liver stiffness evaluated by transiert elastography in hepatitis D virus co-infection in comparison with hepatitis B virus monoinfection. Gut 2011; 60 (Suppl 3): A139

246. S. Iacob, R. Iacob, R. Cerban, G. Smira, A. Constantinescu, L. Gheorghe. Predictive factors of poor prognosis in Wilson cirrhosis. Gut 2011; 60 (Suppl 3): A357

247. C. Gheorghe, L. Gheorghe, G. Smira, S. Iacob, SM Suciu, I. Popescu. Endoscopic colonic lesions in liver transplant candidates. Gut 2011; 60 (Suppl 3): A360

248. G. Smira, S. Iacob, C. Gheorghe, I. Popescu, L. Gheorghe. Adult living donor liver transplantation – how efficient and safe is the donation ? J Hepatol 2012; 56: S94 (A222)

249. L. Gheorghe, S. Iacob, I. Simionov, R. Vadan, I. Constantinescu. Efficacy of antiviral therapy in 102 Romanian patients with chronic hepatitis delta. J Hepatol 2012; 56: S205 (A517)

250. I. Simionov, L. Gheorghe. Clinicopathological features and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. J Hepatol 2012; 56: S382 (A977)

251. L. Gheorghe, R. Cerban, R. Vadan, C. Toader, C. Gheorghe, C. Cotruta. Pyoderma gangrenosum in adult IBD patients: prevalence, risk factors and therapeutic control. JCC 2012; S69 (P149)

252. L. Gheorghe, A. Constantinescu, R. Vadan, R. Cerban, C. Gheorghe. Incidence and predictors of colorectal dysplasia and cancer in a populational-based cohort of IBD patients in Romania. JCC 2012; 56: S68 (P148)

253. C. Gheorghe, R. Iacob, B. Cotruta, I. Bancila, G. Becheanu, M. Dumbrava, L. Gheorghe. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis - a pilot study. JCC 2012; 56: S87 (P195)



254. R. Vadan, L. Gheorghe, C. Gheorghe, S. Suciu. Silent endoscopic relapse in patients with clinical maintained remission and previous deep remission on scheduled treatment with infliximab. JCC 2012; 56: S158 (P373)

255. C. Gheorghe, R. Iacob, B. Cotruta, I. Bancila, G. Becheanu, M. Dumbrava, L. Gheorghe. Mucosal healing in patients with ulcerative colitis assessed by confocal laser endomicroscopy. Abstract Book www.ddw.org: A-477: Sa1604

256. L. Gheorghe, S. Iacob, C. Ghidu, R. Iacob, R. Cerban, I. Simionov, A. Croitoru, C. Gheorghe, I. Popescu. Liver stiffness value assessed by transient elastography correlates with nodule size in patients with hepatocellular carcinoma. Abstract Book www.ddw.org: A-851: Su2040

257. R. Vadan, R. Cerban, C. Toader, C. Gheorghe, C. Cotruta, L. Gheorghe. Skin complications in inflammatory bowel diseases: a prospective evaluation of IBD patients from a gastroenterology tertiary referral center in Romania. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 24 (2.9)

258. R. Vadan, A. Constantinescu, L. Gheorghe, C. Gheorghe. Incidence and predictors of colorectal dysplasia and cancer in a population-based cohort of IBD patients in Romania. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 31-32 (2.16)

259. R. Vadan, L. Gheorghe, C. Angelescu, S. Suciu, C. Gheorghe. The safety of biological anti-TNF treatment for inflammatory bowel diseases in a country with high prevalence of tuberculosis. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 35-36 (2.21)

260. I. Pirvulescu, L. Gheorghe, G. Becheanu, R. Iacob, M. Dumbrava, S. Fica, S. Martin, A. Sarbu, C. Copaescu, C. Gheorghe, M. Diculescu. A noninvasive biomarkers model for distinguish NASH from simple steatosis in obese patients. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 46 (4.1)

261. I. Simionov, L. Gheorghe. Effectiveness and tolerability of triple therapy for HCV in real life. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 54 (4.9)

262. S. Iacob, R. Iacob, A. Nastase, C. Gheorghe, D. Coriu, L. Paslaru, and L. Gheorghe. IL28B CC genotype and mild hepatitis as favorable baseline profile predicting SVR after bitherapy in naive HCV-infected patients. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 54 (4.10)

263. L. Gheorghe, S. Iacob, M. Greere, E. Matei, V. Brasoveanu, I. Popescu. Acute hepatitis B in a patient with sustained virological response to antiviral therapy for recurrent hepatitis C following liver transplantation. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 55 (4.11)

264. S. Iacob, D. Hrehoret, E. Matei, B. Dorobantu, V. Brasoveanu, M. Dumbrava, G. Becheanu, V. Herlea, I. Popescu, and L. Gheorghe. Recurrent hepatitis C following liver transplantation in the Romanian Transplant program – treatment and outcome. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 57 (4.12)

265. G. Smira, S. Iacob, C. Gheorghe, I. Popescu, and L. Gheorghe. Adult living donor liver transplantation – donor safety experience over 8 years. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 76 (5.1)

266. R. Iacob, S. Iacob, A. Nastase, C. Vagu, M. Grigorie, T. Dumitrascu, A.M. Tanase, B. Dorobantu, L. Stoica, L. Paslaru, D. Coriu, S. Dima, A. Croitoru, C. Gheorghe, L. Gheorghe, and I. Popescu. Quantitative gene expression of liver enriched transcription factors in curativelly treated hepatocellular carcinoma. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 110 (6.11)

267. L. Gheorghe, S. Iacob, C. Ghidu, R. Iacob, C. Gheorghe, R. Cerban, I. Simionov, I. Sporea, M. Danila, A. Croitoru, M. Croitoru, D. Hrehoret, and I. Popescu. Management pattern of hepatocellular carcinoma at two tertiary centers in Romania. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 112 (6.13)

268. I. Simionov, L. Gheorghe, C. Gheorghe. Clinicopathological features and outcome of autoimmune hepatitis / primary sclerosing cholangitis overlap syndrome. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 137 (8.2)

269. R. Iacob, S. Iacob, AM Ene, A. Nastase, C. Vagu, A. Constantinescu, D. Anghel, C. Banica, L. Paslaru, D. Coriu, S. Dima, C. Gheorghe, E. Ionica, and L. Gheorghe. Mutations in exon 14 and 16 of ATP7B gene, in Romanian patients with Wilson’s disease referred to a tertiary gastroenterology center. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 139 (8.4)

270. S. Iacob, L. Cvas, M. Greere, R. Vadan, C. Pietrareanu, I. Simionov, and L. Gheorghe. Concordance regarding staging of fibrosis between real-time and transient elastography in chronic hepatitis B and C. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 151 (10.3)

271. L. Gheorghe, S. Iacob, C. Ghidu, R. Iacob, I. Simionov, A. Croitoru, C. Gheorghe, I. Popescu. Corelation between liver stiffness and nodule size in patients with hepatocellular carcinoma. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 152 (10.4)

272. L. Gheorghe, I. Simionov, C. Angelescu, R. Vadan, I. Pirvulescu, G. Smira. Influence of contrast-enhanced ultrasound in diagnosis of focal liver lesions – experience of a single tertiary centre of gastroenterology and hepatology. J Gastrointestin Liver Dis 2012; 21 (Suppl 2): 166 (10.14)



273. R. Vadan, L. Gheorghe, R. Cerban, B. Cotruta, L. Tugui, I. Stanel, C. Angelescu, I. Bancila, M. Diculescu, C. Gheorghe. Deep remission: A recurrent feature in patients with Crohn’s disease and lomg term biologic therapy. JCC 2013; 57: P458

274. Gheorghe L, Csiki IE, Iacob S, Trifan A, Grigorescu M, Motoc A, Suceveanu A, Curescu M, Caruntu F, Sporea I, Brisc C, Rogoveanu I, Tugui L, Alexandrescu A. Prevalence, virological and clinical characteristics of chronic hepatitis delta virus infection (CHD) in Romania. J Hepatol 2013

275. Iacob S, Vagu C, Iacob R, Nastase A, Paslaru L, Popescu I, Ruta S, Gheorghe L. Recipient IL28B gene polymorphism and sustained viral response in Romanian patients with recurrent hepatitis C following liver transplantation. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 4 (OP3)

276. Iacob R, Vagu C, Nastase A, Iacob S, Grigorie M, Herlea V, Croitoru A, Dima S, Gheorghe C, Gheorghe L, Ott M, Popescu I. Quantitative gene expression of liver enriched transcription factors for prediction of tumor recurrence after curative treatment of hepatocellular carcinoma. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 5 (OP6)

277. Tugui L, Iacob S, Gheorghe L, Preda CM, Cerban R, Becheanu G, Dumbrava M, Diculescu M. Treatment of chronic hepatitis delta virus with Peg-interferon. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 26 (OP40)

278. Smira G, Matei E, Dorobantu B, Brasoveanu V, Gheorghe C, Gheorghe L, Popescu I. Donor outcomes in right lobe adult living donor liver transplantation: A single center experience in Romania. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 35 (OP54)

279. Gheorghe L, Iacob S, Caruntu F, Simionov I, Motoc A, Arama V, Preotescu L, Stefan I, Goldis A. A week-8 model predicting early virologic response (EVR) and futility of Boceprevir (BOC), Peginterferon (PEG) and Ribavirin (RBV) regimen. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 40 (OP60)

280. Simionov I, Gheorghe L, Tugui L, Andrei A, Diculescu M. Anemia and its evolution in HCV patients treated by triple therapy. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 41 (OP63)

281. Iacob R, Cotruta B, Bancila I, Gheorghe L, Dumbrava M, Becheanu G, Gheorghe C. Mucosal healing in patients with ulcerative colitis assessed by confocal laser endomicroscopy. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 45 (OP70)

282. Vadan R, Gheorghe L, Iacob R, Cotruta B, Stanel I, Bancila I, Tugui L, Zamfirescu N, Angelescu C, Pirvulescu I, Diculescu M, Gheorghe C. The frequency of infectious complications in patients with inflammatory bowel diseases under treatment with antiTNFα biological therapy. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 49 (OP76)

283. Simionov I, Gheorghe L. Influence of triple therapy on nutritional status of patients with chronic hepatitis C. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 96 (PP67)

284. Pirvulescu I, Gheorghe C, Becheanu G, Dumbrava M, Gheorghe L. The long term prognosis of autoimmune pancreatitis: Literature review and number of cases in our experience. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 114 (PP104)

285. Smira G, Cerban R, Ghidu C, Dumitru R, Grasu M, Popescu I, Gheorghe L. Impact of cytolisis after transarterial chemoembolization for hepatocellular carcinoma – A single center experience. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 121 (PP116)

286. Iacob R, Vagu C, Nastase A, Iacob S, Grigorie M, Stoica L, Herlea V, Croitoru A, Dima S, Coriu D, Paslaru L, Gheorghe L, Popescu I. Quantitative gene expression of liver progenitor cells specific genes in curatively treated hepatocellular carcinoma. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 125 (PP123)

287. Smira G, Dumitru R, Cerban R, Gheorghe C, Popescu I, Gheorghe L. A rare case of severe pancreatitis subsequent to transarterial chemoembolization in an old woman with hepatocellular carcinoma. J Gastrointestin Liver Dis 2013 (Suppl 1); 22: 155 (PP182)

288. Gheorghe L, Csiki I, Cerban R, Trifan A, Grigorescu M, Motoc A, Suceveanu A, Caruntu F, Sporea I, Rogoveanu I, Alexandrescu A. Prevalence, virological and clinical characteristics of chronic hepatitis delta (CHD) in Romania. J Hepatology 2013: Abstract 412

289. Goldis A, Tantau M, Gheorghe L, Gheorghe C, Diculescu M. The prevalence of anemia and iron deficiency in IBD inpatients and outpatients in Romania – An interim analysis on the first 120 patients. JCC 2014: S313

290. Gheorghe C, Dimitriu A, Iacob R, Cojocaru M, Lupei C, Vadan R, … Gheorghe L. Epidemiological and phenotypic characteristics of IBD patients in Romania – Results of a nationwide hospital-based registry. JCC 2014: S333

291. Lupu A, Cijevschi C, Mihai C, Iacob R, Gheorghe L, Dobru D, … Gheorghe C, et al. Is anemia a prognostic factor for disease behavior in IBD? A Romanian National Registry-based evidence study. JCC 2014: S145-S146

292. Vadan R, Gheorghe L, Diculescu M, Iacob R, Bancila I, Cotruta B, … Gheorghe C, et al. Endoscopic follow-up of patients with IBD and biological treatment: achievement and persistence of mucosal healing in patients with clinical remission. JCC 2014: S272



293. Gheorghe L, Iacob R, Iacob S, Vadan R, Guinea L, Greere M, Cotruta B, … Gheorghe C, et al. IBD in elderly Romanian patients: epidemiological and phenotypical characteristics. JCC 2014: S328-S329

294. Mateescu B, Vadan R, Negreanu L, Bengus A, Dinu R, Busuioc B, … Gheorghe L. Opportunistic infections in anti-TNF treated IBD patients: analysis from three tertiary centers in Romania. JCC 2014: S232

295. Iacob R, Guinea L, Vadan R, Greere M, Preda C, Dobru D, … Gheorghe L. Extraintestinal manifestations in Romanian IBD patients – evaluation of a cohort of over 1000 patients. JCC 2014: S331

296. Iacob R, Iacob S, Vagu C, Nastase A, Botea F, Herlea V, Croitoru A ..., Gheorghe L. Quantitative Gene Expression of Stem/Liver Progenitor Cells Specific Genes Could Be Used to Predict the Absence of Early Recurrence of Hepatocellular Carcinoma After a Potentially Curative Treatment. Transplantation 2014; 98: 167

297. Gheorghe L, Iacob R, Vagu CD, Nastase A, Iacob S, Botea F, Herlea V, et al. A predictive score using quantitative gene expression of stem/liver progenitor cells specific genes can be used to identify patients at risk for tumor recurrence in curatively treated hepatocellular carcinoma. Gastroenterology 2014; 146: S-605

298. Liana Gheorghe, Speranta Iacob, Iulia Simionov, Florin Caruntu, Adriana Motoc, Victoria Arama, Adriana Goldis, Ciprian Brisc. A week 8 stopping model for real-life genotype-1 patients with advanced fibrosis treated with Boceprevir-based triple regimen. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 7 (OP6)

299. A. Lupu, G. Robu, C. Cijevschi-Prelipcean, C. Mihai, R. Iacob, L. Gheorghe, D. Dobru, A. Tantau, A. Goldis, M. Ilie, C. Gheorghe, M. Ciocirlan, R. Vadan Anemia in patients with IBD – analysis results of the national IBD Prospect group during one year. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 21 (OP21)

300. S. Iacob, C. Ester, I. Popescu, L. Gheorghe. Risk factors for death in cirrhotic patients with non-malignant portal vein thrombosis on the waiting list for liver transplantation. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 32 (OP34)

301. R. Iacob, C. Vagu, A. Nastase, S. Iacob, F. Botea, R. Grigorie, D. Hrehoret, V. Herlea, A. Croitoru, S. Dima, L. Gheorghe, C. Gheorghe, I. Popescu. Expression profile of stem/progenitor cells specific genes in hepatocellular carcinoma and potential prognostic significance. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 36 (OP38)

302. L. Gheorghe, S. Iacob, C. Ester, R. Cerban, C. Pietrareanu, D. Tomescu, G. Droc, D. Hrehoret, V. Brasoveanu, I. Popescu. Predictors of short-term post-liver transplant mortality in the Romanian Transplant Program. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 38 (OP41)

303. C. Gheorghe, A. Dimitriu, R. Iacob, M. Cojocaru, R. Vadan, D. Dobru, C. Lupei, A. Trifan, M. Tantau, A. Goldis, G. Constantinescu, S. Gologan, B. Mateescu, D. Gheonea, L. Gheorghe, M. Diculescu. Epidemiological and phenotipic characteristics of IBD patients in Romania – results of a nationwide hospital-based registry. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 41 (OP45)

304. R. Cerban, L. Gheorghe, S. Iacob, G. Smira, C. Pietrareanu, R. Iacob, C. Ester, C. Gheorghe. Clostridium difficile infection, a poor outcome predictor in patients with cirrhosis. A tertiary Romanian liver transplant center perspective. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 44 (OP48)

305. A. Goldis, C. Cijevschi, L. Gheorghe, C. Gheorghe, D. Dobru, A. Tantau, R. Iacob, M. Diculescu. Are there any geographical differences in IBD features in Romania ? J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 72 (PP22)

306. R. Iacob, L. Guinea, R. Vadan, M. Greere, C. Preda, D. Dobru, C. Cijevschi-Prelipcean, A. Tantau, A. Goldis, M. Ilie, M. Andrei, L. Negreanu, C. Gheorghe, M. Diculescu, L. Gheorghe. Extraintestinal manifestation in Romanian IBD patients – evaluation of a cohort of over than 1,000 patients. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 104 (PP60)

307. M. Greere, R. Iacob, R. Vadan, B. Cotruta, M. Diculescu, C. Gheorghe, L. Gheorghe. Frequency and clinical characteristics of fistulizing Crohn’s disease in a Romanian tertiary referral center. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 106 (PP62)

308. L. Gheorghe, R. Iacob, S. Iacob, R. Vadan, L. Guinea, M. Greere, B. Cotruta, D. Dobru, C. Mihai, G. Stefanescu, R. Zaharie, M. Ilie, M. Jinga, M. Diculescu, C. Gheorghe. IBD in elderly Romanian patients: epidemiological and phenotypical characteristics. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 107 (PP63)

309. S. Iacob, M. Greere, L. Gheorghe. Both cholestasis and portal hypertension predicted by liver stiffness, but not by spleen stiffness. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 151 (PP114)

310. S. Iacob, R. Iacob, L. Gheorghe. Oligofructose enriched-inulin or lactulose is better for minimal hepatic encephalopathy in liver cirrhosis patients? J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 151 (PP115)

311. L. Gheorghe, S. Iacob, C. Pietrareanu, D. Hrehoret, V. Brasoveanu, D. Tomescu, G. Droc, C. Gheorghe, I. Popescu. Improved overall mortality on the Romanian waiting list for liver transplantation. J Gastrointestin Liver Dis 2014; 23 (Suppl 1): 152 (PP116)



312. Iacob S, Ester C, Iacob R, Gheorghe C, Popescu I, Gheorghe L. Risk factors associated with overalll and bleeding-related moratlity in patients with portal vein thrombosis on the waiting list for liver transplantation. J Hepatol 2015; 62: S361

313. Gheorghe L, Iacob S, Ester C, Iacob R, Gheorghe C, Popescu I. Safety and efficacy of anticoagulation therapy for portal/splanchnic vein thrombosis in patients with liver cirrhosis on the waiting list for liver transplantation. J Hepatol 2015; 62: 312

314. Ispas M, Lupu A, Gheorghe L, Dobru D, Tantau A, Goldis A, Ilie M, … Gheorghe C, et al. Prevalence of malnutrition in patients with inflammatory bowel disease – A Romanian National register-based study. JCC 2014: S276

315. Preda C, Fulger L, Tieranu C, Ionescu M, Gheorghe L, Gheorghe C, et al. Efficacy, safety, and predictors of response to Adalimumab in Crohn’s disease (CD) – A nationwide cohort study. JCC 2014; 9: S126-S127

316. Iacob S, Iacob R, Ester C, Popescu I, Gheorghe C, Gheorghe L. Risk factors associated with overall and bleeding-related mortality in patients with portal vein thrombosis on the waiting list for liver transplantation. Gastroenterology 2015; 148: S-648

317. Iacob S, Gheorghe L, Tabacelia D, Iacob R, Gheorghe C, Popescu I. New allocation score predicting both pre- and post-transplant survival in the Romanian National Transplant Program. Gastroenterology 2015; 148: S-648

318. Gheorghe L, Iacob S, Ester C, Iacob R, Popescu I, Gheorghe C. Safety and efficacy of anticoagulation therapy for splanchnic vein thrombosis in patients with liver cirrhosis on the waiting list for liver transplantation. Gastroenterology 2015; 148: S-1063

319. Iacob R, Vadan R, Csiki IE, Gheorghe L, Gheorghe C, Cijevschi C, et al. Phenotypical characteristics of Romanian IBD patients according to residence area: results of a nationwide multicentric cohort. J Gastrointestin Liver Dis 2015; 24 (Suppl 1): 13-14

320. Dimitriu A, Nicula S, Pop C, Gheorghe C, Nicula A, Gheorghe L. Ulcerative proctitis: epidemiological characteristics and factors associated with disease progression. . J Gastrointestin Liver Dis 2015; 24 (Suppl 1): 60

321. Gheorghe L, Vadan R, Iacob S, Pietrareanu C, Gheorghe C. Evaluation of the nutritional status and role of nutritional therapy in patients with liver cirrhosis included on the waiting list for liver transplantation. J Gastrointestin Liver Dis 2015; 24 (Suppl 1): 75

322. Cerban R, Iacob S, Croitoru A, Dumitru R, Grasu M, Gheorghe L. Transarterial chemoembolization in hepatocellular carcinoma – A single center experience. J Gastrointestin Liver Dis 2015; 24 (Suppl 1): 98

323. Gheorghe L. Iacob S, Popescu I. Treatment of severe recurrent hepatitis C in liver transplant recipients with new direct antivirals. J Gastrointestin Liver Dis 2015; 24 (Suppl 1): 105

324. Iacob S, Popescu I, Gheorghe L. Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir use in pre- and post-transplant setting – Experience of a single large transplant center. J Gastrointestin Liver Dis 2015; 24 (Suppl 1): 115

325. Razvan Iacob, Codruta D. Vagu, Anca Nastase, Speranta Iacob, Florin Botea, Vlad Herlea, Adina E. Croitoru, Simona Dima, Cristian Gheorghe, Irinel Popescu, Michael Ott and Liana Gheorghe. Hepatocyte Reprogramming to a Progenitor-Cell Phenotype Is a Potential Mechanism of Hepatocarcinogenesis - The Role of Reprogramming Factors: OCT4, SOX2 and NANOG. Gastroenterology 2016; 150(4), S296–S297 (Sa1367)

326. Speranta Iacob, Carmen Ester, Mihaela Lita, Liana Gheorghe. Acute Kidney Injury Severity Predicts Mortality and Response to Terlipressin in Patients With End Stage Liver Disease Awaiting Liver Transplantation. Gastroenterology 2016, Vol. 150, Issue 4, S1084 (Sa1644)

327. Gheorghe L, Iacob MS, Popescu I. 100% Virological response with 3D regimen and significant short-term liver stiffness improvement in patients with recurrent hepatitis C following liver transplantation. Am J Gastroenterol 2016; 111 (Suppl 1): S375: #855

328. Gheorghe L, Iacob MS, Trifan A, Stanciu C, Sirli R, Sporea I, ... Gheorghe C, et al. Dynamic of AFP incirrhotic patients with virological response following 3D therapy and severe necroinflammation at Fibromax. Am J Gastroenterol 2016; 111 (Suppl 1): S375: #856

329. Gheorghe L, Trifan A, Iacob MS, Stanciu C, Sirli R, Sporea I, et al...Gheorghe C. 100% virological response and adherence in genotype-1 HCV infected patients with liver cirrhosis treated with 3D regimen in a Romanian real-life cohort. Am J Gastroenterol 2016; 111 (Suppl 1): S375: #898

330. Lita M, Iacob S, Iacob R, Ester C, Cerban R, and Gheorghe L. Female predominance, low rate of PSC-IBD phenotype, low rate of dominant strictures, cholangiocarcinoma and need for transplantation in a Romanian prospective cohort of PSC. J Hepatol 2016; 64:S637: SAT-359



331. Cerban R, Croitoru A, Popescu I, Iacob S, Pietrareanu C, Herlea V, Botea F, Becheanu G, Dumitru R, Gheorghe C, Lupescu I, and Gheorghe L. Management of hepatic epithelioid hemangioendotheloma: A 5-year single-center experience. J Hepatol 2016; 64:S637: SAT-092

332. Iacob S, Popescu I, Gheorghe L. 100% Virological response with 3D regimen and significant short-term liver stiffness improvement in patients with recurrent hepatitis C following liver transplantation. Hepatology 2016; 64:809A (#1635)

333. Mihai C, Trifan A, Stanciu C, Gheorghe L, Iacob S, Diculescu M, Cijevschi C. Metabolic syndrome, hepatic steatosis and genotype 1b HCV infection in the era of DAA therapy. Hepatology 2016; 64:949A (#1918)

334. Trifan A, Singeap AM, Gheorghe L, Curescu M, Cijevschi C, Brisc C, et al. The influence of clinical signoficant portal hypertension (stage Baveno 2) on safety, tolerability, and efficacy of 3D and ribavirin (PrOD+R) in a real-world large cohort of genotype 1b cirrhotic patients. Hepatology 2016; 64:809A (#1920)

335. Gheorghe L, Iacob S, Iacob R, Gheorghe C. Virological response to ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in 150 patients with mixed cryoglobulinemia and HCV infection. Hepatology 2016; 64:956A (#1932)

336. Iacob S, Gheorghe L, Trifan A, Stanciu C, Sirli R, Sporea I, et al. Dynamics of AFP in cirrhotic patients with virological response following 3D therapy and severe necro-inflammation at Fibromax. Hepatology 2016; 64:982A (#1979)

337. Gheorghe L, Trifan A, Iacob S, Stanciu C, Sirli R, Sporea I, et al. 100% virological response and adherence in HCV genotype 1 liver cirrhosis treated with 3D regimen in a Romanian real-life cohort. Hepatology 2016; 64:996A (#2004)

338. Trifan A, Cijevschi C, Gheorghe L, Curescu M, Brisc C, Bataga S, et al. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, dasabuvir + ribavirin for treatment of HCV genotype 1b compensated cirrhosis in patients aged 65 years or older. Hepatology 2016; 64:997A (#2006)

339. Trifan A, Singeap AM, Chiriac S, Cuciureanu T, Prelipcean CC, Ciortescu I, Cojocariu C, Sfarti C, Mihai C, Stefanescu G, Gheorghe L, Iacob S, Stanciu C. Hepatic and non-hepatic events after obtaining a SVR in patients with genotype 1b liver cirrhosis-short time follow-up-single center experience. J Hepatol 2017;66:S127(THU-021)

340. Trifan A, Prelipcean CC, Gheorghe L, Curescu MG, Brisc C, Bataga S, Miftode E, Arama V, Chiriac SA, Cuciureanu T, Sporea I, Goldis A, Popescu A, Iacob S, Cojocariu C, Stefanescu G, Girleanu I, Mihai C, Ciortescu I, Stanciu C. Efficacy and safety of paritaprevir/ritonavir, ombitasvir and dasabuvir plus/minus ribavirin for treatment of hepatitis C virus genotype 1b compensated cirrhosis in patients aged 70 years or older. J Hepatol 2017;66:S284(THU-219)

341. Trifan A, Prelipcean CC, Gheorghe L, Miftode E, Chiriac SA, Cuciureanu T, Sporea I, Goldis A, Iacob S, Cojocariu C, Stefanescu G, Girleanu I, Mihai C, Ciortescu I, Stanciu C. Early regression of liver fibrosis evaluated by non-invasive methods after successful antiviral therapy in patients with HCV genotype 1b compensated cirrhosis. J Hepatol 2017;66:S285(THU-220)

342. Sporea I, Lupusoru R, Mare R, Popescu A, Sirli R, Danila M, Lazar A, Iacob S, Sandulescu L, Gheorghe L. Dynamic oof liver stiffness values by means of transient elastography in patients with hepatitis C virus liver cirrhosis undergoing interferon-free treatment. J Hepatol 2017;66:S245(THU-504)

343. Gheorghe L, Iacob S, Grasu M, Dumitru R, Iacob R, Lupescu I, Gheorghe C. Development of de novo and recurrent hepatocellular carcinoma in a Romanian cohort of compensated HCV genotype 1b liver cirrhosis with SVR after 3D and ribavirin therapy. J Hepatol 2017;66:S445(FRI-070)

344. Vadan R, Iacob S, Stoica B, Ichim S, Lita M, Manuc T, Cijevschi C, Trifan A, Dobru D, Dumitru E, Tantau M, Brisc C, Diculescu M, Gheoorghe C, Gheorghe L. Frequency and causes of malnutrition in liver disease patients: results from a multi-centric cross-sectional survey from gastroenterology tertiary clinics. J Hepatol 2017;66:S571(SAT-031)

345. Iacob S, Gheorghe L, Cijevschi C, Trifan A, Stanciu C, Mihai C, Sporea I, Sirli R, Curescu M, Diculescu M, Alexandrescu L, Sandulescu L, Goldis A, Brisc C, Simionov I, Vadan R, Pirvulescu I, Rogoveanu I, Pietrareanu C, Seicean A, Iacob R, Gheorghe C. Predictors of persistence of clinical significant pportal hypertension in patients with HCV liver cirrhosis following 3D therapy and SVR. J Hepatol 2017;66:S666(SAT-479)

346. Popa RC, Mihai C, Trifan A, Stanciu C, Gheorghe L, Iacob S, Arama V, Rogoveanu I, Diculescu M, Goldis A, Bataga S, Seicean A, Sandulescu L, Nastase R, Molagic V, Brisc C, Curescu M, Prelipcean CC. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without RBV in hepatitis C virus genotype 1-infected patients with compensated cirrhosis and multiple comorbidities. J Hepatol 2017;66:S732(SAT-258)

347. Ester C, Gheorghe L, Iacob S, Cijevschi C, Trifan A, Stanciu C, Sporea I, Sirli R, Curescu M, Brisc C, Goldis A, Arama V, Caruntu F, Rogoveanu I, Seicean A, Simionov I, Vadan R, Pirvulescu I, Pietrareanu C, Iacob R, Gheorghe C,



Diculescu M. Safety, efficacy and risk of complications for cirrhotic HCV patients with thrombocytopenia and hypoalbuminemia treated with ombitasvir/paritaprevir/ritonavir+ribavirin – a real life cohort. UEG Journal 2017;5(Suppl1):A173(P0039)

348. Popescu SA, Lupusoru R, Sirli R, Danila M, Gheorghe L, Seicean A, Trifan A, Curescu M, Goldis A, Sandulescu L, Cijevschi C, Stanciu C, Brisc C, Iacob S, Sporea I. In how many patients we will misdiagnose esophageal varices by using Baveno VI criteria. UEG Journal 2017;5(Suppl1):A629(P1335)

349. Sporea I, Lupusoru R, Popescu SA, Lazar A, Mare R, Gheorghe L, Iacob S, Sirli R. What happened with liver stiffness values assessed by means of transient elastography in patients with HCV liver cirrhosis after DAA treatment. UEG Journal 2017;5(Suppl1):A634(P1353)

350. Lita M, Ester C, Iacob S, Pietrareanu C, Cerban R, Gheorghe C, Gheorghe L. Importance of interferon-gamma release assays in evaluating candidates for liver transplantation in a country endemic for tuberculosis. UEG Journal 2017; 5(Suppl1):A637(P1361)

351. Liana Gheorghe, Speranta Iacob, Cristina Cijevschi Prelipcean, Catalina Mihai, Mugur Grasu, Radu Dumitru, Razvan Iacob, Ioana Lupescu, Pirvulescu I, Gheorghe C. Alpha fetoprotein – a useful tool for surveillance of interferon-free treated cirrhotic patients for hepatocellular carcinoma after SVR. Gastroenterology 2017, Vol. 152, Issue 5, S298(Sat465)

352. Speranta Iacob, Liliana Gheorghe, Cristina Cijevschi Prelipcean, Anca Trifan, Carol Stanciu, Ioan Sporea, Roxana Sirli, Manuela Curescu, Brisc C, Mihai C, Alexandrescu L, Sandulescu L, Goldis A, Arama V, Caruntu F, Hara L, Rogoveanu I, Diculescu M, Iacob R, Gheorghe C, Seicean A, Simionov I, Vadan R, Pirvulescu I, Pietrareanu C. Predictors of liver stiffness regression after SVR in cirrhotic patients treated with 3D regimen. Gastroenterology 2017, Vol. 152, Issue 5, S904-905 (Tu544)

353. Ioan Sporea, Raluca Lupusoru, Roxana Sirli, Alina Popescu, Mirela Danila, Larisa D. Sandulescu, Speranta Iacob, Ruxandra G. Mare, Liana Gheorghe. Dynamic of Liver Stiffness Values by Means of Transient Elastography in Patients with HCV Liver Cirrhosis Undergoing Interferon Free Treatment. Gastroenterology, Vol. 152, Issue 5, S1167 (Mo 1393)

354. Gheorghe L, Iacob S, Cijevschi C, Trifan A, Stanciu C, Sporea I, Sirli R, Curescu M, Brisc C, Mihai C, Alexandrescu L, Sandulescu L, Goldis A, Arama V, Caruntu F, Hara L, Rogoveanu I, Diculescu M, Gheorghe C, Seicean A, Iacob R, Simionov I, Vadan R, Pirvulescu I, Pietrareanu C. Prospective analysis of discordant results between Fibromax® and Fibroscan® in patients with HCV compensated liver cirrhosis before 3D antiviral therapy initiation. Gastroenterology, Vol. 152, Issue 5, S1102 (Sa1540)

355. Anca Trifan, Cristina Cijevschi Prelipcean, Liana Gheorghe, Manuela Curescu, Ciprian Brisc, Simona Bataga, Egidia Miftode, Victoria Arama, Rogoveanu I, Suceveanu A, Singeap AM, Chiriac S, Cuciureanu T, Sporea I, Goldis A, Popescu A, Iacob S et al. Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir Plus/Minus Ribavirin for Treatment of HCV Genotype 1B Compensated Cirrhosis in Patients Aged 70 Years or Older. Gastroenterology, Vol. 152, Issue 5, S904 (Tu1541)

356. Iacob R, Popa C, Herlea V, Becheanu G, Nastase A, Ghetea L, Iacob S, Sorop A, Botea F, Badea L, Vogle AM, Dima S, Croitoru A, Gheorghe C, Ott H, Popescu I, Aloman C, Gheorghe L. The significance of Sox2 expression in hepatocellular carcinoma occurring on liver cirrhosis. Hepatology 2017; 66(Suppl1):972A(1828)

357. Speranta Iacob, Iuliana Pirvulescu, Razvan Iacob, Cristian Gheorghe, Liana Gheorghe. Evaluation with transient elastography and controlled attenuation parameter of a cohort of patients with chronic liver diseases admitted in a hepatology tertiary center. Hepatology 2017; 66(Suppl1):1146A(2168)

358. Iacob R, Oana A, Iacob S, Anghel D, Constantinescu A, Lupescu I, Popescu I, Gheorghe L. Phenotypic characteristics and therapeutic multidisciplinary approach in Romanian patients diagnosed with Wilson’s disease. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 50 (PP 57)

359. Lupescu IC, Iacob S, Gheorghe L. Encephalapp Stroop Test: a modern approach for diagnosing minimal hepatic encephalopathy. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 65 (PP 92) & 123 (PD 14) (* Poster cu distinctie)

360. Lupescu IC, Iacob S, Gheorghe L. Sudden onset of coma in liver cirrhosis: differential diagnosis and precipitating factors. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 56 (PP 72)

361. Iacob S, Pirvulescu I, Iacob R, Gheorghe C and Gheorghe L. Evaluation with transient elastography and controlled attenuation parameter of a cohort of patients with CLD admitted in a hepatology tertiary center. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 68 (PP 99)

362. Iacob S, Gheorghe L, Cijevschi C, Trifan A, Stanciu C, Sporea I, Sirli R, Curescu M, Diculescu M, Sandulescu L, Alexandrescu L, Goldis A, Brisc C, Simionov I, Vadan R, Pirvulescu I, Rogoveanu I, Pietrareanu C, Seicean A, Iacob R, Gheorghe C. Model to predict clinically significant portal hypertension in patients with HCV liver



cirrhosis following SVR post-therapy with Ombitasvir/Paritaprevir/ritonavir and Dasabuvir. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 86 (PP 141)

363. Greere M, Pietrareanu C, Cerban R, Lita M, Iacob S, Brasoveanu V, Popescu I, Gheorghe L. Budd Chiari syndrome – a subacute clinical presentation in a patient with essential thrombocythemia – hematological diagnosis revealed after liver transplant. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 91 (PP 152)

364. Sporea I, Lupusoru R, Mare R, Popescu A, Gheorghe L, Iacob S, Sirli R. Dynamic of liver stiffness values by means of transient elastography in patients with HCV liver cirrhosis undergoing interferon-free treatment. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 108 (PP 190)

365. Tudoroiu MI, Constantin G, Paslaru L, Gheorghe C, Gheorghe L. The role of cystatin c in the diagnosis and prognosis of early acute kidney injury after liver transplantation. J Gastrontest Liver Dis 2017; 26 (Suppl 3): 119 (PD 5) (* Poster cu distinctie)

366. Popescu A, Lupusoru R, Sirli R, Danila M, Gheorghe L, Seicean A, Trifan A, Curescu M, Goldis A, Sandulescu L, Cijevschi C, Stanciu C, Brisc C, Iacob S, Sporea I. In how many patients will we misdiagnose esophageal varices by using the Baveno VI criteria? J Gastrontest Liver Dis 2017; 26 (Suppl 3): 121 (PD 9) (* Poster cu distinctie)

367. Ciocirlan M, Lupu A, Ionescu A, Gheorghe L, Ilie M, Gheorghe C, Dobru D, Tantau A, Goldis A, Ciocirlan M, Cijevschi C, Mihai C, Iacob R, Diculescu M. Nutritional status of patients with inflammatory bowel disease in Romania. J Gastrointestin Liver Dis 2017; 26 (Suppl 3): 128 (PD 24) (* Poster cu distinctie)

368. Lita M, Iacob S, Iacob R, Ester C, Pietrareanu C, Cerban R, Gheorghe C, Gheorghe L. Medium-term prognosis in patients with primary biliary cholangitis – experience of a tertiary hepatology center. J Gastrointestin Liver Dis 2017; 26 (Suppl 3): 128 (PD 25) (* Poster cu distinctie)

369. Pietrareanu C, Jorza C, Iacob S, Gheorghe L. Screening instruments to detect alcohol consumption in cirrhotic patients included on the waiting list for liver transplantation. J Gastrointestin Liver Dis 2017; 26 (Suppl 3): 132 (PD 34) (* Poster cu distinctie)

370. Sporea I, Lupusoru R, Mare R, Popescu A, Gheorghe L, Iacob S, Sirli R. Dynamic of liver stiffness values by means of Transient Elastography in patients with HCV liver cirrhosis undergoing interferon-free treatment. J Gastrointestin Liver Dis 2017; 26 (Suppl 3): 133 (PD 36) (* Poster cu distinctie)

371. Cerban R, Iacob S, Paslaru L, Dumitru R, Grasu M, Ester C, Lita M, Pietrareanu C, Constantin G, Gheorghe C and Gheorghe L. Utility of measurementof alpha-fetoprotein and des-ϒ-carboxy prothrombin for diagnosis of hepatocellular carcinoma in patients admitted in a large transplant center in Romania. J Gastrointestin Liver Dis 2017; 26 (Suppl 3): 135 (PD 39) (* Poster cu distinctie)

IV. CARTI SI CAPITOLE DE CARTE IV. A. CARTI 1. Vademecuum în Gastroenterologie - Afecţiuni ale tubului digestiv (partea I) L. S. Gheorghe, C. Gheorghe, Editura Nemira, Bucureşti 2002 2. Cancerele digestive: diagnostic, supraveghere si tratament – indrumar practic. C. Gheorghe, L. Gheorghe.. Editura Celsius-All, Bucuresti 2005 3. Actualitati in hepatita C – 2006. Sub redactia Liana Gheorghe, Cristian Gheorghe. Editura Celsius, Bucuresti 2006 4. 501 întrebări despre patologia digestivă în sarcină. Liana Gheorghe, Cristian Gheorghe. Editura Celsius, Bucuresti 2008 5. Hepatitis C treatment. Cernescu C, Ruta S, Gheorghe L, Iacob S, Irinel P, Wanless RS. Flying Publisher 2011 6. Recomandari Nutritionale in Gastroenterologie si Hepatologie. Liana Gheorghe, Mircea Diculescu, Cristian Gheorghe, coordonatori. Editura PIM, Bucuresti 2014 (ISBN 978-606-13-1903-9)



IV. B. CAPITOLE DE CARTE 1. Enteropatia glutenică asociată cu dermatita Duhring Brocq M. Mănuc, L. S. Gheorghe, C. Gheorghe, G. Aposteanu, V. Spulber, Al. Oproiu . În: Interdisciplinaritatea medicinei interne, sub redacţia G. Gluhovschi, I. Romoşan şi colab. Timişoara, Editura Helicon, 1993: 393-395 2. Hepatitele cronice: propunere pentru o nouă nomenclatură. Criterii de diagnostic L. S. Gheorghe & C. Gheorghe. În: Actualităţi în hepatologie, sub redacţia M. Voiculescu. Bucureşti, Editura Infomedica 1996: 101-121 3. Sindromul de encefalopatie hepatică L. Gheorghe. În: Actualităţi în hepatologie, sub redacţia M. Voiculescu. Bucureşti, Editura Infomedica 1996: 123-164 4. Tuberculoza peritoneală L. Gheorghe şi C. Gheorghe. În: I. Popescu, C. Vasilescu, eds. Peritonitele: Bucureşti, Celsius 1998: 77-83 5. Infecţia spontană a lichidului de ascită la pacienţii cu ciroză hepatică L. Gheorghe şi C. Gheorghe. În: I. Popescu, C. Vasilescu, eds. Peritonitele: Bucureşti, Celsius 1998: 84-98 6. Sindromul de intestin scurt L. Gheorghe. În: L. Gherasim, ed. Medicina Internă: Bolile digestive, hepatice şi pancreatice: Bucureşti, Editura Medicală 1999: 408-417 7. Enteropatia glutenică L. Gheorghe, Al. Oproiu. În: L. Gherasim, ed. Medicina Internă: Bolile digestive, hepatice şi pancreatice: Bucureşti, Editura Medicală 1999: 418-439 8. Afecţiuni inflamatorii de etiologie nedeterminată (boala Crohn şi colita ulcero-hemoragică) L. Gheorghe, Al. Oproiu. În: L. Gherasim, ed. Medicina Internă: Bolile digestive, hepatice şi pancreatice: Bucureşti, Editura Medicală 1999: 503-543 9. Cancerul colorectal: diagnostic, screening şi supraveghere C. Gheorghe, L. Gheorghe. În: C. Chira, N. Calomfirescu, eds. Patologia medico-chirurgicală a adultului tânăr, Bucureşti, Editura Ministerului de Interne 2001: 125-146 10. Diagnosticul şi tratamentul hepatitei cronice B L. Gheorghe, C. Gheorghe. În: C. Chira, N. Calomfirescu, eds. Patologia medico-chirurgicală a adultului tânăr, Bucureşti, Editura Ministerului de Interne 2001: 147-156 11. Diagnosticul şi tratamentul hepatitei cronice C L. Gheorghe, C. Gheorghe. În: C. Chira, N. Calomfirescu, eds. Patologia medico-chirurgicală a adultului tânăr, Bucureşti, Editura Ministerului de Interne 2001: 157-165 12. Bolile inflamatorii intestinale L. S. Gheorghe, C. Gheorghe. În: M. Grigorescu, ed. Tratat de Gastroenterologie, Bucureşti, Editura Medicală Naţională 2001, Vol. 2: 21-44 13. Polipii rectocolonici L. S. Gheorghe, C. Gheorghe. În: M. Grigorescu, ed. Tratat de Gastroenterologie, Bucureşti, Editura Medicală Naţională 2001, Vol. 2: 111-124 14. Sindroame de polipoză gastrointestinală L. S. Gheorghe, C. Gheorghe. În: M. Grigorescu, ed. Tratat de Gastroenterologie, Bucureşti, Editura Medicală Naţională 2001, Vol. 2: 125-138 15. Cancerul colorectal L. S. Gheorghe, C. Gheorghe, M. Cazacu. În: M. Grigorescu, ed. Tratat de Gastroenterologie, Bucureşti, Editura Medicală Naţională 2001, Vol. 2: 139-173 16. Bolile inflamatorii intestinale idiopatice

L. Gheorghe, C. Gheorghe. În: T. Ciurea, O. Pascu, C. Stanciu, eds. Actualităţi în Gastroenterologie şi Hepatologie 2003. Bucureşti: Editura Medicală 2003: 201-234

17. Ciroza biliară primitivă

L. Gheorghe. În: T. Ciurea, O. Pascu, C. Stanciu, eds. Actualităţi în Gastroenterologie şi Hepatologie 2003. Bucureşti: Editura Medicală 2003: 759-775

18. Tratamentul antiviral al hepatitei recurente post-transplant




19. Tratamentul medical al pancreatitei cronice


20. Principii de terapie nutriţională în gastroenterologie şi hepatologie

L. Gheorghe, C. Gheorghe. În: T. Ciurea, O. Pascu, C. Stanciu, eds. Actualităţi în Gastroenterologie şi Hepatologie 2003. Bucureşti: Editura Medicală 2003: 943-967

21. C. Gheorghe, L. Gheorghe. Hipertensiunea portala. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 743-764

22. L. Gheorghe, C. Gheorghe. Teste functionale hepatice. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 175-184

23. C. Gheorghe, L. Gheorghe. Ascita si peritonita bacteriana spontana. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura “Carol Davila” 2004: 841-852

24. L. Gheorghe, C. Gheorghe. Punctia bioptica hepatica. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 185-198

25. C. Gheorghe, L. Gheorghe. Ciroza hepatica. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 829-840

26. L. Gheorghe, C. Gheorghe. Encefalopatia hepatica. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 853-862

27. L. Gheorghe, C. Gheorghe. Sindromul hepato-renal. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 863-872

28. T. Marinescu, L. Gheorghe. Boala Wilson. In: I. Popescu, ed. Chirurgia ficatului. Bucuresti: Editura Universitara Carol Davila 2004: 897-906

29. L. Gheorghe, C. Gheorghe. Hepatitele autoimune. În: M. Grigorescu, ed. Tratat de Gastroenterologie şi Hepatologie (volumul II). Bucureşti, Ed. Medicala Naţional 2004 : 539-553

30. L. Gheorghe, C. Gheorghe. Sindromul de overlap autoimun. În: M. Grigorescu, ed. Tratat de Gastroenterologie şi Hepatologie (volumul II). Bucureşti, Ed. Medicala Naţional 2004: 554-561

31. Ion Bancila, Radu Tutuian, Elena Savulescu, Cristian Gheorghe, Liana Gheorghe, Donald O. Castell. Differences in baseline esophageal intraluminal impedance between achalasia patients and patients with normal esophageal peristalsis – A case-control study. In: D.L. Dumitrascu, L. Nedelcu, eds. Neurogastroenterology – from basic knowledge to clinical practice. Editura Medicala Universitara “Iuliu Hatieganu”, Cluj Napoca 2005: 88-92

32. L. Gheorghe. Boli inflamatorii intestinale: de la imunopatogeneză la tratament. In: Doru Dejica, ed. Tratat de imunoterapie. Editura Mega, Cluj Napoca 2006: 682-705

33. L. Gheorghe. Standardul actual de tratament in hepatita cronica C – este acesta susceptibil la optimizare? In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Teognost, Cluj Napoca 2006: 36-43 34. L. Gheorghe. Impactul severitatii bolii hepatice asupra raspunsului terapeutic in hepatita C. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2007: 19-27 35. Liana Gheorghe, Speranta Iacob. Infecţia virală C în stadiile terminale ale bolii hepatice şi la transplantaţi. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2008: 36. C. Gheorghe, Liana Gheorghe. Epidemiologia şi istoria naturală a infecţiei virale C. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2008: 37. L. Gheorghe. Sindromul hepato-renal. In: Carol Stanciu, ed. Ghiduri si protocoale de practica medicala vol. II: Boli cronice hepatice. Editura Junimea, Iasi 2008: 264-279



38. L. Gheorghe. Transplantul hepatic: obiective, indicatii si contraindicatii. In: Dan Olteanu, Miora Rizescu, eds. Caiete de Gastroenterologie si Hepatologie. Editura Semne, Bucuresti 2008: 484-503

39. Speranta Iacob, Liana Gheorghe. Transplantul hepatic: alocarea organelor pre- si post-introducerea scorului MELD. In: Dan Olteanu, Miora Rizescu, eds. Caiete de Gastroenterologie si Hepatologie. Editura Semne, Bucuresti 2008: 468-477

40. Liana Gheorghe. Fiziologia ficatului. In: Irinel Popescu, ed. Tratat de Chirurgie, volumul IX, partea a II-a, Chirurgie Generala. Editura Academiei Romane, Bucuresti 2009: 566-579

41. Liana Gheorghe, Irma Eva Csiki, Speranta Iacob, Cristian Gheorghe, Loredana Regep. Prevalenta infectiei virale C in Romania: Proiectii de viitor. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2009: 11-24 42. Cristian Gheorghe, Liana Gheorghe, Speranta Iacob. Evaluarea pre-terapeutica a pacientilor cu hepatita cronica C: de la diagnostic la factori de esec. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2009: 25-36 43. Cristian Gheorghe, Liana Gheorghe. Cand, de ce si prin ce teste se evalueaza pacientul cu infectie virala C. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2010: 30-44 44. Liana Gheorghe, Speranta Iacob. Factori asociati cu lipsa de raspuns la terapia antivirala in infectia virala C – o noua abordare. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cornice virale. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2010: 54-67 45. Cristian Gheorghe, Liana Gheorghe. Se pot introduce noi reguli de individualizare a tratamentului antiviral in infectia cronica virala C genotip 1 in functie de cinetica virala ? In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cronice virale 2011. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2011: 38-48 46. Liana Gheorghe. Care va fi standardul terapeutic al pacientilor naivi cu infectie cronica virala C genotip 1 ? Rolul polimorfismului genetic si al agentilor cu actiune antivirala directa. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cronice virale 2011. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2011: 127-142 47. Liana Gheorghe, Speranta Iacob. Selectia pacientilor pentru transplant hepatic: obiective, indicatii si contraindicatii. In: Transplantul Hepatic, Sub redactia: Irinel Popescu. Editura Academiei Romane, Bucuresti 2011: 51-64 48. Speranta Iacob, Liana Gheorghe. Sisteme de scorificare pentru prioritizarea pacientilor pentru transplant hepatic. Modele de prognostic. In: Transplantul Hepatic, Sub redactia: Irinel Popescu. Editura Academiei Romane, Bucuresti 2011: 65-72 49. Liana Gheorghe. Managementul pacientilor cu ciroza hepatica aflati pe listele de asteptare pentru transplant hepatic. In: Transplantul Hepatic, Sub redactia: Irinel Popescu. Editura Academiei Romane, Bucuresti 2011: 93-108 50. Liana Gheorghe, Speranta Iacob. Recidiva afectiunilor primare post-transplant hepatic. In: Transplantul Hepatic, Sub redactia: Irinel Popescu. Editura Academiei Romane, Bucuresti 2011: 329-348 51. Gheorghe L, Iacob S. Antiviral therapy in non-responders, relapsers and special populations. In: Cernescu C, Ruta S, Gheorghe L, Iacob S, Popescu I, Wanless RS. Hepatitis C treatment. Flying Publisher 2011: 43-75 52. Iacob S, Gheorghe L, Popescu I. Management of recurrent HCV infection following liver transplantation. In Cernescu C, Ruta S, Gheorghe L, Iacob S, Popescu I, Wanless RS. Hepatitis C treatment. Flying Publisher 2011: 75-100 53. Liana Gheorghe. Criterii de selectie a candidatilor pentru dubla si tripla terapie. Indicatii si contraindicatii. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cronice virale 2012. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2012: 62-71 54. Cristian Gheorghe, Liana Gheorghe. Definitii si semnificatii ale raspunsului virusologic in dubla si tripla terapie a infectiei cronice virale C. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cronice virale 2012. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2012: 51-61



55. Liana Gheorghe. Hepatita C recurenta post-transplant hepatic: noi strategii terapeutice si de urmarire. In: M. Grigorescu, C. Stanciu, eds. Actualitati in diagnosticul si tratamentul hepatitelor cronice virale 2012. Editura Medicala Universitara “Iuliu Hatieganu” Cluj Napoca 2012: 190-206 56. Roxana Vadan, Liana Gheorghe, Cristian Gheorghe. Metode de screening si evaluare nutritionala pentru pacientul adult. In: Recomandari Nutritionale in Gastroenterologie si Hepatologie. Liana Gheorghe, Mircea Diculescu, Cristian Gheorghe, coordonatori. Bucuresti: Ed. PIM, 2014: 9-19 57. Cristian Gheorghe, Liana Gheorghe. Nutritia perioperatorie. In: Recomandari Nutritionale in Gastroenterologie si Hepatologie. Liana Gheorghe, Mircea Diculescu, Cristian Gheorghe, coordonatori. Ed. PIM, 2014: 33-41 58. Liana Gheorghe, Mihai Mircea Diculescu. Malnutritia la pacientul hepatic. In: Recomandari Nutritionale in Gastroenterologie si Hepatologie. Liana Gheorghe, Mircea Diculescu, Cristian Gheorghe, coordonatori. Bucuresti: Ed. PIM, 2014: 43-59 59. Liana Gheorghe. Fiziologia şi explorarea în patologia hepato-biliară. În: Irinel Popescu, coordonator. Tratat de Chirurgie Hepato-Bilio-Pancreatică şi Transplant Hepatic. Bucureşti: Editura Academiei Române; 2016: 60-77 60. Liana Gheorghe. Afecţiunile hepatice în stadiu terminal. În: Irinel Popescu, coordonator. Tratat de Chirurgie Hepato-Bilio-Pancreatică şi Transplant Hepatic. Bucureşti: Editura Academiei Române; 2016: 365-382 61. Dana Tomescu, Liana Gheorghe, Speranta Iacob, Irinel Popescu. Aspecte organizatorice si administrative. In: Dana Tomescu, coordonator. Insuficienta hepatica acuta. Bucuresti: Editura Academiei Romane: 185-201 62. Liana Gheorghe, Cristian Gheorghe. Boli hepatice in sarcina (cap. 11). In: Anca Maria Panaitescu, Gheorghe Peltecu. Afectiuni medicale in sarcina: Editura Academiei Romane 2017: 253-284

V. ALTE LUCRARI SI CONTRIBUTII STIINTIFICE/POSTERE PREZENTATE LA MANIFESTARI INTERNATIONALE

1. Hereditary non-popyposis colorectal cancer: the value of genealogical analysis L. Costache, A. Pop, Al. Oproiu 5th International Symposium on Colorectal Cancer, Torino, Italia, 24-26 septembrie 1991 2. Familial adenomatous polyposis: the Establishment of a Polyposis Register L. Costache, A. Pop, Al. Oproiu 5th International Symposium on Colorectal Cancer, Torino, Italia, 24-26 septembrie 1991 3. Cumulative incidence of colorectal cancer in long-standing extensive ulcerative colitis L. Costache, A. Pop, Al. Oproiu 5th International Symposium on Colorectal Cancer, Torino, Italia, 24-26 septembrie 1991 4. The value of endoscopic/endobioptic screening for colorectal cancer detection in long standing and extensive ulcerative colitis L. Costache, A. Pop, G. Aposteanu, Al. Oproiu 5th International Symposium on Colorectal Cancer, Torino, Italia, 24-26 septembrie 1991 5. A populational study on the standard risk for colorectal cancer in Romania L. Costache, A. Pop, Al. Oproiu 5th International Symposium on Colorectal Cancer, Torino, Italia, 24-26 septembrie 1991 6. Endoscopic polypectomy – an adequate method in colorectal adenomas displaying malignant features ? L. Costache, A. Pop, G. Aposteanu, Al. Oproiu 5th International Symposium on Colorectal Cancer, Torino, Italia, 24-26 septembrie 1991 7. Hereditary non-polyposis colorectal cancer – the value of genealogical analysis. A case report.



L. Costache, Al. Oproiu, C. Gheorghe Second United European Gastroenterology Week, Barcelona, 19-24 iulie 1993 8. The standard risk for colorectal cancer in Romania C. Gheorghe, L. Costache, A. Oproiu 4th World Congress International Gastro-Surgical Club, Madrid, 27-30 octombrie 1993 9. Endobioptic surveillance for colorectal cancer in high risk group of ulcerative colitis: A meta-analysis L. Costache, C. Gheorghe, G. Aposteanu, Al. Oproiu 4th World Congress International Gastro-Surgical Club, Madrid, 27-30 octombrie 1993 10. Hereditary non-polyposis colorectal cancer (HNPCC): The value of genealogical analysis L. Costache, C. Gheorghe, Al. Oproiu 4th World Congress International Gastro-Surgical Club, Madrid, 27-30 octombrie 1993 11. The cumulative risk and incidence of colon cancer in patients with extensive and long-standing ulcerative colitis C. Gheorghe, L. Costache, Al. Oproiu 4th World Congress International Gastro-Surgical Club, Madrid, 27-30 octombrie 1993 12. Bacillary peritonitis. Report of three cases C. Gheorghe, L. Costache, G. Aposteanu, Al. Oproiu 4th World Congress International Gastro-Surgical Club, Madrid, 27-30 octombrie 1993 13. Giant mesenchymal hamartoma of the liver. An unusual cause of upper gastrointestinal bleeding. Case report L. Costache, B. Fotiade, Al. Oproiu, V. Ene, M. Stancescu, G. Aposteanu, C. Gheorghe 4th World Congress International Gastro-Surgical Club, Madrid, 27-30 octombrie 1993 1994 14. Culture of peritoneal biopsy specimens – Improvement of the method in the diagnosis of bacillary peritonitis C. Gheorghe, T. Marinescu, G. Aposteanu, L. Combei-Costache, Al. Oproiu 3rd United European Gastroenterology Week (UEGW), Oslo, 25-29 iunie1994 15. Colorectal cancer screening in ulcerative colitis – A meta-analysis C. Gheorghe, L. Gheorghe, G. Aposteanu, Al. Oproiu 2nd International Conference Colorectal tumours, Milano, 11-14 septembrie 1994 16. Familial Adenomatous Polyposis – Establishment of a County Polyposis Register in Romania L. Gheorghe, C. Gheorghe, G. Aposteanu, Al. Oproiu 2nd International Conference Colorectal tumours, Milano, 11-14 septembrie 1994 17. Total parenteral nutrition in inflammatory bowel disease – A meta-analysis L. Gheorghe 10th World Congresses of Gastroenterology (WCG), Los Angeles, 2-7 octombrie 1994 18. Clinical heterogeneity of hereditary non-polyposis colorectal cancer (HNPCC) – influence on screening L. Gheorghe, G. Aposteanu, Al. Oproiu 4th United European Gastroenterology Week, Berlin, 17-21 septembrie 1995 19. Survival analysis in patients with pancreatic cancer C. Gheorghe, L. Gheorghe, I. Popescu, S. Georgescu, G. Aposteanu, Al. Oproiu 7th World Congress of the International Gastro-Surgical Club (IGSC), Budapesta, mai 1996 20. Conventional ultrasound in prediction of non-resectability of pancreatic cancer L. Gheorghe, C. Gheorghe, M. Ionescu, S. Georgescu, G. Jovin, G. Aposteanu, Al. Oproiu 7th World Congress of the International Gastro-Surgical Club (IGSC), Budapesta, mai 1996 21. Correlation between ultrasound criteria for portal hypertension and portal-hypertensive gastropathy in hepatic cirrhosis L. Gheorghe, C. Gheorghe, Al. Oproiu 32nd Annual Meeting of the European Association for the Study of the Liver (EASL), 9-12 April 1996, London, United Kingdom 22. A new mechanism of esophageal injury during balloon dilation – hydrodynamic type C. Gheorghe, C. Popescu, L. Gheorghe, Al. Oproiu, C. Balan 5th World Polydisciplinary Congress of The OESO (Organisation internationale d’Etudes Statistiques pour les maladies de l’Oesophage): The Esophagogastric Junction, Paris, 4-7 septembrie 1996 23. The natural history of Barrett’s esophagus following total gastectomy L. Gheorghe, C. Gheorghe, G. Aposteanu, M. Stancescu, Al. Oproiu 5thWorld Polydisciplinary Congress of The OESO (Organisation internationale d’Etudes Statistiques pour les maladies de



l’Oesophage): The Esophagogastric Junction, Paris, 4-7 septembrie 1996

24. Screening for hereditary non-polyposis colorectal cancer within a County Register in Romania L. Gheorghe, C. Gheorghe, G. Aposteanu, Al. Oproiu 5-th United European Gastroenterology Week (UEGW), Paris, 2-6 noiembrie 1996 25. Correlation between endoscopic findings and histology in portal hypertensive gastropathy C. Gheorghe, L. Gheorghe, G. Aposteanu, A. Oproiu. 5th United European Gastroenterology Week (UEGW), Paris, 2-6 noiembrie 1996 26. Ultrasound criteria predicting the evolution from mild to severe portal-hypertensive gastropathy in cirrhosis L. Gheorghe, C. Gheorghe, Al. Oproiu 6th United European Gastroenterology Week (UEGW), Birmingham, 18-23 octombrie 1997 27. Gastric polyps: Frequency, histologic types, and their relationship to gastritis C. Gheorghe, G. Aposteanu, L. Gheorghe, Al. Oproiu 6-th United European Gastroenterology Week (UEGW), Birmingham, 18-23 octombrie 1997 28. Proposal of a new mechanism for esophageal perforation in the course of esophageal dilation C. Gheorghe, C. Bălan, L. Gheorghe, Al. Oproiu 11st World Congress of gastroenterology (WCG), Viena 6-11 septembrie 1998 29. Ulcerative colitis in Southern Romania – incidence and epidemiological features 1990-1997 L. Gheorghe, C. Gheorghe, G. Aposteanu, C. Popescu, C. Popescu, Al. Oproiu Al 11-lea Congres Mondial de Gastroenterologie, Viena 6-11 septembrie 1998 30. . Prevalence, endoscopic and ultrasound criteria predicting the development of portal-hypertensive colopathy in hepatic cirrhosis C. Gheorghe, L. Gheorghe, R. Vadan, I. Simionov, Al. Oproiu. 34th Annual Meeting of the European Association for the Study of the Liver (EASL), 8-12 aprilie 1999, Napoli, Italia 31. The risk for colorectal cancer in diminutive colonic polyps L. Gheorghe, C. Gheorghe, G. Aposteanu, Al. Oproiu 9th World Congress of the International Gastro-Surgical Club (IGSC), 20-23 octombrie 1999, Nagasaki, Japonia 32. Gastric polyps: Features and relationship with gastritis C. Gheorghe, L. Gheorghe, G. Aposteanu, Al. Oproiu 9th World Congress of the International Gastro-Surgical Club (IGSC), 20-23 octombrie 1999, Nagasaki, Japonia 33. Portal-hypertensive colopathy in hepatic cirrhosis: frequency and their relationship with endoscopic/ultrasound features C. Gheorghe, L. Gheorghe, R. Vădan, I. Simionov, Al. Oproiu Basel Liver Week, 20-25 octombrie 1999, Basel, Elveţia 34. Abdominal lymph nodes and the response to antiviral therapy in chronic hepatitis C L. Gheorghe, C. Gheorghe, G. Aposteanu, C. Pietrăreanu, L. Ţugui, Al. Oproiu Basel Liver Week, 20-25 octombrie 1999, Basel, Elveţia 35. Long term follow-up in patients with celiac disease L. Gheorghe, C. Gheorghe, G. Aposteanu, G. Becheanu, C. Toader-Dragulin, L. Tugui, Al. Oproiu

7th United European Gastroenterology Week (UEGW), 13-17 noiembrie 1999, Roma, Italia

36. Reproducibility of Goseki grading of gastric cancer assessed at endoscopy and surgery C. Gheorghe, L. Gheorghe, G. Aposteanu, G. Becheanu, V. Herlea, I. Simionov, R. Vadan, Al. Oproiu 7th United European Gastroenterology Week (UEGW), 13-17 noiembrie 1999, Roma, Italia

37. Colonoscopic prediction of post-surgical recurrence in patients with Crohn’s disease C. Gheorghe, L. Gheorghe, R. Vadan, C. Toader, I. Popescu, M. Ionescu, Al. Oproiu Falk Symposium, Bucureşti, 4 noiembrie 2000 38. Oral mesalazine for the maintenance therapy in postsurgical patients with Crohn’s disease L. Gheorghe, C. Gheorghe, R. Vadan, C. Toader, I. Popescu, M. Ionescu, Al. Oproiu Falk Symposium, Bucureşti, 4 noiembrie 2000 39. Portal hypertensive gastropathy: prevalence and predictive factors



C. Gheorghe, L. Gheorghe, R. Vădan, I. Simionov, I. Iova, G. Aposteanu 36th Annual Meeting of the European Association for the Study of the Liver, 18-22 aprilie 2001, Praga, Cehia 40. The Vienna classification of Crohn’s disease – Is a relationship between age, behaviour and location ? L. Gheorghe, C. Gheorghe, L. Ţugui, M. Badea, I. Pârvulescu, I. Simionov, G. Aposteanu 9th United European Gastroenterology Week (UEGW), 6-10 octombrie 2001, Amsterdam, Olanda 41. Endoscopic lesions predictive for early postoperative recurrence of Crohn’s disease C. Gheorghe, L. Gheorghe, R. Vădan, C. Toader, O. Stan, I. Popescu, M. Ionescu 9th United European Gastroenterology Week (UEGW), 6-10 octombrie 2001, Amsterdam, Olanda 42. Prophylactic banding ligation of high risk esophageal varices in patients on the waiting list for liver transplantation: An interim report. C. Gheorghe, L. Gheorghe, R. Vadan, D. Hrehoret, I. Popescu Biennial Meeting of the Association for the Study of the Liver and 37-th Annual Meeting of the European Association for the Study of the Liver, Madrid, 15-21 aprilie 2002 43. Compliance of cirrhotic patients with spontaneous bacterial peritonitis to prophylactic antibiotic therapy: influence on the recurrence I. Simionov, L. Gheorghe, C. Gheorghe, R. Vadan Biennial Meeting of the Association for the Study of the Liver and 37-th Annual Meeting of the European Association for the Study of the Liver, Madrid, 15-21 aprilie 2002

44. Diminutive colonic adenomas and the risk for colorectal cancer

C. Gheorghe, L. Gheorghe, G. Becheanu, A. Frujinoiu, C. Mihaila

10th United European Gastroeterology Week (UEGW), Geneva, 19-23 October 2002 45. Predictive factors of rebleeding in patients with endoscopic variceal ligation R. Vadan, C. Gheorghe, I. Iova, C. Mihaila, A. Frujinoiu, C. Croitoru, L. Gheorghe 10th United European Gastroeterology Week (UEGW), Geneva, 19-23 October 2002 46. Infliximab for refractory and fistulizing Crohn’s disease: saving patients from surgical treatment L. Gheorghe, C. Gheorghe, M. Badea, R. Vadan, I. Parvulescu, C. Toader, L. Tugui, I. Popescu 12th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Istanbul, 30 October-2 November 2002 47. Minimal histopathological changes in non-erosive gastroesophageal reflux disease C. Gheorghe, G. Becheanu, I. Parvulescu, L. Gheorghe 12th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Istanbul, 30 October-2 November 2002 48. Efficacy of the treatment with Famotidine in non-erosive gastroesophageal reflux disease I. Parvulescu, C. Gheorghe, G. Becheanu, L. Gheorghe 12th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Istanbul, 30 October-2 November 2002 49. Predictors of death on the waiting list for liver transplantation in Romania. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe, A. Stoicescu, I. Popescu. 11st UEGW, Madrid, 1-6 noiembrie 2003 50. Argon-plasma coagulation in the treatment of radiation proctitis – what power setting to choose? C. Gheorghe, R. Iacob, L. Gheorghe, S. Iacob, I. Simionov, I. Bancila. 11st UEGW, Madrid, 1-6 noiembrie 2003 51. The influence of moderate alcohol intake on the severity of chronic hepatitis C. R. Vadan, L. Gheorghe, G. Becheanu, R. Iacob, M. Dumbrava, C. Gheorghe. 11st UEGW, Madrid, 1-6 noiembrie 2003 52. The side effect profile and tolerability of Peginterferon alpha 2a in combination with RBV compared with conventional interferon alpha 2a and RBV in patients with chronic hepatitis C. R. Iacob, S. Iacob, L. Gheorghe, M. Diculescu, C. Gheorghe, I. Constantinescu, A. Ionescu, M. Ciocarlan. 11st UEGW, Madrid, 1-6 noiembrie 2003 53. A rapid diagnostic test for HBV infection: efficacy and advantages. S. Iacob, R. Iacob, M. Diculescu, L. Gheorghe, I. Simionov, R. Vadan, I. Stanel.



13rd World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Estoril, Portugalia, 3-7 decembrie 2003 54. MELD, Child-Pugh and Maddrey scores in assessing the prognosis of patients with alcoholic hepatitis superimposed on alcoholic cirrhosis. I. Parvulescu, S. Iacob, R. Iacob, L. Gheorghe. 13rd World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Estoril, Portugalia, 3-7 decembrie 2003 55. An alternative model to predict survival for patients on the waiting list for liver transplantation useful in the case of long waiting period. S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, A. Stoicescu, I. Popescu. 13rd World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Estoril, Portugalia, 3-7 decembrie 2003 56. Efficacy and complications of endoscopic dilation in achalasia. C. Gheorghe, R. Iacob, I. Bancila, N. Zamfirescu, L. Gheorghe, S. Iacob, R. Brescan, C. Popescu, C. Zaharia. 13rd World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Estoril, Portugalia, 3-7 decembrie 2003 57. Pros and cons of band ligation versus sclerotherapy in the treatment of variceal bleeding. R. Iacob, C. Gheorghe, M. Diculescu, S. Iacob, L. Gheorghe. 13rd World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Estoril, Portugalia, 3-7 decembrie 2003 58. Incidence and predictive factors associated with small colorectal polyps presenting as advanced adenomas (P101). C. Gheorghe, R. Iacob, I. Bancila, G. Becheanu, L. Gheorghe, S. Iacob. 14th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Zurich, Elvetia, 9-12 septembrie 2004 59. Imaging characteristics or MELD score – which predict better survival in cirrhotic patients ? (P176). R. Iacob, L. Gheorghe, S. Iacob, C. Gheorghe, I. Popescu. 14th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Zurich, Elvetia, 9-12 septembrie 2004 60. Model for End-StageLiver Disease – the predictive value of death for individual components (P184). S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, I. Popescu. 14th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Zurich, Elvetia, 9-12 septembrie 2004 61. Challenges of the diagnosis of Wilson disease in the year 2004 (P259). L. Gheorghe, S. Iacob, C. Gheorghe, R. Vadan, R. Iacob, A. Constantinescu, I. Popescu. 14th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Zurich, Elvetia, 9-12 septembrie 2004 62. Which histologic score is better for diagnosing chronic hepatitis C ? (P268). R. Iacob, G. Becheanu, M. Dumbrava, S. Iacob, L. Gheorghe, C. Gheorghe. 14th World Congress of the International Association of Surgeons and Gastroenterologists (IASG), Zurich, Elvetia, 9-12 septembrie 2004 63. The prevalence and risk factors for malnutrition in patients with cirrhosis (04-A-622-ESPEN). R. Vadan, L. Gheorghe, M. Badea, S. Iacob, C. Gheorghe. 26th Congress of ESPEN, Lisbon, Portugal, 11-14 September 2004 64. Diagnosis of Wilson’s disease: still a challenge (MON-G-94). L. Gheorghe, S. Iacob, C. Gheorghe, R. Vadan, R. Iacob, A. Constantinescu, C. Angelescu, I. Popescu. 12th UEGW, 25-29 September 2004, Prague, Czech Republic 65. Concordance between three histologic scoring systems used for the evaluation of chronic hepatitis C (TUE-G-93). R. Iacob, G. Becheanu, M. Dumbrava, S. Iacob, L. Gheorghe, C. Gheorghe. 12th UEGW, 25-29 September 2004, Prague, Czech Republic 66. Hepatic involvement in celiac disease: prevalence, etiopathogenesis, and risk factors (TUE-G-229). L. Tugui, L. Gheorghe, C. Gheorghe, G. Becheanu, R. Vadan, I. Simionov, A. Dumitru, R. Iacob, M. Diculescu. 12th UEGW, 25-29 September 2004, Prague, Czech Republic 67. Small colorectal advanced adenomas: what incidence and associated risk factors ? (WED-G-187). C. Gheorghe, R. Iacob, I. Bancila, G. Becheanu, L. Gheorghe, S. Iacob. 12th UEGW, 25-29 September 2004, Prague, Czech Republic



68. How can we predict associated portal vein thrombosis when hepatocellular carcinoma is diagnosed in liver cirrhosis ? (WED-G-114). M. Ciocarlan, M.E. Ciocarlan, L.S. Gheorghe, C. Angelescu, I. Simionov, C. Preda, A. Croitoru, M. Diculescu. 12th UEGW, 25-29 September 2004, Prague, Czech Republic 69. Peginterferon alpha-2a and peginterferon alpha-2b: comparison of side effects profile in patients with chronic hepatitis C. S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, I. Simionov, R. Vadan. Falk Symposium No. 144, 16-17 octombrie, Freiburg, Germany 70. Predictive factors for the diagnosis of hepatic Wilson’s disease. R. Iacob, L. Gheorghe, S. Iacob, C. Gheorghe, R. Vadan, C. Angelescu, G. Becheanu. Falk Symposium No. 144, 16-17 octombrie, Freiburg, Germany 71. Autoimmune hepatitis and associated extrahepatic manifestations. R. Iacob, L. Gheorghe, S. Iacob, C. Gheorghe. Falk Symposium No. 142 (Autoimmune Liver Disease), 16-17 octombrie, Freiburg, Germany 72. Azathioprine therapy and adverse drug reactions in patients with primary biliary cirrhosis and primary sclerosing cholangitis. S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, I. Simionov. Falk Symposium No. 142 (Autoimmune Liver Disease), 16-17 octombrie, Freiburg, Germany 73. The prediction of response to treatment in autoimmune hepatitis. I. Simionov, R. Iacob, S. Iacob, L. Gheorghe, C. Gheorghe. Falk Symposium No. 142 (Autoimmune Liver Disease), 16-17 octombrie, Freiburg, Germany 74. Prevalence of malnutrition and risk factors in patients with liver diseases referred to tertiary gastroenterology assistance: a multicentric study. C. Gheorghe, R. Iacob, L. Gheorghe, S. Iacob, R. Vadan, M. Diculescu, A. Goldis, E. Dumitru, D. Dobru, E. Miutescu, A. Saftoiu, A. Fraticiu, O. Pascu. 14th Biennial Conference of the Asian Pacific Association for the Study of the Liver (APASL), 11-15 December 2004 75. Natural history of compensated hepatitis B and D virus - related cirrhosis. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe. 14th Biennial Conference of the Asian Pacific Association for the Study of the Liver (APASL), 11-15 December 2004 76. Predictive factors of non-neoplastic portal vein thrombosis in cirrhotic patients. S. Iacob, L. Gheorghe, A. Istrate, R. Crintea, R. Iacob, C. Gheorghe. 40th Annual Meeting of the European Association for the Study of the Liver (EASL), Paris, 13-17 aprilie 2005 77. Changing epidemiologic pattern of gastric pattern in Romania. C. Gheorghe, S. Iacob, I. Bancila, L. Gheorghe, R. Iacob, M. Fleancu, C. Marica. 15th World Congress of The International Association of Surgeons and Gastroenterologists (IASG), Praga, 7-10 septembrie 2005 78. Risk factors for colorectal polyps in cirrhotic patients included on the waiting list for liver transplantation. C. Gheorghe, S. Iacob, L. Gheorghe, R. Iacob, I. Popescu. 15th World Congress of The International Association of Surgeons and Gastroenterologists (IASG), Praga, 7-10 septembrie 2005 79. Malnutrition as a risk factor for bleeding after endoscopic band ligation in patients with liver cirrhosis. C. Gheorghe, L. Gheorghe, S. Iacob, R. Iacob. 27th Congress of ESPEN, Bruxelles, 27-30 august 2005 80. Liver steatosis in chronic hepatitis B and C. L Gheorghe, S. Iacob, C. Gheorghe, R. Iacob, I. Simionov, R. Vadan, I. Parvulescu. World Congress of Gastroenterology, Montreal, Canada , 10-14 septembrie 2005 81. HBV-HDV versus HBV liver cirrhosis: clinical course and prognosis. S. Iacob, L. Gheorghe, R. Iacob, C. Gheorghe, I. Popescu. World Congress of Gastroenterology, Montreal, Canada , 10-14 septembrie 2005 82. Predictors of hepatocellular carcinoma occurrence in patients with cirrhosis. S. Iacob, L. Gheorghe, C. Gheorghe, R. Iacob, D. Bucur, A. Croitoru. 56th AASLD Annual Meeting, 11-15 November 2005, San Francisco, Statele Unite ale Americii 83. The safety of infliximab use in clinical practice: The experience of an eastern European clinic. Liana Gheorghe, Roxana Vadan, Cristian Gheorghe, Ion Bancila, Ion Calin, Carmen Preda, Mircea Diculescu.



Falk Symposium No. 151 (Emerging Issues in Inflammatory Bowel Diseases), 24-25 martie 2006, Sydney, Australia 84. A model to predict one year graft failure in patients transplanted for HCV cirrhosis. S. Iacob, S. Beckebaum, R. Iacob, V. Cicinnati, C. Klein, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. 41st Annual Meeting of EASL, Viena, 26-30 aprilie 2006 85. Predictive factors of sustained virological and histological response after combined antiviral therapy in transplanted patients with recurrent hepatitis C. S. Iacob, S. Beckebaum, V. Cicinnati, R. Iacob, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. 41st Annual Meeting of EASL, Viena, 26-30 aprilie 2006 86. Protective factors for severe recurrence of hepatitis C after liver transplantation. S. Iacob, S. Beckebaum, V. Cicinnati, R. Iacob, C. Klein, L. Gheorghe, C. Gheorghe, I. Popescu, A. Frilling, M. Malago, G. Gerken, C. Broelsch. Digestive Disease Week, Los Angeles, 20-25 mai 2006 87. Frequency and predictive factors for acute biliary pancreatitis in patients with choledocolithiasis. C. Gheorghe, I. Parvulescu, L. Gheorghe, R. Iacob, I. Bancila. 16th World Congress of the International Association of Surgeons & Gastroenterologists (IASG), Madrid 25-27 mai 2006 88. The role of endoscopic ultrasonography in diagnosis and management of the subepithelial lesions in the upper gastrointestinal tract. M. Jinga, C. Gheorghe, T. Nicolae, L. S. Gheorghe, F. Vasilescu, P. Nuta, R. Costache, D. G. Popescu, L. F. Florea, R. Brescan, E. Michiu, T. Tabaran. 15th International Symposium on Endoscopic Ultrasound EUS 2006, Amsterdam, 28-30 iunie 2006 89. MELD score variation: predictor of death on waiting list for liver transplantation. Speranta Iacob, R. Iacob, Liana Gheorghe, C. Gheorghe, I. Popescu. 13th Congress of the European Society for Organ Transplantation/15th Congress of the European Transplant Coordinators Organization, 29 septembrie-3 octombrie 2007, Praga, Republica Cehă 90. Early diagnosis of small hepatocellular carcinoma in cirrhotic patients using real-time elastography. Liana Gheorghe, Speranta Iacob, Razvan Iacob, Gabriel Becheanu, Mona Dumbrava, Cristian Gheorghe, Ioana Lupescu, Irinel Popescu. Falk Workshop “Strategies of Cancer Prevention in Gastroenterology” Mainz Germany, 17 September 2008: Poster 17 91. Real-time elastography – Clinical usefulness in patients with chronic hepatitis C. Liana Gheorghe, Speranta Iacob, Razvan Iacob, Gabriel Becheanu, Mona Dumbrava. Falk Symposium 167: Liver under constant attack - from fat to viruses, Mainz Germany, September 20-21, 2008: Poster 41 92. Early recurrent hepatitis C following liver transplantation – independent predictor of patient survival. Speranta Iacob, Liana Gheorghe, Doina Hrehoret, Gabriel Becheanu, Vlad Herlea, Irinel Popescu. Falk Symposium 167: Liver under constant attack - from fat to viruses, Mainz Germany, September 20-21, 2008: Poster 56 93. Model to Predict Crohn’s Disease Behaviour Using Mucosal Inflammatory Genes Expression Profile and ASCA Titer. Razvan Iacob, Daniela Iancu, Ligia Barbarii, Ileana Constantinescu, Adela Toader, Bogdan Cotruta, Speranta Iacob, Serban Gologan, Carla Baceanu, Roxana Vadan, Liana Gheorghe, Cristian Gheorghe, Silviu Iobagiu, Mircea Diculescu. Digestive Disease Week, 30 mai – 4 iunie 2009, Chicago, SUA 94. Usefulness of staging systems for hepatocellular carcinoma in predicting recurrence after surgical therapy. S. Iacob, S. Dima, E. Matei, R. Iacob, L. Gheorghe, C. Gheorghe, I. Popescu. 17th UEGW, 21-25 noiembrie 2009, Londra, Marea Britanie 95. The safety of biological anti-TNF treatment for inflammatory bowel diseases in a country with high prevalence of tuberculosis. L. Gheorghe, R. Vadan, G. Smira, C. Angelescu, S. Suciu, C. Gheorghe. Falk Symposium 170: “IBD and IBS: Novel Mechanisms and Future Practice”, 11-12 septembrie 2009, Glasgow, Marea Britanie 96. Azathioprine use, efficacy and tolerance in the treatment of Crohn’s disease in a region with low prevalence of severe cases of the disease. R. Vadan, L. Gheorghe, G. Smira, C. Angelescu, M. Ciocirlan, C. Preda, C. Gheorghe. Falk Symposium 170: “IBD and IBS: Novel Mechanisms and Future Practice”, 11-12 septembrie 2009, Glasgow, Marea Britanie



97. Frequency and treatment of IBS-like symptoms in Crohn’s disease patients with endoscopic remission. I. Bancila, R. Vadan, C. Gheorghe, G. Becheanu, L. Gheorghe. Falk Symposium 170: “IBD and IBS: Novel Mechanisms and Future Practice”, 11-12 septembrie 2009, Glasgow, Marea Britanie 98. Predictors of relapse among patients treated with standard or induction dose of peginterferon alfa-2a (40KD) combined with standard or higher dose ribavirin in difficult-to-cure patients. L. Gheorghe. EASL Viena 2010 99. The impact and the prevalence of nonalcoholic fatty liver disease on chronic hepatitis B. I. Pirvulescu, S. Suciu, A. Lupu, L. Gheorghe, M. Diculescu, C. Gheorghe. EASL, Viena 2010 100. Maintenance treatment with Infliximab versus Azathioprine in Crohn’s disease: a prospective study. L. Gheorghe, R. Vadan, C. Gheorghe. Falk Symposium 172, Miami 2010 101. The evolution of nutritional status in patients with severe forms of Crohn’s disease treated with Infliximab. C. Gheorghe, R. Vadan, L. Gheorghe. Falk Symposium 172, Miami 2010 102. Pegylated interferon alpha-2b for the management of patients with chronic hepatitis delta. L. Gheorghe, S. Iacob, I. Simionov, R. Vadan, I. Constantinescu, I. Sporea, M. Grigorescu. Falk Symposium 179, Brussels 30 sept-1 oct 2011 103. Safety of infliximab treatment in patients with stenosing forms of Crohn’s disease Cristian Gheorghe, Roxana Vadan, Liana Gheorghe, Sebastian Suciu, Mircea Diculescu. Falk Symposium 179, Brussels 30 sept-1 oct 2011 104. Cutaneous complications in Crohn’s disease – A therapeutic challenge Liana Gheorghe, Sebastian Suciu, Roxana Vadan, Bogdan Cotruta, Ion Bancila, Cristian Gheorghe. Falk Symposium 179, Brussels 30 sept-1 oct 2011 105. Serum high sensitivity C-reactive protein (hs-CRP) – a noninvasive biomarker in differentiating non-alcoholic steatohepatitis and simple steatosis in morbidly obese patients. I. Pirvulescu, L. Gheorghe, G. Becheanu, S. Fica, M. Dumbrava, C. Copaescu, C. Gheorghe, M. Diculescu. 19th UEGW Stockholm 22-26 Oct 2011 106. The prevalence and the liver stiffness evaluated by transiert elastography in hepatitis D virus co-infection in comparison with hepatitis B virus monoinfection. I. Pirvulescu, L. Gheorghe, S. Iacob, C. Radu, C. Gheorghe. 19th UEGW Stockholm 22-26 Oct 2011 107. Predictive factors of poor prognosis in Wilson cirrhosis. S. Iacob, R. Iacob, R. Cerban, G. Smira, A. Constantinescu, L. Gheorghe. 19th UEGW Stockholm 22-26 Oct 2011 108. Endoscopic colonic lesions in liver transplant candidates C. Gheorghe, L. Gheorghe, G. Smira, S. Iacob, SM Suciu, I. Popescu. 19th UEGW Stockholm 22-26 Oct 2011 109. L. Gheorghe, R. Vadan, C. Gheorghe. Maintenance treatment with Infliximab versus Azathioprine in Crohn’s disease: a prospective study. Falk Symposium 172, Miami 2011 110. C. Gheorghe, R. Vadan, L. Gheorghe. The evolution of nutritional status in patients with severe forms of Crohn’s disease treated with Infliximab. Falk Symposium 172, Miami 2011 111. L. Gheorghe, R. Cerban, R. Vadan, C. Toader, C. Gheorghe, C. Cotruta. Pyoderma gangrenosum in adult IBD patients: prevalence, risk factors and therapeutic control. ECCO Annual Meeting 2012: P149 112. L. Gheorghe, A. Constantinescu, R. Vadan, R. Cerban, C. Gheorghe. Incidence and predictors of colorectal dysplasia and cancer in a populational-based cohort of IBD patients in Romania. ECCO Annual Meeting 2012: P148 113. C. Gheorghe, R. Iacob, B. Cotruta, I. Bancila, G. Becheanu, M. Dumbrava, L. Gheorghe. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis - a pilot study. ECCO Annual Meeting 2012: P195



114. R. Vadan, L. Gheorghe, C. Gheorghe, S. Suciu. Silent endoscopic relapse in patients with clinical maintained remission and previous deep remission on scheduled treatment with infliximab. ECCO Annual Meeting 2012: P373 115. I. Simionov, L. Gheorghe, C. Angelescu, R. Vadan, I. Pirvulescu, G. Smira. Influence of contrast-enhanced ultrasound in diagnosis of focal liver lesions – experience of a single tertiary centre of gastroenterology and hepatology. EUROSON Congress 2012, 22-24 April 2012, Madrid 116. Liana Gheorghe, Iulia Simionov. Percutaneous radiofrequency ablation with ultrasonographic guidance of focal malignant liver lesions – experience of a single Romania centre. EUROSON Congress 2012, 22-24 April 2012, Madrid 117. Smira G, Iacob S, Gheorghe C, Popescu I, Gheorghe L. Adult living donor liver transplantation – How efficient and safe is the donation? 47the Annual Meeting of EASL, Barcelona, 18-22 april 2012: A222 118. Gheorghe L, Iacob S, Simionov I, Vadan R, Constantinescu I. Efficacy of antiviral therapy in 102 Romanian patients with chronic hepatitis delta. ? 47the Annual Meeting of EASL, Barcelona, 18-22 april 2012: A517 119. I. Simionov, L. Gheorghe. Clinicopathological features and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. 47the Annual Meeting of EASL, Barcelona, 18-22 april 2012: A977 120. S. Iacob, R. Iacob, A. Nastase, D. Coriu, L. Paslaru, I. Popescu, L. Gheorghe. Recipient IL28B gene polymorphism and recurrent hepatitis C following liver transplantation in Romanian patients. ILTS San Francisco 2012 121. L. Gheorghe, S. Iacob, C. Ghidu, R. Iacob, R. Cerban, I. Simionov, A. Croitoru, C. Gheorghe, I. Popescu. Liver stiffness value assessed by transient elastography correlates with nodule size in patients with hepatocellular carcinoma DDW 2012 Accepted Abstracts; A-851 (Su2040) 122. C. Gheorghe, R. Iacob, B. Cotruta, I. Bancila, G. Becheanu, M. Dumbrava, L. Gheorghe. Mucosal healing in patients with ulcerative colitis assessed by confocal laser microscopy DDW 2012 Accepted Abstracts; A-477 (Sa1604) 123. L. Gheorghe, S. Iacob, R. Cerban, D. Coriu, C. Gheorghe. Anticoagulation therapy in cirrhotic patients with nonmalignant portal vein thrombosis 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P26 124. L. Gheorghe, I. Simionov, L. Tugui, M. Diculescu, C. Cotruta, D. Coriu. Efficacy and safety of triple therapy in clinical practice 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P27 125. L. Gheorghe, S. Iacob, C. Ghidu, R. Iacob, C. Gheorghe, I. Simionov, I. Sporea, M. Danila, A. Croitoru, M. Croitoru, D. Hrehoret, I. Popescu. Hepatocellular carcinoma: Aspects of management at two tertiary centres in Romania 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P28 126. R. Iacob, S. Iacob, A. Nastase, M. Grigorie, L. Paslaru, D. Coriu, S. Dima, A. Croitoru, V. Herlea, C. Gheorghe, L. Gheorghe, and I. Popescu. Quantitative gene expression of liver enriched transcription factors in curatively treated hepatocellular carcinoma 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P34 127. S. Iacob, D. Hrehoret, E. Matei, B. Dorobantu, V. Brasoveanu, M. Dumbrava, G. Becheanu, V. Herlea, I. Popescu, and L. Gheorghe. Follow-up and predictors of graft outcome in recurrent hepatitis C post-liver transplantation 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P35 128. I. Simionov, L. Gheorghe. Influence of triple therapy on nutritional status of patients with chronic hepatitis 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P71 129. I. Simionov, C. Gheorghe, L. Gheorghe. Clinopathological features and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P72 130. G. Smira, S. Iacob, C. Gheorghe, I. Popescu, L. Gheorghe. Adult living donor liver transplantation – 8 year donor safety experience 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P74 131. A. Constantinescu, L. Gheorghe, R. Vadan, C. Gheorghe. Survey of the efficacy and safety of Infliximab in the first pediatric patients with Crohn’s disease treated in Romania 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P16



132. Andra Constantinescu, C. Gheorghe, R. Vadan, L. Gheorghe. Frequency, endoscopic characteristics and therapeutic possibilities for dysplastic lesions in inflammatory bowel disease 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P17 133. C. Gheorghe, R. Vadan, Andra Constantinescu, L. Gheorghe. The prevalence and risk factors of colorectal dysplasia in patients with Crohn’s disease 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P33 134. R. Vadan, L. Gheorghe, A. Constantinescu, S. Suciu, M. Diculescu, C. Gheorghe. Long-term efficacy of maintenance treatment with infliximab in current clinical practice: A prospective study in patients with Crohn’s disease 32nd Romanian National Congress of Gastroenterology and Hepatology, Targu Mures: P82 135. Pirvulescu I, Gheorghe L, Becheanu G, Dumbrava M, Fica S, Copaescu C, Gheorghe C, Diculescu M. Noninvasive biomarkers model for the diagnosis of nonalcoholic steatohepatitis in morbidly obese patients. 20th UEGW, Amsterdam 2012: OP296 136. Smira G, Iacob S, Gheorghe C, Popescu I, Gheorghe L. Adult living donor liver transplantation – 8 year donor safety experience. 20th UEGW, Amsterdam 2012: P0042 137. Iacob R, Iacob S, Nastase A, Vagu C, Grigorie M, Dumitrascu T, Tanase AM, Dorobantu B, Stoica L, Paslaru L, Coriu D, Dima SO, Croitoru A, Gheorghe C, Gheorghe L, Popescu I. Quantitative gene expression of liver enriched transcription factors in curatively treated hepatocellular carcinoma. 20th UEGW, Amsterdam 2012: P0049 138. Simionov I, Gheorghe L. Triple therapy for HCV in real life – effectiveness and tolerability. 20th UEGW, Amsterdam 2012: P0591 139. Gheorghe C, Vadan R, Cotruta B, Cerban R, Gheorghe L. Localization of endoscopic lesions in patients with medically induced mucosal healing and new flare of Crohn’s disease. 20th UEGW, Amsterdam 2012: P1398 140. R. Vadan, L. Gheorghe, R. Cerban, B. Cotruta, L. Tugui, I. Stanel, C. Angelescu, I. Bancila, M. Diculescu, C. Gheorghe. Deep remission: A recurrent feature in patients with Crohn’s disease and lomg term biologic therapy ECCO Annual Meeting 2013, Viena: P458 141. Gheorghe L, Csiki I, Cerban R, Trifan A, Grigorescu M, Motoc A, Suceveanu A, Caruntu F, Sporea I, Rogoveanu I, Alexandrescu A. Prevalence, virological and clinical characteristics of chronic hepatitis delta (CHD) in Romania. Falk Symposyum 19, Londra, UK: Liver Diseases in 2013: Advances in Pathogenesis and Treatment: P32* (pg. 136) 142. Lupu A, Cijevschi C, Mihai C, Iacob R, Gheorghe L, Dobru D, Tantau A, Goldis A, Ilie M, Gheorghe C, Ciocarlan M, Diculescu M, on behalf of IBDPROSPECT Study Group. Is anemia a prognostic factor for disease behaviour in IBD? A Romanian National Register evidence based study. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P200 143. Mateescu B, Vadan R, Negreanu L, Bengus A, Dinu R, Busuioc B, Cotruta B, Diculescu M, Gheorghe C, Gheorghe L. Opportunistic infections in anti-TNF treated IBD patients: Analysis from three tertiary centers in Romania. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P400 144. Vadan R, Gheorghe L, Diculescu M, Iacob R, Bancila I, Cotruta B, Zamfirescu N, Stanel I, Greere M, Mateescu B, Gheorghe C. Endoscopic follow-up of patients with IBD and biological treatment: Achievement and persistence of mucosal healing in patients with clinical remission. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P492 145. Goldis A, Tantau M, Gheorghe L, Gheorghe C, Diculescu M. The prevalence of anemia and iron defficiency in IBD inpatients and outpatients in Romania – an interim analysis on the first 120 patients. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P587 146. Goldis A, Dobru D, Gheorghe L, Gheorghe C, Cijevschi C, Tantau M, Cosntantinescu G, Ratiu I, Lazar D, Iacob R, Diculescu M, on behalf of the IBDPROSPECT Study Group. The features of IBD in young patients – evaluation of a batch of more than 1,000 patients. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P590 147. Gheorghe L, Iacob R, Iacob S, Vadan R, Guinea L, Greere M, Cotruta B, Dobru D, Mihai C, Stefanescu G, Zaharie R, Ilie M, Jinga M, Diculescu M, Gheorghe C, on behalf of the IBDPROSPECT Study Group. IBD in elderly Romanian patients: Epidemiological and phenotypical characteristics. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P620 148. Iacob R, Guinea L, Vadan R, Greere M, Preda C, Dobru D, Cijevschi-Prelipcean C, Tantau A, Goldis A, Ilie M,



Andrei M, Negreanu L, Gheorghe C, Diculescu M, Gheorghe L, on behalf of the IBDPROSPECT Study Group. Extraintestinal manifestations in Romanian IBD patients – evaluation of a cohort of over than 1,000 patients. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P626 149. Gheorghe C, Dimitriu A, Iacob R, Cojocaru M, Lupei C, Vadan R, Dobru D, Trifan A, Tantau M, Goldis A, Constantinescu G, Gologan S, Mateescu B, Gheonea D, Gheorghe L, Diculescu M, on behalf of the IBDPROSPECT Study Group. 9th Congress of ECCO, Bella Center Copenhagen, 20-22 Feb 2014: P630 150. Iacob S, Gheorghe L. Which oligosaccharide to use for minimal hepatic encephalopathy in liver cirrhosis patients – oligofructose enriched-inulin or lactulose? ILC 2014, Londra, iunie 2014 151. Liana Gheorghe, Speranta Iacob, Iulia Simionov, Florin Caruntu, Adriana Motoc, Victoria Arama, Adriana Goldis, Ciprian Brisc. A week 8 stopping model for real-life genotype-1 patients with advanced fibrosis treated with Boceprevir-based triple regimen. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP6 152. A. Lupu, G. Robu, C. Cijevschi-Prelipcean, C. Mihai, R. Iacob, L. Gheorghe, D. Dobru, A. Tantau, A. Goldis, M. Ilie, C. Gheorghe, M. Ciocirlan, R. Vadan Anemia in patients with IBD – analysis results of the national IBD Prospect group during one year The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP21 153. S. Iacob, C. Ester, I. Popescu, L. Gheorghe. Risk factors for death in cirrhotic patients with non-malignant portal vein thrombosis on the waiting list for liver transplantation. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP34 154. R. Iacob, C. Vagu, A. Nastase, S. Iacob, F. Botea, R. Grigorie, D. Hrehoret, V. Herlea, A. Croitoru, S. Dima, L. Gheorghe, C. Gheorghe, I. Popescu. Expression profile of stem/progenitor cells specific genes in hepatocellular carcinoma and potential prognostic significance. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP38 154. L. Gheorghe, S. Iacob, C. Ester, R. Cerban, C. Pietrareanu, D. Tomescu, G. Droc, D. Hrehoret, V. Brasoveanu, I. Popescu. Predictors of short-term post-liver transplant mortality in the Romanian Transplant Program. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP41 155. C. Gheorghe, A. Dimitriu, R. Iacob, M. Cojocaru, R. Vadan, D. Dobru, C. Lupei, A. Trifan, M. Tantau, A. Goldis, G. Constantinescu, S. Gologan, B. Mateescu, D. Gheonea, L. Gheorghe, M. Diculescu. Epidemiological and phenotipic characteristics of IBD patients in Romania – results of a nationwide hospital-based registry. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP45 156. R. Cerban, L. Gheorghe, S. Iacob, G. Smira, C. Pietrareanu, R. Iacob, C. Ester, C. Gheorghe. Clostridium difficile infection, a poor outcome predictor in patients with cirrhosis. A tertiary Romanian liver transplant center perspective. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: OP48 157. A. Goldis, C. Cijevschi, L. Gheorghe, C. Gheorghe, D. Dobru, A. Tantau, R. Iacob, M. Diculescu. Are there any geographical differences in IBD features in Romania ? The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: PP22 158. R. Iacob, L. Guinea, R. Vadan, M. Greere, C. Preda, D. Dobru, C. Cijevschi-Prelipcean, A. Tantau, A. Goldis, M. Ilie, M. Andrei, L. Negreanu, C. Gheorghe, M. Diculescu, L. Gheorghe. Extraintestinal manifestation in Romanian IBD patients – evaluation of a cohort of over than 1,000 patients The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: PP60 159. M. Greere, R. Iacob, R. Vadan, B. Cotruta, M. Diculescu, C. Gheorghe, L. Gheorghe. Frequency and clinical characteristics of fistulizing Crohn’s disease in a Romanian tertiary referral center. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014:



PP62 160. L. Gheorghe, R. Iacob, S. Iacob, R. Vadan, L. Guinea, M. Greere, B. Cotruta, D. Dobru, C. Mihai, G. Stefanescu, R. Zaharie, M. Ilie, M. Jinga, M. Diculescu, C. Gheorghe. IBD in elderly Romanian patients: epidemiological and phenotypical characteristics. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: PP63 161. S. Iacob, M. Greere, L. Gheorghe. Both cholestasis and portal hypertension predicted by liver stiffness, but not by spleen stiffness. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: PP114 162. S. Iacob, R. Iacob, L. Gheorghe. Oligofructose enriched-inulin or lactulose is better for minimal hepatic encephalopathy in liver cirrhosis patients? The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: PP115 163. L. Gheorghe, S. Iacob, C. Pietrareanu, D. Hrehoret, V. Brasoveanu, D. Tomescu, G. Droc, C. Gheorghe, I. Popescu. Improved overall mortality on the Romanian waiting list for liver transplantation. The XXXIVth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Oradea, 11-14 June 2014: PP116 164. Iacob S, Ester C, Iacob R, Gheorghe C, Popescu I, Gheorghe L. Risk factors associated with overall and bleeding-related mortality in patients with portal vein thrombosis on the waiting list for liver transplantation Baveno VI Consensus Workshop on Portal Hypertension, Baveno, Italy 165. Gheorghe L, Iacob S, Ester C, Iacob R, Gheorghe C, Popescu I. Safety and efficacy of anticoagulation therapy for portal/splanchnic vein thrombosis in patients with liver cirrhosis on the waiting list for liver transplantation Baveno VI Consensus Workshop on Portal Hypertension, Baveno, Italy 166. Ispas M, Lupu A, Gheorghe L, Dobru D, Tantau A, Goldis A, Ilie M, … Gheorghe C, et al. Prevalence of malnutrition in patients with inflammatory bowel disease – A Romanian National register-based study 10th Congress of ECCO, Barcelona 18-21 February 2015 167. Preda C, Fulger L, Tieranu C, Ionescu M, Gheorghe L, Gheorghe C, et al. Efficacy, safety, and predictors of response to Adalimumab in Crohn’s disease (CD) – A nationwide cohort study 10th Congress of ECCO, Barcelona 18-21 February 2015 168. Iacob S, Iacob R, Ester C, Popescu I, Gheorghe C, Gheorghe L. Risk factors associated with overall and bleeding-related mortality in patients with portal vein thrombosis on the waiting list for liver transplantation. DDW 2015, Washington 16-19 May 2015 169. Iacob S, Gheorghe L, Tabacelia D, Iacob R, Gheorghe C, Popescu I. New allocation score predicting both pre- and post-transplant survival in the Romanian National Transplant Program DDW 2015, Washington 16-19 May 2015 170. Gheorghe L, Iacob S, Ester C, Iacob R, Popescu I, Gheorghe C. Safety and efficacy of anticoagulation therapy for splanchnic vein thrombosis in patients with liver cirrhosis on the waiting list for liver transplantation DDW 2015, Washington 16-19 May 2015 171. Moraru I, Vadan R, Gheorghe L, Dumbrava M, Becheanu G. Microscopic colitis – are there any predictors? P240 11th ECCO Congress 2016, Amsterdam 172. Dimitriu A, Necula S, Cotruta B, Gheorghe L, Pop CS. Epidemiological characteristics and factors associated with ulcerative proctitis progression. P271 11th ECCO Congress 2016, Amsterdam 173. Cerban R, Iacob S, Croitoru A, Dumitru R, Grasu M, ester C, Gheorghe C, Gheorghe L. Transarterial chemoembolization in hepatocellular carcinoma – a single center experience from Romania. JGLD 2016; 25 (Suppl 2): 163 : IV.148 XXXVIth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Cluj-Napoca. 8-11 iunie 2016 174. Ester C, Iacob S, Lita M, Cerban R, Gheorghe L. Risk factors and impact of AKI in liver cirrhosis – the new ICA-AKI recommendations in clinical practice. JGLD 2016; 25 (Suppl 2): 163 : V.201 XXXVIth National Congress of Gastroenterology, Hepatology and Digestive Endoscopy, Cluj-Napoca. 8-11 iunie 2016 175.Gheorghe L, Iacob MS, Popescu I. 100% Virological response with 3D regimen and significant short-term liver stiffness improvement in patients with recurrent hepatitis C following liver transplantation. Am J Gastroenterol 2016; 111 (Suppl 1): S375: #855



ACG Meeting, 14-21 October 2016, Las Vegas, Nevada, USA 176.Gheorghe L, Iacob MS, Trifan A, Stanciu C, Sirli R, Sporea I, ... Gheorghe C, et al. Dynamic of AFP incirrhotic patients with virological response following 3D therapy and severe necroinflammation at Fibromax. ACG Meeting, 14-21 October 2016, Las Vegas, Nevada, USA 177.Gheorghe L, Trifan A, Iacob MS, Stanciu C, Sirli R, Sporea I, et al...Gheorghe C. 100% virological response and adherence in genotype-1 HCV infected patients with liver cirrhosis treated with 3D regimen in a Romanian real-life cohort. Am J Gastroenterol 2016; 111 (Suppl 1): S375: #898 ACG Meeting, 14-21 October 2016, Las Vegas, Nevada, USA 178. Razvan Iacob, Codruta D. Vagu, Anca Nastase, Speranta Iacob, Florin Botea, Vlad Herlea, Adina E. Croitoru, Simona Dima, Cristian Gheorghe, Irinel Popescu, Michael Ott and Liana Gheorghe. Hepatocyte Reprogramming to a Progenitor-Cell Phenotype Is a Potential Mechanism of Hepatocarcinogenesis - The Role of Reprogramming Factors: OCT4, SOX2 and NANOG. DDW, San Diego, USA, 21-24 May 2016 179. Speranta Iacob, Carmen Ester, Mihaela Lita, Liana Gheorghe. Acute Kidney Injury Severity Predicts Mortality and Response to Terlipressin in Patients With End Stage Liver Disease Awaiting Liver Transplantation. DDW, San Diego, USA, 21-24 May 2016 180. Gheorghe L, Iacob MS, Popescu I. 100% Virological response with 3D regimen and significant short-term liver stiffness improvement in patients with recurrent hepatitis C following liver transplantation ACG, Las Vegas USA, October 2016 181. Gheorghe L, Iacob MS, Trifan A, Stanciu C, Sirli R, Sporea I, ... Gheorghe C, et al. Dynamic of AFP incirrhotic patients with virological response following 3D therapy and severe necroinflammation at Fibromax ACG, Las Vegas USA, October 2016 182. Gheorghe L, Trifan A, Iacob MS, Stanciu C, Sirli R, Sporea I, et al...Gheorghe C. 100% virological response and adherence in genotype-1 HCV infected patients with liver cirrhosis treated with 3D regimen in a Romanian real-life cohort ACG, Las Vegas USA, October 2016 183. Lita M, Iacob S, Iacob R, Ester C, Cerban R, and Gheorghe L. Female predominance, low rate of PSC-IBD phenotype, low rate of dominant strictures, cholangiocarcinoma and need for transplantation in a Romanian prospective cohort of PSC EASL, Barcelona, April 2016 184. Cerban R, Croitoru A, Popescu I, Iacob S, Pietrareanu C, Herlea V, Botea F, Becheanu G, Dumitru R, Gheorghe C, Lupescu I, and Gheorghe L. Management of hepatic epithelioid hemangioendotheloma: A 5-year single-center experience EASL, Barcelona, April 2016 185. Iacob S, Popescu I, Gheorghe L. 100% Virological response with 3D regimen and significant short-term liver stiffness improvement in patients with recurrent hepatitis C following liver transplantation AASLD Annual Meeting, Boston USA, 11-15 November 2016 186. Mihai C, Trifan A, Stanciu C, Gheorghe L, Iacob S, Diculescu M, Cijevschi C. Metabolic syndrome, hepatic steatosis and genotype 1b HCV infection in the era of DAA therapy AASLD Annual Meeting, Boston USA, 11-15 November 2016 187. Trifan A, Singeap AM, Gheorghe L, Curescu M, Cijevschi C, Brisc C, et al. The influence of clinical signoficant portal hypertension (stage Baveno 2) on safety, tolerability, and efficacy of 3D and ribavirin (PrOD+R) in a real-world large cohort of genotype 1b cirrhotic patients AASLD Annual Meeting, Boston USA, 11-15 November 2016 188. Gheorghe L, Iacob S, Iacob R, Gheorghe C. Virological response to ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in 150 patients with mixed cryoglobulinemia and HCV infection AASLD Annual Meeting, Boston USA, 11-15 November 2016 189. Iacob S, Gheorghe L, Trifan A, Stanciu C, Sirli R, Sporea I, et al. Dynamics of AFP in cirrhotic patients with virological response following 3D therapy and severe necro-inflammation at Fibromax AASLD Annual Meeting, Boston USA, 11-15 November 2016 190. Gheorghe L, Trifan A, Iacob S, Stanciu C, Sirli R, Sporea I, et al. 100% virological response and adherence in HCV genotype 1 liver cirrhosis treated with 3D regimen in a Romanian real-life cohort AASLD Annual Meeting, Boston USA, 11-15 November 2016 191. Trifan A, Cijevschi C, Gheorghe L, Curescu M, Brisc C, Bataga S, et al. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, dasabuvir + ribavirin for treatment of HCV genotype 1b compensated cirrhosis in patients aged 65 years or older AASLD Annual Meeting, Boston USA, 11-15 November 2016 192. Liliana Gheorghe, Roxana Vadan, Speranta Iacob, Bianca Stoica, Teodora Manuc, Simona Ichim, Mihaela Barbu, Anca



Dimitriu, Mihaela Lita, Mircea Diculescu, Cristian gheorghe: Dietary habits and nutritional status in patients with liver cirrhosis: Results from a cross-sectional study. (e-poster) EASL Monothematic Conference „Nutrition in Liver Disease”25-26 noiembrie Ljubljana, Slovenia 193. Dimitriu A, Ichim S,Cojocaru M, Gheorghe C, Diculescu M, Iacob R, Gheorghe L. Prevalence and characteristics of Romanian patients with upper GI tract involvement in Crohn’s disease. 12th Congress of ECCO, Barcelona, Spain 15-18 Februarie 2017 194. Speranta Iacob, Irinel Popescu, Liana Gheorghe. Changes of liver stiffness and serum markers of fibrosis in liver transplant recipients with SVR following interferon-free treatment. 18th Congress of the European Society for Organ Transplantation (ESOT), Barcelona, Spania, 24-27 September 2017 195. Pietrareanu C, Iacob S, Gheorghe L, Jorza C. The utility of alcohol screening tests in clinical practice in patients with end stage liver disease awaiting liver transplantation – experience of a tertiary hepatology center. Definitions, therapeutic advances and Clinical Endpoints in Allcoholic Liver Disease and Alcoholic Hepatitis. EASL Monothematic Conference, London, UK, 30 September – 1 October 2017 VI. COMUNICARI ORALE LA MANIFESTARI INTERNATIONALE 1. L. Gheorghe, C. Gheorghe, R. Vadan, C. Croitoru, C. Mihaila, I. Bancila, I. Iova. High calorie high protein diet in cirrhotic patients with hepatic encephalopathy Presidential Session (General Session I) Biennial Meeting of the International Association for the Study of the Liver (IASL) and 37-th Annual Meeting of the European Association for the Study of the Liver (EASL), Madrid, 15 aprilie 2002 2. L. Gheorghe, C. Gheorghe, R. Vadan, C. Toader, I. Simionov. Efficacy of simultaneously administration of terlipressine and human albumin versus terlipressine and plasma expanders for the reversion of type I hepato-renal syndrome in patients on the waiting list for liver transplantation Sesiune: “New trends in the management of ascites” 10th UEGW, Geneva, 23 octombrie 2002 3. L. Gheorghe, C. Gheorghe, R. Vadan, I. Parvulescu. Overlap of autoimmune hepatitis and primary cholestatic liver disease: frequency and predictive factors Session: “Cholestatic liver disease” 10th UEGW, Geneva, 22 octombrie 2002 4. L. Gheorghe. Antiviral therapy peri-liver transplantation Session: “Liver transplantation” 5-th Symposium and Postgraduate Course of the International Association of Surgeons and Gastroenterologists (IASG), 9-11 aprilie 2003 5. S. Iacob, L. Gheorghe, C. Gheorghe, R. Iacob, D. Bucur, A. Croitoru Predictive factors for the development of hepatocellular carcinoma in cirrhotic patients Al 14-lea Congres International Association of Surgeons and Gastroenterologists Zurich, 9-12 septembrie 2004 6. Jean Depamphilis, L. Gheorghe, Adebayo Lawal. Management of Hematologic Issues. NV18210 (Randomized, Multicenter, Double-Blind, Phase IV Study Evaluating the Efficacy and Safety of 360 microg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype I Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kg) Investigators’ Meeting, 18-20 octombrie 2006, St. Julinas, Malta 7. L. Gheorghe. Management of Side Effects during Hepatitis C Antiviral Therapy. 14th International Postgraduate Course of IASGO, 7-9 decembrie 2006, Atena, Grecia 8. Liana Gheorghe. Should we treat mild chronic hepatitis C ? 17th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists, 5-8 septembrie, 2007, Bucuresti, Romania 9. L Gheorghe. Ultrasound elastography for detection of small dysplastic nodules in cirrohotic patients:benefits and limits. 15th Postgraduate course of the IASGO 13-15 decembrie 2007 Atena, Grecia



10. Gheorghe Liana, Iacob Speranta, Iacob Razvan, Becheanu Gabriel, Dumbrava Mona. Real-time elastography – A novel approach to assess liver fibrosis in patients with chronic hepatitis C. 18th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists, October 10, 2008, Istanbul, Turkiye (OP178) 11. Liana Gheorghe. Contrast-enhanced ultrasound (CEUS) – clinical cases presentation. BRACCO CEUS Meeting, 20 februarie 2009, Bucuresti 12. Liana Gheorghe. Contrast-enhanced ultrasound (CEUS) – clinical cases. Euroson School – Contrast enhanced ultrasound, Bucharest, 15 mai 2009 13. Liana Gheorghe. Romanian example of successfully influencing public policy Roche Hepatitis Advisory Board Meeting, Brussels, Belgia iunie 2009 14. Liana Gheorghe, O. Pascu, E. Ceausu, IE Csiki, S. Iacob, F. Caruntu. Access to combined antiviral therapy for hepatitis C in Romania (OP201), UEGW octombrie 2010, Barcelona, Spain 15. G. Smira, C. Gheorghe, Liana Gheorghe, S. Iacob, R. Iacob. Chronic administration of Rifaximin for the maintenance of remission of hepatic encephalopathy (oral presentation), UEGW octombrie 2010, Barcelona, Spain 16. Liana Gheorghe for Adina Croitoru, Doina Hrehoret, M. Croitoru, Iulia Simionov, C. Gheorghe. Epidemiology & surveillance for hepatocellular carcinoma in Romania. PATH Bologna Meeting, februarie 2011 17. Liana Gheorghe. Malnutrition in patients with liver diseases. ROSPEN Al XII-lea Simpozion National de Nutritie Clinica, Poiana Brasov 11-13 nov 2011 18. XXXIInd National Congress of Gastroenterology, Hepatology and Digestive Endoscopy : “Sparchez Lecture”: Liana Gheorghe: Transplant Hepatology in Romania 2012 19. Bayer Oncology Academy: Liana Gheorghe. Current surveillance and management of hepatocellular carcinoma in Romania. Sofia 31 august 2012 20. Romtransplant: Liana Gheorghe, Speranta Iacob, Irinel Popescu. Dynamics of the Romanian waiting list for LT: comparison of two periods with regard to patients characteristics, mortality and risk factors, time to LT and overall waiting time. 27-29 septembrie 2012 21. 5th National Symposium of IBD: Liana Gheorghe. Therapeutic alternatives after failure of anti-TNF treatment. Session: “Difficult-to-treat IBD patients” 20-22 septembrie 2012, Sibiu 22. 1st Postgraduate Course on Pancreatic Diseases. Liana Gheorghe: Treatment of pancreatic exocrine insufficiency. September 2013, Central Military Hospital, Bucharest, Romania 23. 23rd World Congress of the IASGO: Liana Gheorghe. Therapy of HCV Infection Befor Liver Transplantation, 18-21 September 2013, Bucharest, Romania 24. 1st Transylvanian Meeting for Liver Interventions. Liana Gheorghe: Liver Transplantation for Hepatocellular Carcinoma. Cluj-Napoca 21st November 2013 25. Up-to-Date in Hepatology Course “Viral Hepatitis and Liver Cirrhosis – Current Challenges and Future Directions, Liana Gheorghe: Hepatitis delta: an update 2014, Bucharest, 25-26th April 2014 26. Up-to-Date in Hepatology Course “Viral Hepatitis and Liver Cirrhosis – Current Challenges and Future Directions, Liana Gheorghe: Treatment of HCV Infection before and after Liver Transplantation, Bucharest, 25-26th April 2014 27. 2nd Pancreatic Disease Course & 3rd EUS Workshop in Pancreatic Diseases, Liana Gheorghe: Pancreatic exocrine insufficiency: definitions, conditions & diagnosis, September 5-6, 2014 28. 6th Annual Symposium of IBD: Liana Gheorghe. Review of recent clinical trials in IBD. 25th-27th septembrie 2014, Bucharest 29. 6th Annual Symposium of IBD: Liana Gheorghe. When to optimize? Session: Biologics in IBD: When to start, when to optimize, when to stop? 25th-27th septembrie 2014, Bucharest 30. 2nd Transylvanian Meeting for Liver Interventions. Liana Gheorghe: Portal vein thrombosis – in relation with liver transplantation. Cluj-Napoca 9th October 2014 31. 50th International Liver Congress 2015. Liana Gheorghe: Current trends in hepatitis B epidemiology and prevention in CEE. Viena, Austria, 22-26 aprilie 2015 32. 2nd Up-to-Date Hepatology Course Bucharest. Treatment of hepatitis C in special populations, Bucharest, 27th-28th May 2015 33. Bucharest PancreaticFest 2015. Liana Gheorghe: Diagnosing & Treating Pancreatic Exocrine Insufficiency: The Romanian Guideline, Bucuresti 11-12 septembrie 2015 34. 7th Annual IBD Symposium: Liana Gheorghe: Infliximab in ulcerative colitis: can we do more? Cheile Gradistei, 24-26 septembrie 2015 35. 7th Annual IBD Symposium: Liana Gheorghe: Cat de importanta este comunicarea medic-pacient in IBD? Cheile



Gradistei, 24-26 septembrie 2015 36. 7th Annual IBD Symposium: Liana Gheorghe: IBD Treatment at the crossroad: role of gut-selective biologic therapy. Cheile Gradistei, 24-26 septembrie 2015 37. 7th Annual IBD Symposium: Liana Gheorghe: Review of recent clinical trials in IBD. Cheile Gradistei, 24-26 septembrie 2015 38. 3rd Transylvanian Meeting for Liver Interventions. Liana Gheorghe: Renal impairement in cirrhosis. Cluj-Napoca 8th October 2015 39. Al XXXV-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Iasi 11-13 iunie 2015. Curs Pre-Congres Hepatologie. Liana Gheorghe: Bolile colestatice hepatice 40. Al XXXV-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Iasi 11-13 iunie 2015. Liana Gheorghe, Roxana Vadan: Rolul calprotectinei fecale in boala Crohn 41. Al XXXV-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Iasi 11-13 iunie 2015. Liana Gheorghe: AKI si sSindromul hepatorenal – concept, implicatii prognostice, tratament 42. Al XXXV-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Iasi 11-13 iunie 2015. Liana Gheorghe: Cum alegem regimul terapeutic IFN-free la pacientii cu genotip 1? 43. Al XXXVI-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Cluj iunie 2016. Liana Gheorghe: Managementul complex al colagitelor primitive; Masa rotunda „Arta si stiinta in managementul bolilor hepatice in 2016”

44. Al XXXVI-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Cluj iunie 2016. Liana Gheorghe: Îmi puteți recomanda un tratament eficient și sigur?; MASA ROTUNDA „Cum raspundem celor mai frecvente intrebari ale pacientilor cu boala Crohn?”

45. Al XXXVI-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Cluj iunie 2016. Liana Gheorghe: Optimizarea SVR la populatiile/pacientii „dificil-de tratat/vindecat” (ciroza decompensata, hepatita recurenta post-transplant, insuficienta renala, esecul anterior la DAA); MASA ROTUNDA „Hepatita C: o abordare critica a terapiei antivirale orale in 2016” 46. Al XXXVI-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Cluj iunie 2016. Liana Gheorghe: Terapia si monitorizarea nutritionala in afectiunile cronice hepatice; MASA ROTUNDA Nutritie „Practici nutritionale in gastroenterologie” 47. Al XXXVI-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Cluj iunie 2016. Liana Gheorghe: Indicatiile PBH in hepatopatii cronice difuze in 2016; MASA ROTUNDA "Invaziv sau noninvaziv in evaluarea hepatopatiilor cronice 48. Al XXXVI-lea Congres National de Gastroenterologie, Hepatologie si Endoscopie Digestiva” Cluj Napoca iunie 2016. UEG Course: Liana Gheorghe: Hepatitis C Disease Burden and Strategies to Minimize its Consequences in the Future. Assumptions and Outputs for Romania

49. 3rd UpDate on Hepatology Course “Clinical challenges, unmet needs and emerging therapies in liver diseases, Bucharest 28-29 April 2016: Liana Gheorghe: The real-world of HCV infection: From clinical trials to the patient realities 50 4th Transylvanian Meeting for Liver Interventions. Liana Gheorghe: Malnutrition and nutritional support in patients with liver cirrhosis. Cluj-Napoca November, 24, 2016 51. 4rd UpDate on Hepatology Course “Hepatology 2017 – A panoramic view”, Bucharest 28-29 April 2016: Liana



Gheorghe: Hepatocellular carcinoma in patients treated with direct-acting antiviral (DAA) agents 52. 5th Transylvanian Meeting for Liver Interventions. Liana Gheorghe: HCC occurrence & recurrence in patients treated with DAA. Cluj-Napoca September 2017 STUDII CLINICE EFECTUATE CA INVESTIGATOR PRINCIPAL SAU COINVESTIGATOR

1. A phase III randomized, controlled study to evaluate the effects of THYMITAQ treatment of patients with unrezectable hepatocellular carcinoma when compared to Doxorubicin (nr protocol ZX101-3010) - 2001 (Coinvestigator)

2. Healing of patients suffering from gastroesophageal reflux esophagitis grade C-D according to Los Angeles Classification after treatment with pantoprazole-magnesium dehydrate 80mg o.d. in comparison to pantoprazole-sodium sesquihydrate 40mg o.d. over 4 or 8 weeks (nr protocol BY 1023-M3-904) – 2004 (Coinvestigator)

3. An international, multicenter, randomized, parallel group, prospective, double blind, placebo controlled clinical trial evaluating the efficacy and safety of a combination treatment administered over 3 years in patients at risk of experiencing recurrence of colorectal adenomas (Colo CP-01) - 2004-2005 (Coinvestigator)

4. A phase 3, multicenter, randomized, double blind, placebo controlled, parallel arm study of the efficacy and safety of OPC 6535 tablets in the treatment of subjects with active ulcerative colitis (protocol 197-02-218) – 2005 (Coinvestigator)

5. A phase 3, multicenter, randomized, double blind, placebo controlled, parallel arm 52 week dose comparison study of the efficacy and safety of 25mg o.d. and 50 mg o.d. of OPC 6535 oral tablets and 800mg bid of Asacol in the maintenance of remission in subjects with ulcerative colitis (protocol 197-02-220) - 2005-2006 (Coinvestigator)

6. A open label uncontrolled study to assess the response to PegIntron in naive patients in chronic hepatitis B and D coinfection (Schering Plough V-P 04603) - 2005-2006 (Principal investigator)

7. Efficacy and safety of Peginterferon alfa 2a (40kDa) (Pegasys) in patients with HBe Ag positive chronic hepatitis B (Protocol ML 18089) - 2005-2006 (Principal investigator)

8. An open-label multicenter trial evaluating efficacy and safety of Peginterferonalfa 2a (Pegasys) in patients with chronic hepatitis D (CHD) (Protocol ML18788) – 2005-2006 (Principal investigator)

9. Evaluarea ratei de ederenta la pacientii ce primesc terapia combinata cu PegIntron pen (Rebetol) pentru tratamentul hepatitei C – 2005 (Principal investigator)

10. A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the safety and efficacy of a new tablet formulation and dosing regimen balsalazide active ulcerative colitis (BZUC 3004) – 2006 (Principal investigator)

11. A multicenter, open-label trial to evaluate the long-term safety and tolerability of a new balsalazide disodium tablet formulation in patients with ulcerative colitis (BZUC 3005) – 2006 (Principal investigator)

12. Randomized, multicenter, double-blinded, phase IV study evaluating the efficacy (as measured by sustained virological response) and safety of 360µg induction dosing of Pegasys in combination with higher Copegus doses in treatment naïve patients with chronic hepatitis C genotype 1 virus infection of high viral titer and baseline body weight greater than or equal to 85kg (Protocol no NV18210A) (phase III study) (Principal investigator)

13. SR121463B in cirrhotic ascites treatment with normonatremia: a placebo-controlled dose-comparison study (NORMO-CAT) – 2004 (Principal investigator)

14. SR121463B in cirrhotic ascites treatment with hyponatremia: a placebo-controlled dose-comparison study (HYPO-CAT) (No LTS5634) – 2004 (Principal investigator)

15. SR121463B in cirrhotic ascites treatment with hyponatremia: a single-blind, placebo-controlled, long-term treatment study (EXPO-CAT) (No LTS5634) – 2004-2006 (Principal investigator)



16. Satavaptan in the prevention of ascites recurrence: a double-blind, randomized, parallel-group comparison of satavaptan at 5 to 10 mg daily vs placebo in the absence of diuretics in patients with recurrent ascites due to cirrhosis of the liver (SPARe-2) (EFC 6682) (Phase III) (2006-2008) (Principal investigator)

17. Satavaptan cirrhotic ascites treatment study:a double-blind, randomized, parallel-group comparison of treatment with satavaptan at 5 to 10mg daily versus placebo on top of conventional treatment in patients with ascites due to cirrhosis of the liver (EFC 4492) (Phase III) (2006-2008) (Principal investigator)

18. Observational, retrospective cohort study to evaluate pretreatment and on treatment predictors of response to peginterferon alfa and ribavirin therapy in chronic viral Hepatitis C in real life medical practice in Romania (HERO 1) – protocol ML 21909 (2008-2009) (Principal investigator)

19. A phase 3b, Randomized, Double-Blind, Double-Dummy Study Evaluating the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy versus Emtricitabine plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects with Chronic Hepatitis B who are resistant to Lamivudine – GS-US-174-0121 (2008-2013) (Phase III study) (Principal Investigator)

20. Randomized double blind study of Nitazoxanide plus Peginterferon alpha-2a and Ribavirin or Nitazoxanide plus Peginterferon alpha2a without Ribavirin compared to Placebo plus Peginterferon alpha-2a and Ribavirin in treatment naive patients with chronic hepatitis C genotype 1 (2010-present) (Phase III study) (Principal investigator)

21. Observational cohort study for prediction of adverse events in patients with chronic hepatitis C treated with Peginterferon alpha-2a and Ribavirin (MV22255) (2009-present)

22. Prospective observational study on predictors of early on treatment response and sustained virological response in a cohort of treatment naive HCV infected patients treated with pegylated interferons (MV21012) (2009-2012) (Principal investigator)

23. An open study to investigate the effects of chronic viral hepatitis B or C on the pharmacokinetics of cholyl lysyl fluorescein before, during and after standard treatment (NRL 972) 2008-2011(Principal investigator)

24. A phase 3 multicenter, randomized, placebo controlled, double blind study to evaluate the safety and efficacy of Golimumab induction and maintenance therapy administered subcutaneously in subjects with moderately to severely active ulcerative colitis (C0524T16-T17-T18) 2008-2012 (Principal investigator)

25. A phase 3, randomized, placebo controlled, blinded, multicenter study of the induction and maintenance of clinical response and remission by Vedolizumab (MLN0002) in patients with moderate to severe Crohn’s disease (C13007-C13008 2009-2013 (Principal investigator)

26. 9mg budesonide OD vs 3mg budesonide tid in active Crohn’s disease (BUG). 2009-2011 27. A phase II, randomized double blind, parallel- group, placebo controled, 12 week treatment adaptative proof

of principle study of twice daily oral dosing of a novel PDE4 inhibitor (ASP9831) in subjects with non-alcoholic-steatohepatitis (NASH) - 2010 (Principal investigator)

28. A Phase 3b/4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/day MMX® Mesalamine/mesalazine Once Daily in Adult Subjects With Ulcerative Colitis 2011-present (Principal investigator)

29. A phase III multicentre, double blind, double dummy, randomized study to assess the superiority of Zegerid 20mg vs Losec 20mg in the Rapid Relief of Heartburn Associated with GERD as on Demand Therapy 2011 (Principal investigator)

30. A phase III randomize, double blind, dose response, stratified, placebo controlled study evaluating the safety and efficacy of SPD476 versus placebo over 104 weeks in the prevention of recurrence of diverticulitis 2010 (Principal investigator)

31. A phase II, multidose, double blind placebo controlled randomized multicenter study of MDX 1100 (anti CXCL 10 human monoclonal antibody) in subjects with active ulcerative colitis - 2009-2010 (Principal investigator)

32. Double blind, randomized, placebo controlled, multicentre study to investigate the efficacy and safety of GLPG 0634 in subjects with active Crohn’s disease with evidence of mucosal ulceration 2014-2015 (Principal investigator)

33. Studiu deschis, multicentric, care evalueaza eficacitatea si siguranta a doi algoritmi terapeutici la subiectii cu boala Crohn moderata pina la severa (CALM) 2013-2015 (Principal investigator)



34. A phase 2b, multicenter, randomized, double blind, placebo controlled, parallel group, dose response study evaluating the efficacy and safety of JNJ-54781532 in subjects with moderately to severely active ulcerative colitis. 2014-2015 (Principal investigator)

35. A phase III, randomized, double-blind trial to evaluate the efficacy, safety and tolerability of TMC435 vs telaprevir, both in combination with PegIFN alpha 2a and ribavirin in chronic hepatitis C genotype 1 infected subjects who were null or partial responders to prior PegIFN alpha and ribavirin therapy (ATTAIN Study, TMC435HPC3001) -2012-2014 (Principal Investigator)

36. A randomized, open-labeled study to evaluate the efficacy and safety of ABT-450/Ritonavir/ABT-267 and ABT-333 co-adminstred with ribavirin compared to telaprevir co-administred with pegylated interferon α-2a and ribavirin in treatment-experienced adults with chronic hepatitis C genotype-1 virus infection (MALACHITE-II) – 2013 -2015 (Principal Investigator)

37. An International, Multi-Center Study evaluating the correlation of IL28B genotypes with chronic hepatitis C disease characteristics and patient demographics (MV25600) – 2011-2013 (Principal Investigator)

38. Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on the Pegylated Interferon for the Treatment of Chronic Hepatitis C (MV25599) – 2012-2014 (Principal Investigator)

39. An Open-Label, Multicenter Study to evaluate long-term outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 with or without ribavirin (RBV) in adults with genotype 1 chronic hepatitis C virus (HCV) infection (TOPAZ-I) (M14-423) – 2014-2017 (Principal Investigator)

40. A Phase III, Open-Label Clinical Trial to study the efficacy and safety of the combination regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in treatment-naive and PR prior treatment failure subjects with chronic HCV GT1, 4 or 6 infection (MK 5172-077) – 2014-2017 (Principal Investigator)

41. A phase IIb, doble blind, randomized controlled clinical trial to evaluate the efficacy and safety of two Aramchol doses versus placebo in patients with non-alcoholic steatohepatitis (NASH) (Aramchol 005) – 2014-2019 (Principal Investigator)

42. Studiu pentru evaluarea eficacitatii si sigurantei GFT505 administrat o data/zi pentru steatoza hepatica la subiectii cu steatoza hepatica non-alcoolica (GENFIT Clinical Trial Protocol GFT505-212-7) – 2013-2016 (Principal Investigator)

43. An international multicenter prospective observational study to evaluate the epidemiology, humanistic and economic outcomes for chronic hepatitis C (MOSAIC) – 2013 – 2015 (Principal Investigator)

44. Multicenter, open-label early access program of Telaprevir in combination with PegInterferon alfa and ribavirin in genotype 1 chronic hepatitis C subjects with severe fibrosis and compensated cirrhosis (VX-950HEP3002) – 2012-2015 (Principal Investigator)

45. TRICO

informaŢii liliana simona gheorghe personale Ş · curs “actualităţi în patologia...

Documents